0001615774-18-003697.txt : 20180514 0001615774-18-003697.hdr.sgml : 20180514 20180514144052 ACCESSION NUMBER: 0001615774-18-003697 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20180331 FILED AS OF DATE: 20180514 DATE AS OF CHANGE: 20180514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XG SCIENCES INC CENTRAL INDEX KEY: 0001435375 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821] IRS NUMBER: 000000000 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-209131 FILM NUMBER: 18830029 BUSINESS ADDRESS: STREET 1: 3101 GRAND OAK DRIVE STREET 2: SUITE 212 CITY: LANSING STATE: MI ZIP: 48911 BUSINESS PHONE: 517-203-1110 MAIL ADDRESS: STREET 1: 3101 GRAND OAK DRIVE STREET 2: SUITE 212 CITY: LANSING STATE: MI ZIP: 48911 10-Q 1 s110005_10q.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: March 31, 2018

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______to______.

		XG SCIENCES, INC.
		(Exact name of registrant as specified in its charter)

Michigan		333-209131		20-4998896
(State or other jurisdiction of incorporation or organization)		(Commission File No.)		(I.R.S. Employer Identification No.)

3101 Grand Oak Drive

Lansing, MI 48911

(Address of principal executive offices) (zip code)

(517) 703-1110

(Issuer Telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company filer. See definition of “accelerated filer” and “large accelerated filer” in Rule 12b-2 of the Exchange Act (Check one):

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☑
(Do not check if a smaller reporting company)		Emerging growth company	☑

If an emerging growth company, indicate by checkmark if the registrant has not elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☑

Indicate by check mark whether the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act. Yes ☐ No ☒

As of May 14, 2018, there were 2,662,525 shares outstanding of the registrant’s common stock.

XG SCIENCES, INC.

FORM 10-Q

March 31, 2018

INDEX

PART I

ITEM 1.	FINANCIAL STATEMENTS	4

ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	15

ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	26

ITEM 4.	CONTROLS AND PROCEDURES	26

PART II

ITEM 1.	LEGAL PROCEEDINGS	26

ITEM 1A.	RISK FACTORS	26

ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	26

ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	26

ITEM 4.	MINE SAFETY DISCLOSURES	26

ITEM 5.	OTHER INFORMATION	26

ITEM 6.	EXHIBITS	27

SIGNATURES		28

FORWARD-LOOKING STATEMENTS

The information in this Quarterly Report on Form 10-Q contains “forward-looking statements” and information within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) relating to XG Sciences, Inc., a Michigan corporation and its subsidiary, XG Sciences IP, LLC, a Michigan limited liability company (collectively referred to as “we”, “us”, “our”, “XG Sciences”, “XGS”, or the “Company”), which are subject to the “safe harbor” created by those sections. These forward-looking statements include, but are not limited to, statements concerning our strategy, future operations, future financial position, future revenue, projected costs, prospects and plans and objectives of management. The words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties that could cause our actual results, performance or achievements to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the risks set forth on beginning on page 13 under the section entitled “Risk Factors” in our annual report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on April 2, 2018.

XG SCIENCES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

	March 31, 2018			December 31, 2017
ASSETS	(unaudited)
CURRENT ASSETS
Cash	$	2,285,117		$	2,845,798
Accounts receivable, less allowance for doubtful accounts of $40,000 at March 31, 2018 and December 31, 2017		668,040			468,623
Inventories		209,711			171,864
Other current assets		91,588			15,781
Total current assets		3,254,456			3,502,066

PROPERTY, PLANT AND EQUIPMENT, NET		3,266,797			2,601,571

RESTRICTED CASH FOR LETTER OF CREDIT		195,865			195,792

LEASE DEPOSIT		20,156			20,156

INTANGIBLE ASSETS, NET		574,579			571,938

TOTAL ASSETS	$	7,311,853		$	6,891,523
LIABILITIES AND STOCKHOLDERS’ EQUITY

CURRENT LIABILITIES
Accounts payable and other current liabilities	$	1,332,951		$	858,077
Deferred revenue		189			7,298
Current portion of capital lease obligations		91,985			118,553
Total current liabilities		1,425,125			983,928

LONG-TERM LIABILITIES
Long-term portion of capital lease obligations		14,639			15,527
Long term debt		4,869,714			4,794,596
Total long-term liabilities		4,884,353			4,810,123

TOTAL LIABILITIES		6,309,478			5,794,051

STOCKHOLDERS’ EQUITY
Series A convertible preferred stock, 3,000,000 shares authorized, 1,864,956 and 1,857,816 shares issued and outstanding, liquidation value of $22,379,472 and $22,293,792 at March 31, 2018 and December 31, 2017, respectively		22,002,717			21,917,046
Common stock, no par value, 25,000,000 shares authorized, 2,555,275 and 2,353,350 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively		20,741,574			19,116,012
Additional paid-in capital		7,899,722			7,831,958
Accumulated deficit		(49,641,638	)		(47,767,544	)
Total stockholders’ equity		1,002,375			1,097,472

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	7,311,853		$	6,891,523

See notes to unaudited condensed consolidated financial statements

XG SCIENCES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

	For the Three Months Ended March 31,
	2018			2017
REVENUE				(Restated)
Product sales	$	886,337		$	157,700
Grants		—			99,489
Licensing revenue		—			25,000
Total revenues		886,337			282,189

COST OF GOODS SOLD
Direct costs		468,191			116,770
Unallocated manufacturing expenses		746,583			371,150
Total cost of goods sold		1,214,774			487,920

GROSS LOSS		(328,437	)		(205,731	)

OPERATING EXPENSES
Research and development		277,063			263,564
Sales, general and administrative		1,186,679			996,587
Total operating expenses		1,463,742			1,260,151

OPERATING LOSS		(1,792,179	)		(1,465,882	)

OTHER INCOME (EXPENSE)
Interest expense, net		(85,169	)		(59,088	)
Gain from change in fair value of derivative liability – warrants		—			29,171
Government incentives, net		3,253			(24	)
Total other expense		(81,916	)		(29,941	)

NET LOSS	$	(1,874,095	)	$	(1,495,823	)

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING – Basic and diluted		2,454,314			1,920,090
NET LOSS PER SHARE – Basic and diluted	$	(0.76	)	$	(0.78	)

See notes to unaudited condensed consolidated financial statements

XG SCIENCES, INC.

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(unaudited)

	Preferred stock (A)				Common stock					Additional paid-in		Accumulated
	Shares		Amount		Shares		Amount			capital		deficit			Total
Balances, December 31, 2017		1,857,816	$	21,917,046		2,353,350	$	19,116,012		$	7,831,958	$	(47,767,544	)	$	1,097,472
Stock issued for cash		—		—		201,925		1,615,400			—		—			1,615,400
Stock issuance fees and expenses		—		—		—		(9,838	)		—		—			(9,838	)
Preferred stock issued to pay capital lease obligations		7,140		85,671		—		—			—		—			85,671
Stock-based compensation		—		—		—		20,000			67,764		—			87,764
Net loss		—		—		—		—			—		(1,874,095	)		(1,874,095	)

Balances, March 31, 2018		1,864,956	$	22,002,717		2,555,275	$	20,741,574		$	7,899,722	$	(49,641,638	)	$	1,002,375

See notes to unaudited condensed consolidated financial statements

XG SCIENCES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

	For the Three Months Ended March 31,
	2018			2017
				(Restated)
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(1,874,095	)	$	(1,495,823	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		209,131			214,770
Amortization of intangible assets		12,934			10,590
Stock-based compensation expense		87,764			88,370
Non-cash interest expense		85,973			59,480
Non-cash equipment rent expense		53,082			—
Gain from change in fair value of derivative liability – warrants		—			(29,171	)
Changes in current assets and liabilities:
Accounts receivable		(199,417	)		14,680
Inventory		(37,847	)		8,229
Other current and non-current assets		(75,881	)		103,558
Accounts payable and other liabilities		467,765			17,576
NET CASH USED IN OPERATING ACTIVITIES		(1,270,591	)		(1,007,741	)

CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment		(874,357	)		(203,664	)
Purchases of intangible assets		(15,574	)		(37,769	)
NET CASH USED IN INVESTING ACTIVITIES		(889,931	)		(241,433	)

CASH FLOWS FROM FINANCING ACTIVITIES
Repayments of capital lease obligations		(5,721	)		(4,875	)
Proceeds from issuance of common stock		1,615,400			771,800
Common stock issuance fees and expenses		(9,838	)		(154,413	)
NET CASH PROVIDED BY FINANCING ACTIVITIES		1,599,841			612,512

NET DECREASE IN CASH AND CASH EQUIVALENTS		(560,681	)		(636,662	)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD		2,845,798			1,785,343

CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	2,285,117		$	1,148,681

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	$	220		$	—

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING:
Value of preferred stock issued for AAOF capital lease obligations	$	85,671		$	85,672
Reclassification of derivative liability warrants to equity – ASU 2017-11 (see note 2)	$	—		$	125,481

See notes to unaudited condensed consolidated financial statements

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2018 AND 2017

NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION

XG Sciences, Inc., a Michigan company located in Lansing, Michigan and its subsidiary, XG Sciences IP, LLC (collectively referred to as “we”, “us”, “our”, or the “Company”) manufactures graphene nanoplatelets made from graphite, using two proprietary manufacturing processes to split natural flakes of crystalline graphite into very small and thin particles, which we sell as xGnP^® graphene nanoplatelets. We sell our nanoparticles in the form of bulk powders or dispersions to other companies for use as additives to make composite and other materials with specially engineered characteristics. We also manufacture and sell integrated, value-added products containing these graphene nanoplatelets such as greases, composites, thin sheets, inks and coating formulations that we sell to other companies. Additionally, we license our technology to other companies in exchange for royalties and other fees.

Basis of Presentation

The accompanying interim condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and the instructions to Form 10-Q and do not include all of the information and footnotes required by GAAP for complete financial statements. All intercompany transactions have been eliminated in consolidation.

Certain information and footnote disclosures normally included in our annual audited consolidated financial statements and accompanying notes have been condensed or omitted in these interim condensed consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2017, as filed with the Securities and Exchange Commission (“SEC”) on Form 10-K on April 2, 2018.

The results of operations presented in this quarterly report are not necessarily indicative of the results of operations that may be expected for any future periods. In the opinion of management, these unaudited condensed consolidated financial statements include all adjustments and accruals, consisting only of normal recurring adjustments that are necessary for a fair statement of the results of all interim periods reported herein.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Liquidity

We have historically incurred losses from operations and we may continue to generate negative cash flows as we implement our business plan. Our condensed consolidated financial statements are prepared using US GAAP as applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.

We filed a Registration Statement on Form S-1 (File No. 333-209131) with the SEC on April 11, 2016 which was declared effective by the SEC on April 13, 2016 (as amended, the “Registration Statement”). The Registration Statement registered up to 3,000,000 shares of common stock at a fixed price of $8.00 per share to the general public in a self-underwritten offering (the “Offering” or our “IPO”). Post-Effective Amendment No. 1 to the Registration Statement was declared effective August 26, 2016, Post-Effective Amendment No. 2 was declared effective August 31, 2016, Post-Effective Amendment No. 3 was declared effective January 17, 2017, and Post-Effective Amendments No. 4 and No. 5 were dated April 12, 2017. Post-Effective Amendment No. 5 was declared effective April 14, 2017. Although we are currently selling shares of our common stock in our IPO pursuant to our Registration Statement, we have not yet listed the company for trading on any exchanges.

In December 2016, we entered into a draw loan note and agreement (the “Dow Facility”) with The Dow Chemical Company (“Dow”) to provide up to $10 million of secured debt financing at an interest rate of 5% per year, drawable at our request under certain conditions. As of May 14, 2018, we had drawn $5.0 million under the Dow Facility. The remaining $5 million will become available to us once we have raised $10 million of equity capital after October 31, 2016. As of May 14, 2018, we have sold 1,276,007 shares of common stock pursuant to our IPO at a price of $8.00 per share for gross proceeds of $10,208,056. However, only $7,007,024 of this amount has been raised during the measurement period beginning November 1, 2016. Thus, we still need to raise $2,992,976 of additional equity capital prior to the remaining $5.0 million under the Dow Facility becoming available to us.

As of May 14, 2018, we had cash on hand of $1,660,600. We believe our cash from increasing commercial sales activity and various financing sources will fund our operations for at least the next 12 months. We intend that the primary means for raising funds will be through our IPO and the additional $5 million of proceeds from the Dow Facility that becomes available to us after we have raised another $3 million of equity capital as noted above; however, we can make no assurances that we will raise such equity capital and be able to access the additional $5 million under the Dow Facility. Taking into account our current cash position as noted above, an additional $3 million in proceeds from our IPO, which would allow us to draw up to $5 million from the Dow Facility, we believe that we can fund our operations including planned capital expenditures for at least the next 12 months. In addition, two of our shareholders have committed to provide up to $4.5 million in funding for the twelve-month period ended March 31, 2019 to the extent the Company is unable to raise such funds from other third parties.

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2018 AND 2017

In the event we are unable to fund our operations from existing cash on hand, operating cash flows, additional borrowings or raising equity capital, we may be forced to reduce our expenses, slow down our growth rate, or discontinue operations. Our condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

Use of Estimates

The preparation of our condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, together with amounts disclosed in the related notes to the financial statements. Actual results and outcomes may differ from our estimates, judgments and assumptions. Significant estimates, judgments and assumptions used in these condensed consolidated financial statements include, but are not limited to, those related to revenue, accounts receivable and related allowances, contingencies, useful lives and recovery of long-term assets, including intangible assets, income taxes, and the fair value of stock-based compensation. These estimates, judgments, and assumptions are reviewed periodically and the effects of material revisions in estimates are reflected in the financial statements prospectively from the date of the change in estimate.

Inventory

Inventory consists of raw materials, work-in-process and finished goods, all of which are stated at the lower of cost or market. Cost is determined on a first in, first out basis.

The following amounts were included in inventory at the end of the period:

	March 31,		December 31,
	2018		2017
Raw materials	$	79,581	$	39,841
Finished goods		130,130		132,023
Total	$	209,711	$	171,864

Derivative Financial Instruments

We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. The terms of convertible preferred stock and convertible notes that we issue are reviewed to determine whether or not they contain embedded derivative instruments that are required by ASC 815: “Derivatives and Hedging” to be accounted for separately from the host contract and recorded at fair value. In addition, freestanding warrants are also reviewed to determine if they achieve equity classification. Certain stock warrants that we issued did not meet the conditions for equity classification at inception and were classified as derivative instrument liabilities measured at fair value.

In July 2017, the FASB issued Accounting Standards Update No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities From Equity (Topic 480), Derivatives and Hedging (Topic 815) (“ASU 2017-11”). This update changes the classification analysis of certain equity-linked financial instruments with down-round features. We elected to early adopt ASU 2017-11 at September 30, 2017 by applying the standard retrospectively to outstanding financial instruments with a down round feature by means of a cumulative-effect adjustment to the Company’s beginning accumulated deficit as of January 1, 2017. There were 972,720, warrants indexed to Series A Preferred Stock which were originally recorded as derivative liabilities because of their anti-dilution features. We chose to early adopt ASU 2017-11 because it permitted these warrants to be recorded as equity rather than derivative liabilities. The impact to the financial statements for the three months ended March 31, 2017 is as follows:

	For three months ended March 31, 2017
	As previously			As
	reported			Adjusted
Operating loss	$	(1,465,882	)	$	(1,465,882	)

Other income (expense):
Incentive refund and interest income		368			368
Interest expense, net		(59,480	)		(59,480	)
Gain from change in fair value of derivative warrants		154,652			29,171
Total other income (expense)		95,540			(29,941	)

Net loss	$	(1,370,342	)	$	(1,495,823	)

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2018 AND 2017

Fair Value Measurements

The Company utilizes a valuation hierarchy that prioritizes fair value measurements based on the types of inputs used for the various valuation techniques related to its financial assets and financial liabilities in accordance to Accounting Standards Codification (“ASC”) Topic 820 Fair Value Measurements and Disclosures.

For financial instruments such as cash, accounts payable and other current liabilities, the Company considers the recorded value of such financial instruments approximate to the current fair value because of their short-term nature.

Recent Accounting Pronouncements

ASU No. 2014-09 (ASC 606), Revenue from Contracts with Customers became effective for us beginning with the first quarter of 2018, and we adopted the new accounting standard using the modified retrospective transition approach. The modified retrospective transition approach recognized any changes from the beginning of the year of initial application through retained earnings with no restatement of comparative periods. We will record revenue under ASC 606 at a single point in time, when control is transferred to the customer, which is consistent with past practice. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure under the new standard. Based on the results of the evaluation, we have determined that the adoption of the new standard presents no material impact on our consolidated financial statements. Application of the transition requirements of the new standard did not have a material impact on opening retained earnings.

NOTE 3 — WARRANTS AND FINANCING AGREEMENTS

Dow Facility

In December 2016, we entered into the Dow Facility which provides us with up to $10 million of secured debt financing at an interest rate of 5% per year, drawable at our request under certain conditions. We received $2 million at closing and an additional $1 million on July 18, 2017, September 22, 2017 and December 4, 2017, respectively. An additional $5 million becomes available once we have raised $10 million of equity capital after October 31, 2016; however, we can make no assurances that we will raise such equity capital and be able to access the additional $5 million under the Dow Facility. As of May 14, 2018, we have sold 1,276,007 shares of common stock pursuant to our IPO at a price of $8.00 per share for gross proceeds of $10,208,056. However, only $7,007,024 of this amount has been raised during the measurement period beginning November 1, 2016. Thus, we still need to raise $2,992,976 of equity capital prior to the remaining $5.0 million under the Dow Facility becoming available to us.

The Dow Facility is senior to most of our other debt and is secured by all of our assets (Dow is subordinate only to the capital leases with Aspen Advanced Opportunity Fund, LP (“AAOF”). The loan matures on December 1, 2021 (subject to certain mandatory prepayments based on our equity financing activities). Interest is payable beginning January 1, 2017 although we may elect to capitalize interest through January 1, 2019. Dow received warrant coverage of one share of common stock for each $40 in loans received by us, equating to 20% warrant coverage, with an exercise price of $8.00 per share for the warrants issued at closing of the initial $2 million draw. After the initial closing, the strike price of future warrants issued is subject to adjustment if we sell shares of common stock at a lower price. As of March 31, 2018, we had issued 125,000 warrants to Dow, which are exercisable on or before the expiration date of December 1, 2023.

The aforementioned warrants meet the criteria for classification within stockholders’ equity. Proceeds were allocated between the debt and the warrants at their relative fair value. During the fiscal year ended December 31, 2017, we recognized amortization expense of $161,702, and the resulting carrying value of the Dow Facility on our balance sheet as of December 31, 2017 was $4,794,596. During the three months ended March 31, 2018, we recognized amortization expense of $75,118, and the resulting carrying value of the Dow Facility on our balance sheet as of March 31, 2018 was $4,869,714.

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2018 AND 2017

NOTE 4 – STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS

The following table summarizes the warrants (including the warrants previously accounted for as derivatives) outstanding at March 31, 2018, which are accounted for as equity instruments, all of which are exercisable:

Date Issued	Expiration Date	Indexed Stock	Exercise Price		Number of Warrants

07/01/2009	07/01/2019	Common	$	8.00		6,000
10/08/2012	10/08/2027	Common	$	12.00		5,000
01/15/2014 – 12/31/2014	01/15/2024	Series A Convertible Preferred	$	6.40		972,720
04/30/2015- 05/26/2015	04/30/2022	Common	$	16.00		218,334
06/30/2015	06/30/2022	Common	$	16.00		6,563
12/31/2015	12/31/2020	Common	$	8.00		20,625
03/31/2016	03/31/2021	Common	$	10.00		10,600
04/30/2016	04/30/2021	Common	$	10.00		895
12/14/2016	12/01/2023	Common	$	8.00		50,000
07/18/2017	12/01/2023	Common	$	8.00		25,000
09/22/2017	12/01/2023	Common	$	8.00		25,000
12/04/2017	12/01/2023	Common	$	8.00		25,000
						1,365,737

The warrants indexed to Series A Convertible Preferred Stock are currently exercisable and are exchangeable into 1.875 shares of common stock.

NOTE 5 — STOCKHOLDERS’ EQUITY (DEFICIT)

Common Stock

The Company is authorized to issue 25,000,000 shares of common stock, no par value per share of which 2,555,275 and 2,353,350 shares were issued and outstanding as of March 31, 2018 and December 31, 2017, respectively.

During the three months ended March 31, 2018, the Company issued 201,925 shares of common stock pursuant to the Offering. As of May 14, 2018, the Company has sold 1,276,007 shares of common stock in its IPO at a price of $8.00 per share for gross proceeds of $10,208,056.

Series A Convertible Preferred Stock

The Company is authorized to issue up to 3,000,000 shares of Series A Convertible Preferred Stock (the “Series A Preferred”). Each share of the Series A Preferred, which has a liquidation preference of $12.00 per share, is convertible at any time, at the option of the holder, into one share of Common Stock at the lower of: (a) $12.00 per share, or (b) 80% of the price at which the Company sells any equity or equity-linked securities in the future. The Series A Preferred also contains typical anti-dilution provisions that provide for adjustment of the conversion price to reflect stock splits, stock dividends, or similar events. The Series A Preferred is subject to mandatory conversion into Common Stock upon the listing of the Company’s common stock on a Qualified National Exchange. However, the Series A Preferred is not subject to the mandatory conversion until all outstanding convertible securities are also converted into common stock. The Series A Preferred ranks senior to all other equity or equity equivalent securities of the Company other than those securities which are explicitly senior or pari passu in rights and liquidation preference to the Series A Preferred and pari passu with the Company’s Series B Preferred Stock.

The Company issued 1,456,126 shares of Series A Preferred in connection with the conversion of certain convertible notes on December 31, 2015.

In December 2015, the conversion price of the Series A Preferred was reduced from $12.00 to $6.40 (80% of $8.00), and thus, each share of Series A Preferred Stock is convertible into 1.875 shares of common stock.

As of March 31, 2018, and December 31, 2017, the Company had 1,864,956 and 1,857,816 shares of Series A Preferred Stock issued and outstanding, respectively.

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2018 AND 2017

During the three months ended March 31, 2018, the Company issued 7,140 shares of Series A Preferred to AAOF as payment under the terms of their Master Leasing Agreement.

Series B Convertible Preferred Stock

As of March 31, 2018, and December 31, 2017, 1,500,000 shares have been designated as Series B Convertible Preferred Stock (“Series B Preferred”), of which no shares were issued and outstanding. Each share of the Series B Preferred, which has a liquidation preference of $16.00 per share, is convertible at any time, at the option of the holder, into one share of common stock at $16.00 per share. The Series B Preferred also contains typical anti-dilution provisions that provide for adjustment of the conversion price to reflect stock splits, stock dividends, or similar events. Each share of Series B Preferred is subject to mandatory conversion into common stock at the then-effective Series B conversion rate upon the public listing by the Company of its common stock on a Qualified National Exchange. However, the Series B Preferred is not subject to the mandatory conversion until all outstanding convertible securities are also converted into common stock. The Series B Preferred ranks senior to all other equity or equity equivalent securities of the Company other than those securities which are explicitly senior or pari passu in rights and liquidation preference to the Series B Preferred and pari passu with the Company’s Series A Preferred.

NOTE 6 – EQUITY INCENTIVE PLAN

We previously established the 2007 Stock Option Plan (the “2007 Plan”), which was scheduled to expire on October 30, 2017 and under which we granted key employees and directors options to purchase shares of our common stock at not less than fair market value as of the grant date. On May 4, 2017, the Board approved the 2017 Equity Incentive Plan (the “2017 Plan”) to replace the 2007 Plan, which became effective upon the approval of the stockholders holding a majority of the voting power in the Company on July 18, 2017. The 2017 Plan replaced the 2007 Plan and authorizes us to grant awards (stock options and restricted stock) up to a maximum of 1,200,000 shares of our common stock.

On July 24, 2017, certain stock options from the 2007 Plan were cancelled and replacement stock options were awarded. The replacement stock option awards have an exercise price of $8.00 per share and a seven-year term. Fifty percent of such awards vested on the date of grant with the remaining vesting over a 4-year period, subject to certain other terms. Each option holder received options equal to 150% of the number of cancelled stock options.

On August 10, 2017, the Company granted stock options and restricted stock to each of its Board members as part of its Board compensation package. Each of the 4 independent Board members received 2,500 stock options and 2,500 shares of restricted stock for Board services. The options were granted at a price of $8.00 per share and had an aggregate grant date fair value of $26,120. The options vest ratably over a four-year period beginning on the one-year anniversary. The restricted stock issued to the Board members has an aggregate fair value of $80,000 and vest ratably in arrears over four quarters on the last day of each fiscal quarter following the grant date. As of March 31, 2018, 7,500 shares of restricted stock had vested, resulting in total compensation expense of $60,000.

A summary of the stock option activity for the three months ended March 31, 2018 is as follows:


			Weighted
	Number		Average
	Of		Exercise
	Options		Price

Options outstanding at December 31, 2017		677,125	$	8.00
Changes during the period:
Expired		—		—
New Options Granted – at market price		10,000		8.00
Exercised		—		—

Options outstanding at March 31, 2018		687,125	$	8.00

Options exercisable at March 31, 2018		337,158	$	8.00

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2018 AND 2017

All options granted thus far under the 2017 Plan have an exercise price of $8.00 per share and vesting of the options ranges from immediate to 20% per year, with most options vesting on a straight-line basis over a four-year period from the date of grant. The options expire in seven years from the date of grant.

During the three months ended March 31, 2018, the Company granted 10,000 employee stock options with an aggregate grant date fair value of $28,755. The fair value of the options granted was estimated on the date of grant using the Black Scholes option-pricing model using the following assumptions: Stock price: $8.00, Exercise Price: $8.00, Expected Term: 4.75, Volatility: 37.34%, Risk free rate: 2.65%, Dividend rate: 0%. As of March 31, 2018, 687,125 stock options and 10,000 shares of restricted stock awards were outstanding under our 2017 Plan.

Stock-based compensation expense was $87,764 and $88,370 for the three months ended March 31, 2018 and 2017, respectively. As of March 31, 2018 there was approximately $895,00 in unrecognized compensation cost related to the options granted under the 2017 plan.

NOTE 7 – CAPITAL LEASES

As of March 31, 2018, and December 31, 2017, we have capital lease obligations as follows:

	March 31, 2018			December 31, 2017

Capital lease obligations	$	114,970		$	149,120
Unamortized warrant discount		(8,346	)		(15,040	)
Net obligations		106,624			134,080
Short-term portion of obligations		(91,985	)		(118,553	)
Long-term portion of obligations	$	14,639		$	15,527

NOTE 8 — Customer, Supplier, country, and Product Concentrations

Grants and Licensing Revenue Concentration

There was no licensing or grant revenue to report during the first quarter of 2018. Two grantors accounted for 94% and 6% respectively of total grant revenue reported during the first quarter of 2017. The company’s licensing revenue in the first quarter of 2017 came from one licensor.

Product Concentration

During the first quarter of 2018 and 2017, we had concentrations of product revenue from only one product that was greater than 10% of total product revenues. Revenue from one of the Company’s graphene nanoplatelets materials, Grade C 500 m²/g, was 83% as of March 31, 2018 and 29% as of March 31, 2017. We attempt to minimize the risk associated with product concentrations by continuing to develop new products to add to our portfolio.

Customer Concentration

During the first quarter of 2018, we had one customer whose purchases accounted for 83% of total product revenues. During the first quarter of 2017 we had two customers that represented 29% and 22 % of total product revenues. At March 31, 2018 and 2017, there were two customers who each had an accounts receivable balance greater than 10% of our total outstanding receivable balance.

Country Concentration

We sell our products on a worldwide basis. Revenue derived from customers outside of the U.S. during the first quarter of 2018 was 3% as compared with 40% during the first quarter of 2017. All of these sales are denominated in U.S. dollars.

As of March 31, 2018, there were no foreign countries with greater than 10% of product revenue. During the quarter ended March 31, 2017, two countries, the United Kingdom and South Korea accounted for approximately 24% and 16%, respectively, of total product revenue.

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2018 AND 2017

Suppliers

We buy raw materials used in manufacturing from several sources. These materials are available from a large number of sources. A change in suppliers has no material effect on the Company’s operations. We did not have purchases from any suppliers that were greater than 10% of total purchases during the quarters ended March 31, 2018 and 2017.

NOTE 9 - RELATED PARTY TRANSACTIONS

We have a licensing agreement for exclusive use of patents and pending patents with Michigan State University (“MSU”), a shareholder of the Company via the MSU Foundation. We incurred $12,500 of licensing expense in each of the three month periods ended March 31, 2018 and 2017.

We have also entered into product licensing agreements with certain other shareholders. No royalty revenue or expenses have been recognized related to these agreements during the three months ended March 31, 2018. For the three months ended March 31, 2017, $25,000 of royalty revenue was recorded from POSCO, a shareholder.

During each of the three months ended March 31, 2018 and 2017 we issued 7,140 shares of Series A Preferred Stock to AAOF as payment for lease financing obligations under the terms of the Master Lease Agreement, dated March 18, 2013.

NOTE 10 – SUBSEQUENT EVENTS

During the period from April 1 through May 14, 2018, we received common stock proceeds of $858,000 for the sale of 107,250 shares of common stock in our IPO.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

In this Quarterly Report on Form 10-Q, unless otherwise indicated, the words “we”, “us”, “our”, “XG”, “XGS”, “XG Sciences” or the “Company” refer to XG Sciences, Inc. and its wholly owned subsidiary, XG Sciences IP, LLC, a Michigan limited liability company.

Introduction

The following discussion and analysis should be read in conjunction with the unaudited condensed consolidated financial statements, and the notes thereto included herein. The information contained below includes statements of the Company’s or management’s beliefs, expectations, hopes, goals and plans that, if not historical, are forward-looking statements subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. For a discussion on forward-looking statements, see the information set forth in the introductory note to this quarterly report on Form 10-Q under the caption “Forward-Looking Statements”, which information is incorporated herein by reference.

Overview of our Business

XG Sciences was formed in May 2006 for the purpose of commercializing certain technology to produce graphene nanoplatelets. First isolated and characterized in 2004, graphene is a single layer of carbon atoms configured in an atomic-scale honeycomb lattice. Among many noted properties, monolayer graphene is harder than diamonds, lighter than steel but significantly stronger, and conducts electricity better than copper. Graphene nanoplatelets are particles consisting of multiple layers of graphene. Graphene nanoplatelets have unique capabilities for energy storage, thermal conductivity, electrical conductivity, barrier properties, lubricity and the ability to impart physical property improvements when incorporated into plastics or other matrices.

We believe the unique properties of graphene and graphene nanoplatelets will enable numerous new product applications and the market for such products will quickly grow to be a significant market opportunity. Our business model is to design, manufacture and sell advanced materials we call xGnP^® graphene nanoplatelets and value-added products incorporating xGnP^® nanoplatelets. We currently have hundreds of customers trialing our products for numerous applications, including, but not limited to lithium ion batteries, lead acid batteries, thermally conductive adhesives, composites, thermal transfer fluids, thermal management and heat transfer, inks and coatings, printed electronics, construction materials, cement, and military uses. We believe our proprietary processes have enabled us to be a low-cost producer of high quality, graphene nanoplatelets and that we are well positioned to address a wide range of end-use applications.

Our Customers

We sell products to customers around the world and have sold materials to over 1,000 customers in 47 countries since 2008. Some of these customers are research organizations and some are commercial organizations. Our customers have included well-known automotive and OEM suppliers around the world (Ford, Johnson Controls, Magna, Honda Engineering), global-scale lithium ion battery manufacturers in the U.S., South Korea and China (Samsung SDI, LG Chemical, Lishen, A123) and diverse specialty material companies (3M, BASF, Henkel, Dow Chemical, DuPont), as well as leading research centers such as Lawrence Livermore National Laboratory and Oakridge National Laboratory. We have also licensed some of our base manufacturing technology to other companies, and we consider technology licensing a component of our business model. Our licensees include POSCO, the fourth largest steel manufacturer in the world by volume of output, and Cabot Corporation (“Cabot”), a leading global specialty chemicals and performance materials company. These licensees further extend our technology through their customer networks. Ultimately, we believe we will benefit in terms of royalties on sales of xGnP^® nanoplatelets produced and sold by our licensees. As can be seen in the below bar chart, the cumulative number of customers has steadily grown over the last ten years.

Cumulative Customers, By Year

We believe average order size is an indicator of commercial traction. The majority of our customers are still ordering in smaller quantities consistent with their development and engineering qualification work. As can be seen in the chart below, our quarterly average order size was relatively modest until 2017, when a number of customers reached commercial status with different product applications. These data represent orders shipped in the respective quarter and exclude no charge orders targeted mainly for R&D purposes. The data show that the average order size has increased steadily over the last two years, and we believe that it will continue to increase through 2018 as more customers commercialize products using our materials. As a result of this increasing order size, in 2017 our customer shipments increased by over 600% to almost 18 metric tons of products from the 2.5 metric tons shipped in 2016. In the first quarter of 2018, we saw an incremental increase in the average order size to $15,827 from $14,541 in the fourth quarter of 2017. Also, in the first quarter of 2018, we shipped products containing over 10 metric tons of graphene nanoplatelets, on a dry powder basis, up from just over 9 metric tons in the fourth quarter of 2017, on a similar basis.

Average Order Size of Fulfilled Orders

Our Products

Bulk Materials. We target our xGnP^® nanoplatelets for use in a wide range of large and growing end-use markets. Our proprietary manufacturing processes allow us to produce nanoplatelets with varying performance characteristics that can be tuned to specific end-use applications based on customer requirements. We currently offer four commercial “grades” of bulk materials, each of which is available in various particle sizes and thickness, which allows for surface areas ranging from 50 to 800 square meters per gram of material depending on the product. Other grades may be made available, depending on the needs for specific applications. In addition, we sell our xGnP^® graphene nanoplatelets in the form of pre-dispersed mixtures with water, alcohol, or other organic solvents and resins. In addition to selling bulk graphene nanoplatelets, we also offer the following integrated, value-added products that contain our graphene nanoplatelets in various forms:

Composites. These consist of compositions of specially designed xGnP^® graphene nanoplatelets formulated in pre-dispersed mixtures that can be easily dispersed in various polymers. Our integrated composites portfolio includes pre-compounded resins derived from a range of thermoplastics as well as mother batches of resins and xGnP^® nanoplatelets and their combination with resins and fibers for use in various end-use applications that may include industrial, automotive and sporting goods and which have demonstrated efficacy in standard injection molding, compression molding, blow molding and 3-D processes, to name but a few. In addition, we offer various bulk materials with demonstrated efficacy in plastic composites to impart improved physical performance to such matrices, which may be supplied as dry powders or as aqueous or solvent-based dispersions or cakes. We have also targeted use of our graphene nanoplatelets as an additive in cement mixtures, which we believe results in improved barrier resistance, durability, toughness and corrosion protection. Our GNP^®Concrete Additive promotes the formation of more uniform and smaller grain structure in cement. This fine-grain and uniform structure gives the concrete improvements in flexural and compressive strength. In addition, the embedded graphene nanoplatelets will stop cracks from forming and retard crack propagation, should any cracks form – the combination of which will improve lifetime and durability of cement.

Energy Storage Materials. These consist of specialty advanced materials that have been formulated for specific applications in the energy storage segment. Chief among these is our proprietary, specially formulated silicon-graphene composite material (also referred to as “SiG” or “XG SiG^®”) for use in lithium-ion battery anodes. XG SiG^® targets the never-ending need for higher battery capacity and longer life. In several customer trials, our SiG material has demonstrated the potential to increase battery energy storage capacity by 3-5x what is currently available with conventional lithium ion batteries today. Additionally, we offer various bulk materials for use as conductive additives for cathodes and anodes in lithium-ion batteries, as an additive to anode slurries for lead-carbon batteries, as a component in coatings for current collectors in lithium-ion batteries and we are investigating the use of our materials as part of other battery components.

Inks and Coatings. These consist of specially-formulated dispersions of xGnP^®together with solvents, binders, and other additives to make electrically or thermally conductive products designed for printing or coating and which are showing promise in diverse customer applications such as advanced packaging, electrostatic dissipation and thermal management. We also offer a set of standardized ink formulations suitable for printing. These inks offer the capability to print electrical circuits or antennas and may be suitable for other electrical or thermal applications. All of these formulations can be customized for specific customer requirements.

Thermal Management Materials. These consist mainly of two types of products, our XG Leaf^® sheet products and various thermal interface materials (“TIM”) in the form of custom greases or pastes. XG Leaf^® is a family of sheet products ideally suited for use in thermal management in portable electronics, which may include cell phones, tablets and notebook PC’s. As these devices continue to adopt faster electronics, higher data management capabilities, brighter displays with ever increasing definition, they generate more and more heat. Managing that heat is a key requirement for the portable electronics market and our XG Leaf^® product line is well suited to address the need. These sheets are made using special formulations of xGnP^® graphene nanoplatelets as precursors, along with other materials for specific applications. There are several different types of XG Leaf^® available in various thicknesses, depending on the end-use requirements for thermal conductivity, electrical conductivity, or resistive heating. Our custom XG TIM^® greases and pastes are also designed to be used in various high temperature environments. Additionally, we offer various bulk materials for use as active components in liquids, coatings and plastic composites to impart improved thermal management performance to such matrices.

Our Focus Areas

We believe we are a “platform play” in advanced materials, because our proprietary processes allow us to produce varying grades of graphene nanoplatelets that can be mapped to a variety of applications in many market segments. However, we are prioritizing our efforts in specific areas and with specific customers that we believe represent opportunities for either relatively near-term revenue or especially large and attractive markets. At this time, we are focused on three high priority areas: Composites, Energy Storage, and more broadly, Thermal Management. The following table shows examples of the types of applications we are pursuing, the expecting timing of revenue and the addressable market size of selected market opportunities.

XGS Market/Application Focus Areas & 2018 Market Size

(1)

Avicenne Energy, “The Worldwide Rechargeable Battery Market 2014 - 2025”, 24th Edition - V3, July 2015.

(2)

Avicenne Energy, The Battery Show; Novi, MI; September, 2017.

(3)

Avicenne Energy, The Battery Show; Novi, MI; September, 2017. & Internal Estimates.

(4)

ArcActive via Nanalyze, April 3, 2015.

(5)

ArcActive via Nanalyze, April 3, 2015 & Internal Estimates.

(6)

Future Markets Insights, “Consumer Electronics Market: Global Industry Analysis and opportunity Assessment 2015 – 2020”, May 8, 2015.

(7)

Prismark, “Market Assessment: Thin Carbon-Based Heat Spreaders”, August 2014.

(8)

Reporterlink.com, “Semiconductor & IC Packaging Materials Market…”, May 2014.

(9)

Prismark, 2015.

(10)

Grand View Research, “Global Plastics Market Analysis…”, August 2014.

(11)

From (10) and internal estimates: 2018 = 305 million tons of plastic, if 10% of the market adopted xGnP to enhance their properties, and at only 1% by weight as an additive, then in 2018 305,000 tons or 305,000,000 kilos of xGnP would be required. At $30 a Kg - the value is $9.1 Bn per year.

Commercialization Process

Because graphene is a new material, most of our customers are still developing applications that use our products. Commercialization is a process, the exact timing of which is often difficult to predict. It starts with our own internal R&D to validate performance for an identified market or customer-specific need. Our customers then validate the performance of our materials and determine whether our products can be incorporated into their manufacturing processes. This is initially done at pilot production scale levels. Our customers then have to introduce products that incorporate our materials to their own customers to validate performance. After their customers have validated performance, our customers will then move to commercial scale production. Every customer goes through the same process, but will do so at varying speeds, depending on the customer, the product application and the end-use market. Thus, we are not always able to predict when our customers will begin ordering commercial volumes of our materials or predict their expected volumes over time. However, as customers move through the process, we generally receive feedback and gain greater insights regarding their commercialization plans. The following are examples where our products are providing value to our customers at levels that are either in commercial production or we believe will warrant their use on a commercial basis.

	•	Callaway Golf Company incorporated our graphene nanoplatelets into the outer core of their Chrome Soft golf balls, resulting in a new class of golf ball that enables higher driving speeds, greater distance and increased control, which is allowing Calloway to command a premium price for their golf balls in the marketplace, and

	•	Lead acid battery manufacturer demonstrating approximately 90% improvement in measured cycle life, appreciable improvement in capacity and charge acceptance and without any loss in water retention performance, and

•

Light emitting diode module and product company demonstrated approximately 50% improvement in thermal management capability when compared to existing commercial thermal management products, translating into a 15% improvement in thermal management at the device level, and

	•	Automotive parts supplier demonstrating improvements in thermal stability for polymer composites incorporating our materials, allowing for approximately 20% higher operating temperatures and a 50% improvement in strength at the elevated temperature, and

	•	Construction company demonstrating less than one weight percent of our product in construction material composites improves flexural strength by more than 30%, and

	•	Plastics composite part manufacturer demonstrating 7-30% improvement in strength and 40% improvement in modulus when used in sheet molding compound, and

	•	Engineering design firm for automotive manufacturers found approximately 20% reduction in operating temperature and in thermal uniformity when XG Leaf^®replaces standard cooling fins in lithium ion battery packs, and

	•	Plastic composite parts manufacturer demonstrating 25% increase in tensile strength and 15% improvement in flex modulus for a high-density polyethylene composite.

The process of “designing-in” new materials is relatively complex and involves the use of relatively small amounts of the new material in laboratory and engineering development for an extended period of time. Following successful development, customers that incorporate our materials into their products will then order much larger quantities of material to support commercial production. Although, our customers are under no obligation to report to us on the usage of our materials, some have indicated that they have introduced or will soon introduce commercial products that use our materials. Thus, while many of our customers are currently purchasing our materials in kilogram (one or two pound) quantities, some are now ordering at multiple ton quantities and we believe many will require tens of tons or even hundreds of tons of material as they commercialize products that incorporate our materials. We also believe that those customers already in production will increase their order volume as demand increases and others will begin to move into commercial volume production as they gain more experience in working with our materials and engage new customers. For example, in the first half of 2017 we shipped 3.4 metric tons of product for various end-use customers and in the second half of 2017 we shipped just shy of 14 metric tons. In the fourth quarter of 2017, we received orders that exceeded our then capacity. In the first quarter of 2018 we shipped products comprising over 10 metric tons of graphene nanoplatelets. In addition, we used approximately 300 Kg of dry powder to produce and ship approximately 9 metric tons of additional product in the form of a slurry, cake or other integrated products. This demand profile is further evidence that we are transitioning into higher-volume production. Based on customer forecasts and management estimates, we expect to ship from 100 to 200 metric tons in 2018.

2018 Expected Revenue

We are tracking the commercial and development status of more than 75 different customer applications using our materials with some customers pursuing multiple applications. As of March 31, 2018, we had seventeen specific customer applications where our materials are incorporated into our customers’ products and such customers are actively selling these products to their own customers. In addition, we have another twelve customer applications where our customers have indicated that they expect to begin shipping product incorporating our materials in the next 3 – 6 months and have another eighteen customer applications where our customers have indicated an intent to commercialize in the next 6 – 9 months. We are also working with numerous additional customers that have not yet indicated an exact date for commercialization, but we believe have the potential to contribute to revenue in 2018. The following graphic demonstrates the trend over the past 8 quarters as an increasing number of customers indicate their intent to commercialize applications and move into actively selling products for future sales. We anticipate that the average order size for these customers will increase throughout 2018 as their demand grows. As a result, we believe we will begin shipping significantly greater quantities of our products, and thus continue scaling revenue through 2018. Based on the status of current discussions with customers and their feedback on the performance of our materials in their products, we believe we will be able to recognize approximately $8 – $15 million of revenue in 2018, although this cannot be assured.

(a)

Customer applications where our materials are used in customer products and they are actively selling them to their customers.

(b)

Customer applications where our customers are indicating that they expect to begin shipping products incorporating our materials in the next 3-6 months.

(c)

Customer applications where our customers are indicating an intent to commercialize in the next 6-9 months.

Additional 10’s of customers demonstrating efficacy and moving through qualification process.

Addressable Markets

The markets that we serve are large and rapidly growing. For example, as shown in the figure below, Avicenne Energy (The Battery Show, Novi MI, September 2017) estimates that the market for materials used in lithium ion batteries is currently approximately $10.4 billion and with a double-digit compound annual growth rate. We believe our ability to address next generation battery materials represents a significant opportunity for us.

2016 Lithium Ion Battery Value Chain – Market Demand

According to Prismark Partners, LLC, a leading electronics industry consulting firm specializing in advanced materials, the market for finished graphitic heat spreaders as sold to the OEM and EMS companies with adhesive, PET, and/or copper backing for selected portable applications is expected to reach $900 million in 2018. The market has been in a significant expansion period driven by the demand for portable devices. In a press release dated October 17, 2017, Gartner, Inc., a leading research organization, estimated the 2018 global smartphone market at more than 1.6 billion units and worldwide combined shipments of devices (PC’s, tablets, ultra phones and mobile devices) are expected to reach 2.35 billion units in 2018. Every cell phone has some form of thermal management system, and we believe many of the new smart phones and other portable devices being developed can benefit from the thermal management properties of our XG Leaf^® product line. In November 2017, International Data Corporation (IDC) in their Worldwide Quarterly Tablet Tracker, estimated the global shipment of tablets in the third quarter at 40 million units (Q1 at 36.2 million units and Q2 at 37.9 million units). Thus, we believe our XG Leaf^® product line is well positioned to address a very large and rapidly growing market.

Our Intellectual Property

Some of our proprietary manufacturing processes were developed at Michigan State University (MSU) and licensed to us in 2006. We license three U.S. patents and patent applications from MSU. On August 8, 2016, we signed an agreement acquiring an exclusive license to Metna’s background IP for use of graphene nanoplatelets as additives to concrete mixtures. For purposes of the agreement, Metna’s background IP relates to the U.S. Patent 8,951,343. Also, on August 8, 2016, we entered into a second agreement for an exclusive license related to all Metna’s background technology and foreground technology, including any jointly-owned foreground technology where the end use is known to be any graphite additive dispersed in concrete mixtures. Over time, our scientists and engineers have made many further discoveries and inventions that are embodied in the form of (and as of March 31, 2018): eight additional U.S. patents, ten foreign patents, 16 additional U.S. patent applications, and numerous trade secrets. For many of the applications filed in the U.S., additional filings are made in other countries such as the European Union, Japan, South Korea, China, Taiwan or other applicable countries. As of March 31, 2018, we maintained 36 international patent applications. These filings and analyses are made on a case-by-case basis. Typically, patents that are defensive in nature are not filed abroad, while those that are protective of active XGS products or applications are filed in relevant countries abroad. Our general IP strategy is to keep as trade secrets those manufacturing processes that are difficult to enforce should they be disclosed and to seek patent coverage for other manufacturing processes, materials derived from those processes, unique combinations of materials and end uses of materials containing graphene nanoplatelets. We believe that the combination of our rights under the MSU license, our patents and patent applications, and our trade secrets create a strong intellectual property position.

Operating Segment

We have one reportable operating segment that manufactures xGnP^® graphene nanoplatelets and value-added products produced therefrom, conducts research on graphene nanoplatelets and related products, and licenses our technology as appropriate. As of March 31, 2018, we shipped products on a worldwide basis, but all of our assets were located within the United States.

Results of Operations for the Three Months Ended March 31, 2018 Compared with the Three Months Ended March 31, 2017

	For the Three Months Ended March 31,
	2018			2017 (Restated)			Change
Total Revenues	$	886,337		$	282,189		$	604,148
Cost of Goods Sold		1,214,774			487,920			726,854
Gross Loss		(328,437	)		(205,731	)		(122,706	)
Research & Development Expense		277,063			263,564			13,499
Sales, General & Administrative Expense		1,186,679			996,587			190,092
Total Operating Expense		1,463,742			1,260,151			203,591
Operating Loss		(1,792,179	)		(1,465,882	)		(326,298	)
Other Expense		(81,916	)		(29,941	)		(51,975	)
Net Loss	$	(1,874,095	)	$	(1,495,823	)	$	(378,272	)

Revenue

Revenues for the three months ended March 31, 2018 and 2017, by category, are shown below.

	For the Three Months Ended March 31,
	2018		2017		Change
Product Sales	$	886,337	$	157,700	$	728,637
Grants		—		99,489		(99,489	)
Licensing Revenues		—		25,000		(25,000	)
Total	$	886,337	$	282,189	$	604,148

Product sales consist of two broad categories: (1) material sold to customers for research or development purposes; and (2) production orders for customers. Typically, the order sizes for the first category are relatively small, however we expect orders in the second category to be much larger in the future. For the three months ended March 31, 2018, product sales increased by $728,637, or 462% from the comparable period in the prior year. The main reason for the increase in product sales was customers moving through development programs towards commercialization, requiring larger quantities of our materials for advanced testing, pilot production and commercial-scale production activities. We believe that those customers already in production will increase their order volume as demand increases and other customers will begin to move into commercial volume production as they gain more experience in working with our materials and engage their own customers. As a result of this movement, we shipped over 10 metric tons of bulk powders in the three months ended March 31, 2018.

We ship our products from our Lansing, MI manufacturing facilities to customers around the world. During the three months ended March 31, 2018, we shipped materials to customers in 12 countries, as compared to 20 countries during the same three-month period in 2017. For the three months ended, March 31, 2018, there were no shipments to any one country that accounted for more than 10% of product sales. For the three months ended March 31, 2017, shipments to two countries, South Korea and the United Kingdom accounted for more than 10% of product sales.

Order Summary

The table below shows a comparison of domestic and international orders fulfilled (note that this does not include orders for free samples). The table also includes the average order size for product sales. These numbers indicate that our customer base remains active with research and development projects that use our materials, but that the order size is increasing as more customers order for production purposes or approach commercial status with products using our materials. The average order size for the product revenue during the three months ended March 31, 2018 increased by 613% as compared to the same period in 2017. Although the average size of these orders is still relatively small, we have begun shipping in metric ton quantities to multiple customers.

	For the Three Months Ended March 31,				Change
	2018		2017					%
Number of orders – domestic		38		30		8			26.7
Number of orders – international		18		41		(23	)		(56.1	)
Number of orders – total		56		71		(15	)		(21.1	)
Average order size for product sales recorded in Statement of Operations	$	15,827	$	2,221		13,606			612.6

Grant Revenue

There was no grant revenue for the three months ended March 31, 2018. Grant revenue for the three months ended March 31, 2017 consisted of proceeds from sources as shown in the table below:

	For the Three Months Ended March 31,
	2018		2017
US Department of Energy Grant	$	—	$	93,747
Daimler / University of Michigan		—		5,742
Total	$	—	$	99,489

Licensing Revenue

For the three months ended March 31, 2018 we had no licensing revenue. Licensing revenue for the three months ended March 31, 2017 was $25,000. The licensing revenue in 2017 was from POSCO, a shareholder of the Company. The original license agreement dated June 8, 2011 was modified on November 3, 2017. Under the terms of the revised agreement no current licensing revenue is due from POSCO.

Cost of Goods Sold

We use a standard cost system to estimate the direct costs of products sold. Direct costs include estimates of raw material costs, packaging, freight charges net of those billed to customers, and an allocation for direct labor and manufacturing overhead. Because of the nature of our production processes, there is a substantial fixed manufacturing expense requirement that represents the ongoing cost of maintaining production facilities that are not directly related to products sold, so we use a “full capacity” allocation of overhead based on an estimate of what product costs would be if the manufacturing facilities were operating on a full-time basis and producing products at the designed capacity.

The following table shows the relationship of direct costs to product sales for the three months ended March 31, 2018 and 2017:

Direct Margin and Gross Profit Summary	For the Three Months Ended March 31,
	2018			2017			Change
Product Sales	$	886,337		$	157,700		$	728,637
Direct Costs		468,191			116,770			351,421
Direct Cost Margin		418,146			40,930			377,216
% of Sales		47.2	%		26.0	%		21.2	%

Unallocated Manufacturing Expense		746,583			371,150			375,433
Gross Loss on Product Sales	$	(328,437	)	$	(330,220	)	$	1,783
% of Sales		(37.1	)%		(209.4	)%		172.3	%

We believe that the fluctuations in gross loss on product sales and direct cost from period to period are not indicative of future margins because of the relatively small size of our sales in comparison to our future expectations. Direct costs vary depending on the size of an order, the specific products being ordered, and other factors like shipping destination (which on small orders can represent a significant percentage of the cost).

Costs associated with grant revenue tend to be a mixture of facilities use, management time, labor from scientists, technicians and manufacturing personnel, and some supplies. Because of the difficulty of developing and maintaining an administrative system to gather direct costs for grants, together with the relatively small size of grant revenue, we do not track direct costs for grant revenue as a separate cost category. Therefore, we do not calculate direct cost margins associated with grant revenue but, rather, we view this revenue as being supported by indirect corporate expenses.

Costs associated with licensing revenue tend to be a mixture of IP costs as well as management and administrative expenses that are indirect in nature. As such, we do not assign direct costs to licensing revenue. Where revenue from a license agreement can be assigned to specific product revenue, we classify this revenue as product sales and, using our standard cost system, assign direct costs to those sales.

The remaining “non-direct” costs of operating our manufacturing facilities are recorded as unallocated manufacturing expenses. These expenses include personnel costs, rent, utilities, indirect supplies, depreciation, and related indirect expenses. Unallocated manufacturing expenses are expensed as incurred. We allocate these costs to direct product costs based on the proportion of these expenses that would be representative direct product costs if we were operating our factory at full capacity.

For the three months ended March 31, 2018, unallocated manufacturing expenses increased by 101% to $746,583 as compared to $371,150 in 2017. The increase of $375,433 is largely due to higher levels of manufacturing overhead expense as we prepare for and fulfill higher volume commercial orders.

Sales, General and Administrative Expenses

During the first three months ended March 31, 2018 we incurred selling, general and administrative expenses (SGA) of $1,186,679. This is an increase of approximately $190,092 or 19.1% from the same period in 2017, primarily due to increases in personnel costs as a result of our growth in sales. As we continue to grow and gain traction in the marketplace our SGA expenses will increase but we expect them to become more fixed in nature as we achieve economies of scale.

Research and Development Expenses

Research and development expenses for the three months ended March 31, 2018 were $277,064 as compared to $263,564 for the same period in 2017, an increase of $13,500 or 5%.

Other Income (Expense)

The following table shows a comparison of other income and expense by major expense component for the three months ended March 31, 2018 and 2017:

	For the Three Months Ended March 31,
	2018			2017 (Restated)			$
Interest expense, net	$	(85,169	)	$	(59,088	)		(26,081	)
Gain from change in fair value of derivative liability – warrants		—			29,171			(29,171	)
Government incentives, net		3,253			(24	)		3,277
Total	$	(81,916	)	$	(29,941	)		(51,975	)

Interest expense, net of interest income in the three months ended March 31, 2018, increased by $26,081 compared to the same period in 2017. The increase is due to an increase in the amount of indebtedness outstanding under the Dow Facility, the balance of which increased to $5 million as of March 31, 2018, from $2 million as of March 31, 2017.

Gain/(loss) from changes in the fair value of derivative liability warrants from the previous valuation period are characterized as other income (expense) on our Statement of Operations as a result of the GAAP requirement to use variable accounting for such instruments. These values fluctuate from period to period as a result of updating inputs used in the trinomial lattice model used to value such warrants, including risk free rate, volatility, remaining term of each warrant, and the underlying stock price assumption used in such calculations. On September 30, 2017, we reclassified 224,897 warrants related to Series B Preferred stock from derivative liabilities to equity and we are no longer required to record the change in fair values for these instruments.

Government incentives include accruals for incentive awards from state and local government entities, these incentives often relate to new hires or job creation activities.

Cash Flow Summary

The following condensed cash flow statement compares cash flow from operating, investing, and financing activities for the three months ended March 31, 2018 and 2017:

	For the Three Months Ended March 31,
	2018			2017			$
Cash, beginning of period	$	2,845,798		$	1,785,343			1,060,455
Net Cash provided (used) by:
Operating activities		(1,270,591	)		(1,007,741	)		(262,850	)
Investing Activities		(889,931	)		(241,433	)		(648,498	)
Financing Activities		1,599,841			612,512			987,329
Net decrease in cash		(560,681	)		(636,662	)		75,981
Cash, end of period	$	2,285,117		$	1,148,681			1,136,436

Investing activities for the three months ended March 31, 2018 included net capital expenditures for the purchase of property and equipment of $874,357 and $15,574 for intellectual property as compared with $203,664 for property and equipment and $37,769 for intellectual property during the same period in 2017. These levels of capital expenditures are higher as we have begun to update and install equipment necessary to increase production capacity to meet anticipated customer orders for those customers who are moving into commercialization of products containing our materials.

Financing activities provided a net increase in cash of $1,599,841 and $612,512 for the three months ended March 31, 2018 and 2017, respectively. For the three months ended March 31, 2018 gross proceeds from the issuance of common stock was $1,615,400 and stock issuance expenses were $9,838 as compared to proceeds from the issuance of common stock for the three months ended March 31, 2017 of $771,800 and stock issuance expenses of $154,413.

Liquidity and Capital Expenditures

In December 2016, we entered into the Dow Facility to provide up to $10 million of secured debt financing at an interest rate of 5% per year, drawable at our request under certain conditions. As of May 14, 2018, we had drawn $5.0 million under the Dow Facility. The remaining $5 million will become available to us once we have raised $10 million of equity capital after October 31, 2016. As of May 14, 2018, we have sold 1,276,007 shares of common stock pursuant to our IPO at a price of $8.00 per share for gross proceeds of $10,208,056. However, only $7,007,024 of this amount has been raised during the measurement period beginning November 1, 2016. Thus, we still need to raise $2,992,976 of equity capital prior to the remaining $5.0 million under the Dow Facility becoming available to us.

Critical Accounting Policies

In preparing the condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), we have adopted various accounting policies. Our most significant accounting policies are disclosed in Note 2 to the consolidated financial statements included in our Form 10-K for the year ended December 31, 2017.

The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Our estimates and assumptions, including those related to inventories, intangible assets, property, plant and equipment, legal proceedings, research and development, warranty obligations, product liability, fair valued liabilities, sales returns and discounts, going concern, and income taxes are updated as appropriate, which in most cases is at least quarterly. We base our estimates on historical experience, or various judgements about the reported values of assets, liabilities, revenue and expenses. Actual results may materially differ from these estimates.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Smaller reporting companies are not required to provide this information.

Item 4. Controls and Procedures

(a) Evaluation of disclosure controls and procedures. We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

As required by SEC Rule 15d-15, our management carried out an evaluation, under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.

(b) Changes in internal controls. There were no changes in our internal control over financial reporting that occurred during the three months ended March 31, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

Smaller reporting companies are not required to provide this information.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

During each of the three months ended March 31, 2018 and 2017 we issued 7,140 shares per period of Series A Preferred Stock to Aspen Advanced Opportunity Fund, LP as payment for lease financing obligations under the terms of the Master Lease Agreement dated March 18, 2013.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

None.

Item 5. Other Information.

None

Item 6. Exhibits.

EXHIBIT NUMBER	DESCRIPTION	LOCATION

31.1	Certifications of the Chief Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	Filed herewith

32.1	Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act Of 2002*	Filed herewith

101. INS	XBRL Instance Document	Filed herewith

101. CAL	XBRL Taxonomy Extension Calculation Link base Document	Filed herewith

101. DEF	XBRL Taxonomy Extension Definition Link base Document	Filed herewith

101. LAB	XBRL Taxonomy Label Link base Document	Filed herewith

101. PRE	XBRL Extension Presentation Link base Document	Filed herewith

101. SCH	XBRL Taxonomy Extension Scheme Document	Filed herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Dated: May 14, 2018	By:	/s/ Philip L. Rose
	Name:	Philip L. Rose
	Title:	Chief Executive Officer, President, Treasurer, Principal Executive Officer and Principal Financial Officer

Dated: May 14, 2018	By:	/s/ Corinne Lyon
	Name:	Corinne Lyon
	Title:	Controller and Principal Accounting Officer

EX-31.1 2 s110005_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Philip L. Rose, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of XG Sciences, Inc. for the period ended March 31, 2018;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

(a)

designed such disclosure controls and procedures, or have caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the period covered by this report based on such evaluation; and

(d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

(a)

all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process summarize and report financial information; and

(b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

DATE: May 14, 2018

By: /s/Philip L. Rose

Name: Philip L. Rose

Titles: Chief Executive Officer, President,
Treasurer, Principal Executive Officer and
Principal Financial Officer

EX-32.1 3 s110005_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of XG Sciences, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Philip L. Rose, Principal Executive Officer and Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

DATE: May 14, 2018

	By:/s/ Philip L. Rose
	Name: Philip L. Rose
	Titles: Chief Executive Officer, President, Treasurer, Principal Executive Officer and Principal Financial Officer

GRAPHIC 4 img001_v1.jpg GRAPHIC begin 644 img001_v1.jpg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end GRAPHIC 5 img002_v1.jpg GRAPHIC begin 644 img002_v1.jpg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end GRAPHIC 6 img003_v1.jpg GRAPHIC begin 644 img003_v1.jpg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img004_v1.jpg GRAPHIC begin 644 img004_v1.jpg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end GRAPHIC 8 img005_v1.jpg GRAPHIC begin 644 img005_v1.jpg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end EX-101.INS 9 cik0001435375-20180331.xml XBRL INSTANCE FILE 0001435375 2018-01-01 2018-03-31 0001435375 2018-05-14 0001435375 2016-12-31 0001435375 2017-12-31 0001435375 2018-03-31 0001435375 us-gaap:ConvertiblePreferredStockMember 2018-03-31 0001435375 us-gaap:ConvertiblePreferredStockMember 2017-12-31 0001435375 2017-01-01 2017-03-31 0001435375 us-gaap:PreferredStockMember 2018-01-01 2018-03-31 0001435375 us-gaap:PreferredStockMember 2017-12-31 0001435375 us-gaap:PreferredStockMember 2018-03-31 0001435375 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001435375 us-gaap:CommonStockMember 2017-12-31 0001435375 us-gaap:CommonStockMember 2018-03-31 0001435375 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001435375 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001435375 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001435375 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001435375 us-gaap:RetainedEarningsMember 2017-12-31 0001435375 us-gaap:RetainedEarningsMember 2018-03-31 0001435375 2017-03-31 0001435375 us-gaap:WarrantMember 2018-01-01 2018-03-31 0001435375 us-gaap:WarrantMember 2018-03-31 0001435375 cik0001435375:Warrant1Member 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant1Member 2018-03-31 0001435375 cik0001435375:Warrant2Member 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant2Member 2018-03-31 0001435375 cik0001435375:Warrant2Member us-gaap:MinimumMember 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant2Member us-gaap:MaximumMember 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant3Member 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant3Member 2018-03-31 0001435375 cik0001435375:Warrant3Member us-gaap:MinimumMember 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant3Member us-gaap:MaximumMember 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant4Member 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant4Member 2018-03-31 0001435375 cik0001435375:Warrant5Member 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant5Member 2018-03-31 0001435375 cik0001435375:Warrant6Member 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant6Member 2018-03-31 0001435375 cik0001435375:Warrant7Member 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant7Member 2018-03-31 0001435375 cik0001435375:Warrant8Member 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant8Member 2018-03-31 0001435375 cik0001435375:Warrant9Member 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant9Member 2018-03-31 0001435375 cik0001435375:Warrant10Member 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant10Member 2018-03-31 0001435375 cik0001435375:Warrant11Member 2018-01-01 2018-03-31 0001435375 cik0001435375:Warrant11Member 2018-03-31 0001435375 cik0001435375:IncentiveStockOptionPlanMember 2018-01-01 2018-03-31 0001435375 cik0001435375:StockOptionPlan2007Member us-gaap:MaximumMember 2018-03-31 0001435375 cik0001435375:StockOptionPlan2007Member 2018-01-01 2018-03-31 0001435375 cik0001435375:StockOptionPlan2007Member us-gaap:RestrictedStockMember cik0001435375:FourBoardDirectorMember 2018-01-01 2018-03-31 0001435375 cik0001435375:LicensingAgreementMember cik0001435375:MichiganStateUniversityMember 2018-01-01 2018-03-31 0001435375 cik0001435375:LicensingAgreementMember cik0001435375:MichiganStateUniversityMember 2017-01-01 2017-03-31 0001435375 cik0001435375:MasterLeasingAgreementMember cik0001435375:AspenAdvanceOpportunityFundLPMember us-gaap:SeriesAPreferredStockMember 2018-01-01 2018-03-31 0001435375 cik0001435375:MasterLeasingAgreementMember cik0001435375:AspenAdvanceOpportunityFundLPMember us-gaap:SeriesAPreferredStockMember 2017-01-01 2017-03-31 0001435375 us-gaap:SubsequentEventMember 2018-04-01 2018-05-14 0001435375 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember cik0001435375:CustomerMember 2018-03-31 0001435375 us-gaap:ProductConcentrationRiskMember us-gaap:SalesRevenueNetMember cik0001435375:ProductOneMember 2018-01-01 2018-03-31 0001435375 us-gaap:ProductConcentrationRiskMember us-gaap:SalesRevenueNetMember cik0001435375:ProductOneMember 2017-01-01 2017-03-31 0001435375 cik0001435375:GrantsAndLicensingRevenueConcentrationMember cik0001435375:GrantRevenueMember cik0001435375:GrantorOneMember 2017-01-01 2017-03-31 0001435375 cik0001435375:GrantsAndLicensingRevenueConcentrationMember cik0001435375:GrantRevenueMember cik0001435375:GrantorTwoMember 2017-01-01 2017-03-31 0001435375 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember cik0001435375:CustomerOneMember 2018-01-01 2018-03-31 0001435375 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember cik0001435375:CustomerOneMember 2017-01-01 2017-03-31 0001435375 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember cik0001435375:CustomerTwoMember 2017-01-01 2017-03-31 0001435375 us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:GeographicDistributionForeignMember 2018-01-01 2018-03-31 0001435375 us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:GeographicDistributionForeignMember 2017-01-01 2017-03-31 0001435375 us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember country:GB 2017-01-01 2017-03-31 0001435375 us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember currency:KRW 2017-01-01 2017-03-31 0001435375 us-gaap:ConvertiblePreferredStockMember 2015-01-01 2015-12-31 0001435375 us-gaap:IPOMember 2018-01-01 2018-03-31 0001435375 us-gaap:SubsequentEventMember us-gaap:IPOMember 2018-05-13 2018-05-14 0001435375 us-gaap:SubsequentEventMember us-gaap:IPOMember 2018-05-14 0001435375 us-gaap:ConvertiblePreferredStockMember 2018-01-01 2018-03-31 0001435375 us-gaap:ConvertiblePreferredStockMember 2015-12-31 0001435375 us-gaap:ConvertiblePreferredStockMember cik0001435375:AspenAdvanceOpportunityFundLPMember cik0001435375:MasterLeasingAgreementMember 2018-01-01 2018-03-31 0001435375 us-gaap:SeriesBPreferredStockMember 2018-03-31 0001435375 us-gaap:SeriesBPreferredStockMember 2017-12-31 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2018-01-01 2018-03-31 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2018-03-31 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2017-01-01 2017-12-31 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2017-12-31 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2016-12-01 2016-12-31 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2016-12-31 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2017-07-17 2017-07-18 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2017-09-21 2017-09-22 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2017-12-03 2017-12-04 0001435375 cik0001435375:TheDowChemicalCompanyMember 2018-01-01 2018-03-31 0001435375 us-gaap:ScenarioPreviouslyReportedMember 2017-01-01 2017-03-31 0001435375 us-gaap:RestatementAdjustmentMember 2017-01-01 2017-03-31 0001435375 us-gaap:SeriesAPreferredStockMember 2018-03-31 0001435375 us-gaap:IPOMember 2016-04-12 2016-04-13 0001435375 us-gaap:IPOMember 2016-04-13 0001435375 us-gaap:SubsequentEventMember cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2018-05-13 2018-05-14 0001435375 us-gaap:SubsequentEventMember 2018-05-14 0001435375 cik0001435375:StockOptionPlan2007Member 2017-07-23 2017-07-24 0001435375 cik0001435375:StockOptionPlan2007Member us-gaap:EmployeeStockOptionMember cik0001435375:FourBoardDirectorMember 2017-08-09 2017-08-10 0001435375 cik0001435375:StockOptionPlan2007Member us-gaap:RestrictedStockMember cik0001435375:FourBoardDirectorMember 2017-08-09 2017-08-10 0001435375 cik0001435375:StockOptionPlan2007Member 2018-03-31 0001435375 cik0001435375:StockOptionPlan2007Member us-gaap:EmployeeStockOptionMember 2018-03-31 0001435375 cik0001435375:StockOptionPlan2007Member us-gaap:RestrictedStockMember 2018-03-31 0001435375 cik0001435375:POSCOMember 2017-01-01 2017-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure cik0001435375:Customer XG SCIENCES INC 0001435375 10-Q 2018-03-31 false --12-31 No No Yes Smaller Reporting Company Q1 2018 2662525 6891523 7311853 1097472 1002375 22002717 20741574 7899722 -49641638 -47767544 -49641638 7831958 7899722 19116012 20741574 5794051 6309478 4810123 4884353 4794596 4869714 15527 14639 983928 1425125 118553 91985 7298 189 858077 1332951 6891523 7311853 571938 574579 195792 195865 2601571 3266797 3502066 3254456 15781 91588 171864 209711 468623 668040 1785343 2845798 2285117 1148681 1660600 22002717 21917046 20156 20156 40000 40000 3000000 3000000 1500000 1500000 1864956 1857816 0 0 1864956 1857816 0 0 22379472 22293792 25000000 25000000 2353350 2555275 2353350 2555275 0 0 -0.76 -0.78 2454314 1920090 -1874095 -1495823 -1874095 -1370342 -1495823 -81916 -29941 95540 -29941 3253 -24 368 368 29171 154652 29171 85169 59088 59480 59480 -1792179 -1465882 -1465882 -1465882 1463742 1260151 1186679 996587 277063 263564 -328437 -205731 1214774 487920 746583 371150 468191 116770 886337 282189 25000 99489 886337 157700 1857816 1864956 2353350 2555275 1097472 21917046 19116012 7831958 -47767544 201925 7140 7140 107250 1615400 1615400 9838 9838 7140 85671 85671 87764 20000 67764 125481 85671 85672 220 -560681 -636662 1599841 612512 9838 154413 1615400 771800 858000 5721 4875 -889931 -241433 15574 37769 874357 203664 -1270591 -1007741 467765 17576 75881 -103558 37847 -8229 199417 -14680 -29171 85973 59480 87764 88370 12934 10590 209131 214770 NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION   XG Sciences, Inc., a Michigan company located in Lansing, Michigan and its subsidiary, XG Sciences IP, LLC (collectively referred to as “we”, “us”, “our”, or the “Company”) manufactures graphene nanoplatelets made from graphite, using two proprietary manufacturing processes to split natural flakes of crystalline graphite into very small and thin particles, which we sell as xGnP® graphene nanoplatelets. We sell our nanoparticles in the form of bulk powders or dispersions to other companies for use as additives to make composite and other materials with specially engineered characteristics. We also manufacture and sell integrated, value-added products containing these graphene nanoplatelets such as greases, composites, thin sheets, inks and coating formulations that we sell to other companies. Additionally, we license our technology to other companies in exchange for royalties and other fees.   Basis of Presentation   The accompanying interim condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and the instructions to Form 10-Q and do not include all of the information and footnotes required by GAAP for complete financial statements. All intercompany transactions have been eliminated in consolidation.   Certain information and footnote disclosures normally included in our annual audited consolidated financial statements and accompanying notes have been condensed or omitted in these interim condensed consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2017, as filed with the Securities and Exchange Commission (“SEC”) on Form 10-K on April 2, 2018.   The results of operations presented in this quarterly report are not necessarily indicative of the results of operations that may be expected for any future periods. In the opinion of management, these unaudited condensed consolidated financial statements include all adjustments and accruals, consisting only of normal recurring adjustments that are necessary for a fair statement of the results of all interim periods reported herein. NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   Liquidity   We have historically incurred losses from operations and we may continue to generate negative cash flows as we implement our business plan. Our condensed consolidated financial statements are prepared using US GAAP as applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.   We filed a Registration Statement on Form S-1 (File No. 333-209131) with the SEC on April 11, 2016 which was declared effective by the SEC on April 13, 2016 (as amended, the “Registration Statement”). The Registration Statement registered up to 3,000,000 shares of common stock at a fixed price of $8.00 per share to the general public in a self-underwritten offering (the “Offering” or our “IPO”). Post-Effective Amendment No. 1 to the Registration Statement was declared effective August 26, 2016, Post-Effective Amendment No. 2 was declared effective August 31, 2016, Post-Effective Amendment No. 3 was declared effective January 17, 2017, and Post-Effective Amendments No. 4 and No. 5 were dated April 12, 2017. Post-Effective Amendment No. 5 was declared effective April 14, 2017. Although we are currently selling shares of our common stock in our IPO pursuant to our Registration Statement, we have not yet listed the company for trading on any exchanges.   In December 2016, we entered into a draw loan note and agreement (the “Dow Facility”) with The Dow Chemical Company (“Dow”) to provide up to $10 million of secured debt financing at an interest rate of 5% per year, drawable at our request under certain conditions. As of May 14, 2018, we had drawn $5.0 million under the Dow Facility. The remaining $5 million will become available to us once we have raised $10 million of equity capital after October 31, 2016.  As of May 14, 2018, we have sold 1,276,007 shares of common stock pursuant to our IPO at a price of $8.00 per share for gross proceeds of $10,208,056. However, only $7,007,024 of this amount has been raised during the measurement period beginning November 1, 2016. Thus, we still need to raise $2,992,976 of additional equity capital prior to the remaining $5.0 million under the Dow Facility becoming available to us.   As of May 14, 2018, we had cash on hand of $1,660,600. We believe our cash from increasing commercial sales activity and various financing sources will fund our operations for at least the next 12 months. We intend that the primary means for raising funds will be through our IPO and the additional $5 million of proceeds from the Dow Facility that becomes available to us after we have raised another $3 million of equity capital as noted above; however, we can make no assurances that we will raise such equity capital and be able to access the additional $5 million under the Dow Facility. Taking into account our current cash position as noted above, an additional $3 million in proceeds from our IPO, which would allow us to draw up to $5 million from the Dow Facility, we believe that we can fund our operations including planned capital expenditures for at least the next 12 months. In addition, two of our shareholders have committed to provide up to $4.5 million in funding for the twelve-month period ended March 31, 2019 to the extent the Company is unable to raise such funds from other third parties.   In the event we are unable to fund our operations from existing cash on hand, operating cash flows, additional borrowings or raising equity capital, we may be forced to reduce our expenses, slow down our growth rate, or discontinue operations. Our condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.   Use of Estimates   The preparation of our condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, together with amounts disclosed in the related notes to the financial statements. Actual results and outcomes may differ from our estimates, judgments and assumptions. Significant estimates, judgments and assumptions used in these condensed consolidated financial statements include, but are not limited to, those related to revenue, accounts receivable and related allowances, contingencies, useful lives and recovery of long-term assets, including intangible assets, income taxes, and the fair value of stock-based compensation. These estimates, judgments, and assumptions are reviewed periodically and the effects of material revisions in estimates are reflected in the financial statements prospectively from the date of the change in estimate.   Inventory   Inventory consists of raw materials, work-in-process and finished goods, all of which are stated at the lower of cost or market. Cost is determined on a first in, first out basis.   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>The following amounts were included in inventory at the end of the period:</td> <td> </td> <td colspan="6" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center">March 31,</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">December 31,</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2018</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2017</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 72%; text-align: left; padding-left: 10pt; text-indent: -10pt">Raw materials</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 11%; text-align: right">79,581</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 11%; text-align: right">39,841</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 10pt; text-indent: -10pt">Finished goods</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">130,130</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">132,023</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; padding-left: 10pt; text-indent: -10pt">Total</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">209,711</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">171,864</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table>   Derivative Financial Instruments   We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. The terms of convertible preferred stock and convertible notes that we issue are reviewed to determine whether or not they contain embedded derivative instruments that are required by ASC 815: “Derivatives and Hedging” to be accounted for separately from the host contract and recorded at fair value. In addition, freestanding warrants are also reviewed to determine if they achieve equity classification. Certain stock warrants that we issued did not meet the conditions for equity classification at inception and were classified as derivative instrument liabilities measured at fair value.   In July 2017, the FASB issued Accounting Standards Update No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities From Equity (Topic 480), Derivatives and Hedging (Topic 815) (“ASU 2017-11”). This update changes the classification analysis of certain equity-linked financial instruments with down-round features. We elected to early adopt ASU 2017-11 at September 30, 2017 by applying the standard retrospectively to outstanding financial instruments with a down round feature by means of a cumulative-effect adjustment to the Company’s beginning accumulated deficit as of January 1, 2017. There were 972,720, warrants indexed to Series A Preferred Stock which were originally recorded as derivative liabilities because of their anti-dilution features. We chose to early adopt ASU 2017-11 because it permitted these warrants to be recorded as equity rather than derivative liabilities. The impact to the financial statements for the three months ended March 31, 2017 is as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center">For three months ended March 31, 2017</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center">As previously</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">As</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">reported</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Adjusted</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 72%; text-align: justify">Operating loss</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 11%; text-align: right">(1,465,882</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 11%; text-align: right">(1,465,882</td> <td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Other income (expense):</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Incentive refund and interest income</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">368</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">368</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Interest expense, net</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(59,480</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(59,480</td> <td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify">Gain from change in fair value of derivative warrants</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">154,652</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">29,171</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: justify">Total other income (expense)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">95,540</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(29,941</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: justify">Net loss</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">(1,370,342</td> <td style="padding-bottom: 2pt; text-align: left">)</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">(1,495,823</td> <td style="padding-bottom: 2pt; text-align: left">)</td></tr> </table>   Fair Value Measurements   The Company utilizes a valuation hierarchy that prioritizes fair value measurements based on the types of inputs used for the various valuation techniques related to its financial assets and financial liabilities in accordance to Accounting Standards Codification (“ASC”) Topic 820 Fair Value Measurements and Disclosures.   For financial instruments such as cash, accounts payable and other current liabilities, the Company considers the recorded value of such financial instruments approximate to the current fair value because of their short-term nature.   Recent Accounting Pronouncements   ASU No. 2014-09 (ASC 606), Revenue from Contracts with Customers became effective for us beginning with the first quarter of 2018, and we adopted the new accounting standard using the modified retrospective transition approach. The modified retrospective transition approach recognized any changes from the beginning of the year of initial application through retained earnings with no restatement of comparative periods. We will record revenue under ASC 606 at a single point in time, when control is transferred to the customer, which is consistent with past practice. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure under the new standard. Based on the results of the evaluation, we have determined that the adoption of the new standard presents no material impact on our consolidated financial statements. Application of the transition requirements of the new standard did not have a material impact on opening retained earnings.  Dow Facility   In December 2016, we entered into the Dow Facility which provides us with up to $10 million of secured debt financing at an interest rate of 5% per year, drawable at our request under certain conditions. We received $2 million at closing and an additional $1 million on July 18, 2017, September 22, 2017 and December 4, 2017, respectively. An additional $5 million becomes available once we have raised $10 million of equity capital after October 31, 2016; however, we can make no assurances that we will raise such equity capital and be able to access the additional $5 million under the Dow Facility.  As of May 14, 2018, we have sold 1,276,007 shares of common stock pursuant to our IPO at a price of $8.00 per share for gross proceeds of $10,208,056. However, only $7,007,024 of this amount has been raised during the measurement period beginning November 1, 2016. Thus, we still need to raise $2,992,976 of equity capital prior to the remaining $5.0 million under the Dow Facility becoming available to us.    The Dow Facility is senior to most of our other debt and is secured by all of our assets (Dow is subordinate only to the capital leases with Aspen Advanced Opportunity Fund, LP (“AAOF”). The loan matures on December 1, 2021 (subject to certain mandatory prepayments based on our equity financing activities). Interest is payable beginning January 1, 2017 although we may elect to capitalize interest through January 1, 2019. Dow received warrant coverage of one share of common stock for each $40 in loans received by us, equating to 20% warrant coverage, with an exercise price of $8.00 per share for the warrants issued at closing of the initial $2 million draw. After the initial closing, the strike price of future warrants issued is subject to adjustment if we sell shares of common stock at a lower price. As of March 31, 2018, we had issued 125,000 warrants to Dow, which are exercisable on or before the expiration date of December 1, 2023.    The aforementioned warrants meet the criteria for classification within stockholders’ equity. Proceeds were allocated between the debt and the warrants at their relative fair value. During the fiscal year ended December 31, 2017, we recognized amortization expense of $161,702, and the resulting carrying value of the Dow Facility on our balance sheet as of December 31, 2017 was $4,794,596. During the three months ended March 31, 2018, we recognized amortization expense of $75,118, and the resulting carrying value of the Dow Facility on our balance sheet as of March 31, 2018 was $4,869,714. NOTE 4 – STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS   The following table summarizes the warrants (including the warrants previously accounted for as derivatives) outstanding at March 31, 2018, which are accounted for as equity instruments, all of which are exercisable:    <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center">Date Issued</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: center">Expiration Date</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: center">Indexed Stock</td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Exercise Price</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Number of  Warrants</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 24%">07/01/2009</td> <td style="width: 1%"> </td> <td style="width: 18%">07/01/2019</td> <td style="width: 1%"> </td> <td style="width: 18%; text-align: center">Common</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 16%; text-align: right">8.00</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 16%; text-align: right">6,000</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>10/08/2012</td> <td> </td> <td>10/08/2027</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">12.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">5,000</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>01/15/2014 – 12/31/2014</td> <td> </td> <td>01/15/2024</td> <td> </td> <td style="text-align: center">Series A Convertible Preferred</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">6.40</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">972,720</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>04/30/2015- 05/26/2015</td> <td> </td> <td>04/30/2022</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">16.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">218,334</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>06/30/2015</td> <td> </td> <td>06/30/2022</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">16.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">6,563</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>12/31/2015</td> <td> </td> <td>12/31/2020</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">8.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">20,625</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>03/31/2016</td> <td> </td> <td>03/31/2021</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">10.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">10,600</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>04/30/2016</td> <td> </td> <td>04/30/2021</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">10.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">895</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>12/14/2016</td> <td> </td> <td>12/01/2023</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">8.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">50,000</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>07/18/2017</td> <td> </td> <td>12/01/2023</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">8.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">25,000</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>09/22/2017</td> <td> </td> <td>12/01/2023</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">8.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">25,000</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">12/04/2017</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt">12/01/2023</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: center">Common</td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left">$</td> <td style="text-align: right">8.00</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">25,000</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt"> </td> <td style="padding-bottom: 2pt"> </td> <td style="padding-bottom: 2pt"> </td> <td style="padding-bottom: 2pt"> </td> <td style="padding-bottom: 2pt; text-align: center"> </td> <td style="padding-bottom: 2pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left"> </td> <td style="border-bottom: black 2pt double; text-align: right">1,365,737</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table>      The warrants indexed to Series A Convertible Preferred Stock are currently exercisable and are exchangeable into 1.875 shares of common stock. NOTE 5 — STOCKHOLDERS’ EQUITY (DEFICIT)   Common Stock   The Company is authorized to issue 25,000,000 shares of common stock, no par value per share of which 2,555,275 and 2,353,350 shares were issued and outstanding as of March 31, 2018 and December 31, 2017, respectively.   During the three months ended March 31, 2018, the Company issued 201,925 shares of common stock pursuant to the Offering. As of May 14, 2018, the Company has sold 1,276,007 shares of common stock in its IPO at a price of $8.00 per share for gross proceeds of $10,208,056.   Series A Convertible Preferred Stock   The Company is authorized to issue up to 3,000,000 shares of Series A Convertible Preferred Stock (the “Series A Preferred”). Each share of the Series A Preferred, which has a liquidation preference of $12.00 per share, is convertible at any time, at the option of the holder, into one share of Common Stock at the lower of: (a) $12.00 per share, or (b) 80% of the price at which the Company sells any equity or equity-linked securities in the future. The Series A Preferred also contains typical anti-dilution provisions that provide for adjustment of the conversion price to reflect stock splits, stock dividends, or similar events. The Series A Preferred is subject to mandatory conversion into Common Stock upon the listing of the Company’s common stock on a Qualified National Exchange. However, the Series A Preferred is not subject to the mandatory conversion until all outstanding convertible securities are also converted into common stock. The Series A Preferred ranks senior to all other equity or equity equivalent securities of the Company other than those securities which are explicitly senior or pari passu in rights and liquidation preference to the Series A Preferred and pari passu with the Company’s Series B Preferred Stock.   The Company issued 1,456,126 shares of Series A Preferred in connection with the conversion of certain convertible notes on December 31, 2015.   In December 2015, the conversion price of the Series A Preferred was reduced from $12.00 to $6.40 (80% of $8.00), and thus, each share of Series A Preferred Stock is convertible into 1.875 shares of common stock.   As of March 31, 2018, and December 31, 2017, the Company had 1,864,956 and 1,857,816 shares of Series A Preferred Stock issued and outstanding, respectively.   Series B Convertible Preferred Stock   As of March 31, 2018, and December 31, 2017, 1,500,000 shares have been designated as Series B Convertible Preferred Stock (“Series B Preferred”), of which no shares were issued and outstanding. Each share of the Series B Preferred, which has a liquidation preference of $16.00 per share, is convertible at any time, at the option of the holder, into one share of common stock at $16.00 per share. The Series B Preferred also contains typical anti-dilution provisions that provide for adjustment of the conversion price to reflect stock splits, stock dividends, or similar events. Each share of Series B Preferred is subject to mandatory conversion into common stock at the then-effective Series B conversion rate upon the public listing by the Company of its common stock on a Qualified National Exchange. However, the Series B Preferred is not subject to the mandatory conversion until all outstanding convertible securities are also converted into common stock. The Series B Preferred ranks senior to all other equity or equity equivalent securities of the Company other than those securities which are explicitly senior or pari passu in rights and liquidation preference to the Series B Preferred and pari passu with the Company’s Series A Preferred. NOTE 6 – EQUITY INCENTIVE PLAN   We previously established the 2007 Stock Option Plan (the “2007 Plan”), which was scheduled to expire on October 30, 2017 and under which we granted key employees and directors options to purchase shares of our common stock at not less than fair market value as of the grant date. On May 4, 2017, the Board approved the 2017 Equity Incentive Plan (the “2017 Plan”) to replace the 2007 Plan, which became effective upon the approval of the stockholders holding a majority of the voting power in the Company on July 18, 2017. The 2017 Plan replaced the 2007 Plan and authorizes us to grant awards (stock options and restricted stock) up to a maximum of 1,200,000 shares of our common stock.      On July 24, 2017, certain stock options from the 2007 Plan were cancelled and replacement stock options were awarded. The replacement stock option awards have an exercise price of $8.00 per share and a seven-year term. Fifty percent of such awards vested on the date of grant with the remaining vesting over a 4-year period, subject to certain other terms. Each option holder received options equal to 150% of the number of cancelled stock options.   On August 10, 2017, the Company granted stock options and restricted stock to each of its Board members as part of its Board compensation package. Each of the 4 independent Board members received 2,500 stock options and 2,500 shares of restricted stock for Board services. The options were granted at a price of $8.00 per share and had an aggregate grant date fair value of $26,120. The options vest ratably over a four-year period beginning on the one-year anniversary. The restricted stock issued to the Board members has an aggregate fair value of $80,000 and vest ratably in arrears over four quarters on the last day of each fiscal quarter following the grant date. As of March 31, 2018, 7,500 shares of restricted stock had vested, resulting in total compensation expense of $60,000.   A summary of the stock option activity for the three months ended March 31, 2018 is as follows:    <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 10%; width: 65%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Weighted</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center">Number</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Average</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center">Of</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Exercise</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Options</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Price</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: justify">Options outstanding at December 31, 2017</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 18%; text-align: right">677,125</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 18%; text-align: right">8.00</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Changes during the period:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Expired</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">New Options Granted – at market price</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">10,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">8.00</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: justify">Exercised</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: justify">Options outstanding at March 31, 2018</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left"> </td> <td style="border-bottom: black 2pt double; text-align: right">687,125</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">8.00</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: justify">Options exercisable at March 31, 2018</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left"> </td> <td style="border-bottom: black 2pt double; text-align: right">337,158</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">8.00</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table>   All options granted thus far under the 2017 Plan have an exercise price of $8.00 per share and vesting of the options ranges from immediate to 20% per year, with most options vesting on a straight-line basis over a four-year period from the date of grant. The options expire in seven years from the date of grant.   During the three months ended March 31, 2018, the Company granted 10,000 employee stock options with an aggregate grant date fair value of $28,755. The fair value of the options granted was estimated on the date of grant using the Black Scholes option-pricing model using the following assumptions: Stock price: $8.00, Exercise Price: $8.00, Expected Term: 4.75, Volatility: 37.34%, Risk free rate: 2.65%, Dividend rate: 0%. As of March 31, 2018, 687,125 stock options and 10,000 shares of restricted stock awards were outstanding under our 2017 Plan.   Stock-based compensation expense was $87,764 and $88,370 for the three months ended March 31, 2018 and 2017, respectively. As of March 31, 2018 there was approximately $895,00 in unrecognized compensation cost related to the options granted under the 2017 plan. NOTE 7 – CAPITAL LEASES   As of March 31, 2018, and December 31, 2017, we have capital lease obligations as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">March 31, 2018</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">December 31, 2017</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: justify">Capital lease obligations</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">114,970</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">149,120</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify">Unamortized warrant discount</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(8,346</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(15,040</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Net obligations</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">106,624</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">134,080</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify">Short-term portion of obligations</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(91,985</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(118,553</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: justify">Long-term portion of obligations</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">14,639</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">15,527</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table> NOTE 8 — Customer, Supplier, country, and Product Concentrations   Grants and Licensing Revenue Concentration   There was no licensing or grant revenue to report during the first quarter of 2018. Two grantors accounted for 94% and 6% respectively of total grant revenue reported during the first quarter of 2017. The company’s licensing revenue in the first quarter of 2017 came from one licensor.   Product Concentration   During the first quarter of 2018 and 2017, we had concentrations of product revenue from only one product that was greater than 10% of total product revenues. Revenue from one of the Company’s graphene nanoplatelets materials, Grade C 500 m2/g, was 83% as of March 31, 2018 and 29% as of March 31, 2017. We attempt to minimize the risk associated with product concentrations by continuing to develop new products to add to our portfolio.   Customer Concentration   During the first quarter of 2018, we had one customer whose purchases accounted for 83% of total product revenues. During the first quarter of 2017 we had two customers that represented 29% and 22 % of total product revenues. At March 31, 2018 and 2017, there were two customers who each had an accounts receivable balance greater than 10% of our total outstanding receivable balance.   Country Concentration   We sell our products on a worldwide basis. Revenue derived from customers outside of the U.S. during the first quarter of 2018 was 3% as compared with 40% during the first quarter of 2017. All of these sales are denominated in U.S. dollars.   As of March 31, 2018, there were no foreign countries with greater than 10% of product revenue. During the quarter ended March 31, 2017, two countries, the United Kingdom and South Korea accounted for approximately 24% and 16%, respectively, of total product revenue.   Suppliers   We buy raw materials used in manufacturing from several sources. These materials are available from a large number of sources. A change in suppliers has no material effect on the Company’s operations. We did not have purchases from any suppliers that were greater than 10% of total purchases during the quarters ended March 31, 2018 and 2017. NOTE 9 - RELATED PARTY TRANSACTIONS   We have a licensing agreement for exclusive use of patents and pending patents with Michigan State University (“MSU”), a shareholder of the Company via the MSU Foundation. We incurred $12,500 of licensing expense in each of the three month periods ended March 31, 2018 and 2017.   We have also entered into product licensing agreements with certain other shareholders. No royalty revenue or expenses have been recognized related to these agreements during the three months ended March 31, 2018. For the three months ended March 31, 2017, $25,000 of royalty revenue was recorded from POSCO, a shareholder.   During each of the three months ended March 31, 2018 and 2017 we issued 7,140 shares of Series A Preferred Stock to AAOF as payment for lease financing obligations under the terms of the Master Lease Agreement, dated March 18, 2013. NOTE 10 – SUBSEQUENT EVENTS   During the period from April 1 through May 14, 2018, we received common stock proceeds of $858,000 for the sale of 107,250 shares of common stock in our IPO. Liquidity   We have historically incurred losses from operations and we may continue to generate negative cash flows as we implement our business plan. Our condensed consolidated financial statements are prepared using US GAAP as applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.   We filed a Registration Statement on Form S-1 (File No. 333-209131) with the SEC on April 11, 2016 which was declared effective by the SEC on April 13, 2016 (as amended, the “Registration Statement”). The Registration Statement registered up to 3,000,000 shares of common stock at a fixed price of $8.00 per share to the general public in a self-underwritten offering (the “Offering” or our “IPO”). Post-Effective Amendment No. 1 to the Registration Statement was declared effective August 26, 2016, Post-Effective Amendment No. 2 was declared effective August 31, 2016, Post-Effective Amendment No. 3 was declared effective January 17, 2017, and Post-Effective Amendments No. 4 and No. 5 were dated April 12, 2017. Post-Effective Amendment No. 5 was declared effective April 14, 2017. Although we are currently selling shares of our common stock in our IPO pursuant to our Registration Statement, we have not yet listed the company for trading on any exchanges.   In December 2016, we entered into a draw loan note and agreement (the “Dow Facility”) with The Dow Chemical Company (“Dow”) to provide up to $10 million of secured debt financing at an interest rate of 5% per year, drawable at our request under certain conditions. As of May 14, 2018, we had drawn $5.0 million under the Dow Facility. The remaining $5 million will become available to us once we have raised $10 million of equity capital after October 31, 2016.  As of May 14, 2018, we have sold 1,276,007 shares of common stock pursuant to our IPO at a price of $8.00 per share for gross proceeds of $10,208,056. However, only $7,007,024 of this amount has been raised during the measurement period beginning November 1, 2016. Thus, we still need to raise $2,992,976 of additional equity capital prior to the remaining $5.0 million under the Dow Facility becoming available to us.   As of May 14, 2018, we had cash on hand of $1,660,600. We believe our cash from increasing commercial sales activity and various financing sources will fund our operations for at least the next 12 months. We intend that the primary means for raising funds will be through our IPO and the additional $5 million of proceeds from the Dow Facility that becomes available to us after we have raised another $3 million of equity capital as noted above; however, we can make no assurances that we will raise such equity capital and be able to access the additional $5 million under the Dow Facility. Taking into account our current cash position as noted above, an additional $3 million in proceeds from our IPO, which would allow us to draw up to $5 million from the Dow Facility, we believe that we can fund our operations including planned capital expenditures for at least the next 12 months. In addition, two of our shareholders have committed to provide up to $4.5 million in funding for the twelve-month period ended March 31, 2019 to the extent the Company is unable to raise such funds from other third parties.   In the event we are unable to fund our operations from existing cash on hand, operating cash flows, additional borrowings or raising equity capital, we may be forced to reduce our expenses, slow down our growth rate, or discontinue operations. Our condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern. Use of Estimates   The preparation of our condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, together with amounts disclosed in the related notes to the financial statements. Actual results and outcomes may differ from our estimates, judgments and assumptions. Significant estimates, judgments and assumptions used in these condensed consolidated financial statements include, but are not limited to, those related to revenue, accounts receivable and related allowances, contingencies, useful lives and recovery of long-term assets, including intangible assets, income taxes, and the fair value of stock-based compensation. These estimates, judgments, and assumptions are reviewed periodically and the effects of material revisions in estimates are reflected in the financial statements prospectively from the date of the change in estimate. Inventory   Inventory consists of raw materials, work-in-process and finished goods, all of which are stated at the lower of cost or market. Cost is determined on a first in, first out basis.   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>The following amounts were included in inventory at the end of the period:</td> <td> </td> <td colspan="6" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center">March 31,</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">December 31,</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2018</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2017</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 72%; text-align: left; padding-left: 10pt; text-indent: -10pt">Raw materials</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 11%; text-align: right">79,581</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 11%; text-align: right">39,841</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 10pt; text-indent: -10pt">Finished goods</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">130,130</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">132,023</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; padding-left: 10pt; text-indent: -10pt">Total</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">209,711</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">171,864</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr></table> Fair Value Measurements   The Company utilizes a valuation hierarchy that prioritizes fair value measurements based on the types of inputs used for the various valuation techniques related to its financial assets and financial liabilities in accordance to Accounting Standards Codification (“ASC”) Topic 820 Fair Value Measurements and Disclosures.   For financial instruments such as cash, accounts payable and other current liabilities, the Company considers the recorded value of such financial instruments approximate to the current fair value because of their short-term nature. Recent Accounting Pronouncements   ASU No. 2014-09 (ASC 606), Revenue from Contracts with Customers became effective for us beginning with the first quarter of 2018, and we adopted the new accounting standard using the modified retrospective transition approach. The modified retrospective transition approach recognized any changes from the beginning of the year of initial application through retained earnings with no restatement of comparative periods. We will record revenue under ASC 606 at a single point in time, when control is transferred to the customer, which is consistent with past practice. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure under the new standard. Based on the results of the evaluation, we have determined that the adoption of the new standard presents no material impact on our consolidated financial statements. Application of the transition requirements of the new standard did not have a material impact on opening retained earnings.  Derivative Financial Instruments   We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. The terms of convertible preferred stock and convertible notes that we issue are reviewed to determine whether or not they contain embedded derivative instruments that are required by ASC 815: “Derivatives and Hedging” to be accounted for separately from the host contract and recorded at fair value. In addition, freestanding warrants are also reviewed to determine if they achieve equity classification. Certain stock warrants that we issued did not meet the conditions for equity classification at inception and were classified as derivative instrument liabilities measured at fair value.   In July 2017, the FASB issued Accounting Standards Update No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities From Equity (Topic 480), Derivatives and Hedging (Topic 815) (“ASU 2017-11”). This update changes the classification analysis of certain equity-linked financial instruments with down-round features. We elected to early adopt ASU 2017-11 at September 30, 2017 by applying the standard retrospectively to outstanding financial instruments with a down round feature by means of a cumulative-effect adjustment to the Company’s beginning accumulated deficit as of January 1, 2017. There were 972,720, warrants indexed to Series A Preferred Stock which were originally recorded as derivative liabilities because of their anti-dilution features. We chose to early adopt ASU 2017-11 because it permitted these warrants to be recorded as equity rather than derivative liabilities. The impact to the financial statements for the three months ended March 31, 2017 is as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center">For three months ended March 31, 2017</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center">As previously</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">As</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">reported</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Adjusted</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 72%; text-align: justify">Operating loss</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 11%; text-align: right">(1,465,882</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 11%; text-align: right">(1,465,882</td> <td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Other income (expense):</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Incentive refund and interest income</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">368</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">368</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Interest expense, net</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(59,480</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(59,480</td> <td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify">Gain from change in fair value of derivative warrants</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">154,652</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">29,171</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: justify">Total other income (expense)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">95,540</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(29,941</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: justify">Net loss</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">(1,370,342</td> <td style="padding-bottom: 2pt; text-align: left">)</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">(1,495,823</td> <td style="padding-bottom: 2pt; text-align: left">)</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>The following amounts were included in inventory at the end of the period:</td> <td> </td> <td colspan="6" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">March 31,</td> <td> </td> <td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">December 31,</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2018</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2017</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt; text-indent: -10pt; width: 72%">Raw materials</td> <td style="width: 1%"> </td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 11%">79,581</td> <td style="text-align: left; width: 1%"> </td> <td style="width: 1%"> </td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 11%">39,841</td> <td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 10pt; text-indent: -10pt">Finished goods</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">130,130</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">132,023</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; padding-left: 10pt; text-indent: -10pt">Total</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">209,711</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">171,864</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table> The impact to the financial statements for the three months ended March 31, 2017 is as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="white-space: nowrap; text-align: center">For three months ended March 31, 2017</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">As previously</td> <td> </td> <td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">As</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">reported</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Adjusted</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 72%; text-align: justify">Operating loss</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 11%; text-align: right">(1,465,882</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 11%; text-align: right">(1,465,882</td> <td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Other income (expense):</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Incentive refund and interest income</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">368</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">368</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Interest expense, net</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(59,480</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(59,480</td> <td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify">Gain from change in fair value of derivative warrants</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">154,652</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">29,171</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: justify">Total other income (expense)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">95,540</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(29,941</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: justify">Net loss</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">(1,370,342</td> <td style="padding-bottom: 2pt; text-align: left">)</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">(1,495,823</td> <td style="padding-bottom: 2pt; text-align: left">)</td></tr></table> The following table summarizes the warrants (including the warrants previously accounted for as derivatives) outstanding at March 31, 2018, which are accounted for as equity instruments, all of which are exercisable:    <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center">Date Issued</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: center">Expiration Date</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: center">Indexed Stock</td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Exercise Price</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Number of  Warrants</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 24%">07/01/2009</td> <td style="width: 1%"> </td> <td style="width: 18%">07/01/2019</td> <td style="width: 1%"> </td> <td style="width: 18%; text-align: center">Common</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 16%; text-align: right">8.00</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 16%; text-align: right">6,000</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>10/08/2012</td> <td> </td> <td>10/08/2027</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">12.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">5,000</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>01/15/2014 – 12/31/2014</td> <td> </td> <td>01/15/2024</td> <td> </td> <td style="text-align: center">Series A Convertible Preferred</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">6.40</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">972,720</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>04/30/2015- 05/26/2015</td> <td> </td> <td>04/30/2022</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">16.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">218,334</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>06/30/2015</td> <td> </td> <td>06/30/2022</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">16.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">6,563</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>12/31/2015</td> <td> </td> <td>12/31/2020</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">8.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">20,625</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>03/31/2016</td> <td> </td> <td>03/31/2021</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">10.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">10,600</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>04/30/2016</td> <td> </td> <td>04/30/2021</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">10.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">895</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>12/14/2016</td> <td> </td> <td>12/01/2023</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">8.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">50,000</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>07/18/2017</td> <td> </td> <td>12/01/2023</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">8.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">25,000</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>09/22/2017</td> <td> </td> <td>12/01/2023</td> <td> </td> <td style="text-align: center">Common</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">8.00</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">25,000</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">12/04/2017</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt">12/01/2023</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: center">Common</td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left">$</td> <td style="text-align: right">8.00</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">25,000</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt"> </td> <td style="padding-bottom: 2pt"> </td> <td style="padding-bottom: 2pt"> </td> <td style="padding-bottom: 2pt"> </td> <td style="padding-bottom: 2pt; text-align: center"> </td> <td style="padding-bottom: 2pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left"> </td> <td style="border-bottom: black 2pt double; text-align: right">1,365,737</td></tr> </table> A summary of the stock option activity for the three months ended March 31, 2018 is as follows:    <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 10%; width: 65%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Weighted</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center">Number</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Average</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center">Of</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Exercise</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Options</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Price</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: justify">Options outstanding at December 31, 2017</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 18%; text-align: right">677,125</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 18%; text-align: right">8.00</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Changes during the period:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Expired</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">New Options Granted – at market price</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">10,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">8.00</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: justify">Exercised</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: justify">Options outstanding at March 31, 2018</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left"> </td> <td style="border-bottom: black 2pt double; text-align: right">687,125</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">8.00</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: justify">Options exercisable at March 31, 2018</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left"> </td> <td style="border-bottom: black 2pt double; text-align: right">337,158</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">8.00</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table> As of March 31, 2018, and December 31, 2017, we have capital lease obligations as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center">March 31, 2018</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center">December 31, 2017</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: justify">Capital lease obligations</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">114,970</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">149,120</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify">Unamortized warrant discount</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(8,346</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(15,040</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Net obligations</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">106,624</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">134,080</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify">Short-term portion of obligations</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(91,985</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; text-align: left"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(118,553</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: justify">Long-term portion of obligations</td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">14,639</td> <td style="padding-bottom: 2pt; text-align: left"> </td> <td style="padding-bottom: 2pt"> </td> <td style="border-bottom: black 2pt double; text-align: left">$</td> <td style="border-bottom: black 2pt double; text-align: right">15,527</td> <td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table> 2009-07-01 2012-10-08 2014-01-15 2014-12-31 2015-04-30 2015-05-26 2015-06-30 2015-12-31 2016-03-31 2016-04-30 2016-12-14 2017-07-18 2017-09-22 2017-12-04 2019-07-01 2027-10-08 2024-01-15 2022-04-30 2022-06-30 2020-12-31 2021-03-31 2021-04-30 2023-12-01 2023-12-01 2023-12-01 2023-12-01 8.00 12.00 6.40 16.00 16.00 8.00 10 10.00 8.00 8.00 8 8.00 8.00 Common Common Series A Convertible Preferred Common Common Common Common Common Common Common Common Common 1365737 6000 5000 972720 218334 6563 20625 10600 895 50000 25000 25000 25000 677125 687125 687125 10000 10000 2500 2500 337158 8 8 8 8.00 8.00 8 1200000 0.20 Vesting of the options ranges from immediate to 20% per year, with most options vesting on a straight-line basis over a four-year period from the date of grant. Fifty percent of such awards vested on the date of grant with the remaining vesting over a 4-year period The options vest ratably over a four-year period beginning on the one-year anniversary. Vesting of the options ranges from immediate to 20% per year, with most options vesting on a straight-line basis over a four-year period from the date of grant. P7Y 60000 P4Y9M 0.00 0.3734 0.0265 7500 12500 12500 53082 0.83 0.29 0.94 0.06 0.83 0.29 0.22 0.03 0.40 0.24 0.16 2 Graphene nanoplatelets materials, Grade C 500 m2/g 201925 1276007 3000000 10208056 12.00 16.00 Series A Preferred was reduced from $12.00 to $6.40 (80% of $8.00), and thus, each share of Series A Preferred Stock is convertible into 1.875 shares of common stock. one share of Common Stock at the lower of: (a) $12.00 per share, or (b) 80% of the price at which the Company sells any equity or equity-linked securities in the future. 12.00 16.00 6.40 1456126 7140 4869714 4794596 10000000 2000000 1000000 1000000 1000000 75118 161702 125000 Interest is payable beginning January 1, 2017 although we may elect to capitalize interest through January 1, 2019. Dow received warrant coverage of one share of common stock for each $40 in loans received by us, equating to 20% warrant coverage, with an exercise price of $8.00 per share for the warrants issued at closing of the initial $2 million draw. 0.05 2021-12-01 8.00 8.00 2992976 7007024 5000000 5000000 132023 130130 39841 79581 972720 The remaining $5 million will become available to us once we have raised $10 million of equity capital after October 31, 2016.  Additional $5 million becomes available under the Dow Facility if we have raised $10 million of equity capital after October 31, 2016. 4500000 P7Y Each option holder received options equal to 150% of the number of cancelled stock options. 26120 80000 8.00 8.00 28755 149120 114970 15040 8346 134080 106624 25000 89500 EX-101.SCH 10 cik0001435375-20180331.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - WARRANTS AND FINANCING AGREEMENTS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - EQUITY INCENTIVE PLAN link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - CAPITAL LEASES link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - CUSTOMER, SUPPLIER, COUNTRY AND PRODUCT CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - EQUITY INCENTIVE PLAN (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - CAPITAL LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - WARRANTS AND FINANCING AGREEMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - EQUITY INCENTIVE PLAN (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - EQUITY INCENTIVE PLAN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - CAPITAL LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - CUSTOMER, SUPPLIER, COUNTRY AND PRODUCT CONCENTRATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 cik0001435375-20180331_cal.xml XBRL CALCULATION FILE EX-101.DEF 12 cik0001435375-20180331_def.xml XBRL DEFINITION FILE EX-101.LAB 13 cik0001435375-20180331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Series A Convertible Preferred Stock [Member] Equity Components [Axis] Preferred Stock (A) [Member] Common Stock [Member] Additional Paid-In Capital [Member] Accumulated Deficit [Member] Warrant [Member] Warrant 1 [Member] Warrant 2 [Member] Range [Axis] Minimum [Member] Maximum [Member] Warrant 3 [Member] Warrant 4 [Member] Warrant 5 [Member] Warrant 6 [Member] Warrant 7 [Member] Warrant 8 [Member] Warrant 9 [Member] Warrant 10 [Member] Warrant 11 [Member] Plan Name [Axis] Incentive Stock Option Plan [Member] 2007 Stock Option Plan [Member] Award Type [Axis] Restricted Stock [Member] Related Party [Axis] Four Diretors [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Licensing Agreement [Member] Michigan State University (Patents and Pending Patents) [Member] Master Leasing Agreement [Member] Legal Entity [Axis] Aspen Advance Opportunity Fund, LP (AAOF) [Member] Series A Preferred stock [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Accounts Receivable Greater Than 10% [Member] Customer [Axis] Customer [Member] Product Concentration Risk [Member] Total Product Revenues [Member] Products and Services [Axis] Product One [Member] Grants and Licensing Revenue Concentration [Member] Total Grant Revenue [Member] Grantor One [Member] Grantor Two [Member] Customer One [Member] Customer Two [Member] Country Concentration Risk [Member] Geographic Distribution [Axis] Foreign [Member] Geographical [Axis] United Kingdom Korea (South), Won Sale of Stock [Axis] IPO [Member] Aspen Advance Opportunity Fund, LP [Member] Preferred stock (B) [Member] Draw Loan Note And Agreement [Member] Debt Instrument [Axis] Senior Secured Debt Financing [Member] The Dow Chemical Company [Member] Scenario [Axis] Scenario, Previously Reported [Member] As Adjusted [Member] Stock Option [Member] POSCO [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity a Well-known Seasoned Issuer Entity a Voluntary Filer Entity's Reporting Status Current Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement [Table] Statement [Line Items] ASSETS CURRENT ASSETS Cash Accounts receivable, less allowance for doubtful accounts of $40,000 at March 31, 2018 and December 31, 2017 Inventories Other current assets Total current assets PROPERTY, PLANT AND EQUIPMENT, NET RESTRICTED CASH FOR LETTER OF CREDIT LEASE DEPOSIT INTANGIBLE ASSETS, NET TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable and other current liabilities Deferred revenue Current portion of capital lease obligations Total current liabilities LONG-TERM LIABILITIES Long-term portion of capital lease obligations Long term debt Total long-term liabilities TOTAL LIABILITIES STOCKHOLDERS' EQUITY Preferred stock, value Common stock, no par value, 25,000,000 shares authorized, 2,555,275 and 2,353,350 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively Additional paid-in capital Accumulated deficit Total stockholders' equity TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Allowance for doubtful accounts Preferred stock, authorized Preferred stock, issued Preferred stock, outstanding Preferred stock, liquidation value Common stock, no par value (in dollars per share) Common stock, authorized Common stock, issued Common stock, outstanding Condensed Consolidated Statements Of Operations REVENUE Product sales Grants Licensing revenue Total revenues COST OF GOODS SOLD Direct costs Unallocated manufacturing expenses Total cost of goods sold GROSS LOSS OPERATING EXPENSES Research and development Sales, general and administrative Total operating expenses OPERATING LOSS OTHER INCOME (EXPENSE) Interest expense, net Gain from change in fair value of derivative liability - warrants Government incentives, net Total other expense NET LOSS WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - Basic and diluted (in shares) NET LOSS PER SHARE - Basic and diluted (in dollars per share) Increase (Decrease) in Stockholders' Equity [Roll Forward] Balances at beginning Balances at beginning (in shares) Stock issued for cash Stock issued for cash (in shares) Stock issuance fees and expenses Preferred stock issued to pay capital lease obligations Preferred stock issued to pay capital lease obligations (in shares) Stock-based compensation expense Net loss Balances at ending Balances at ending (in shares) Condensed Consolidated Statements Of Cash Flows CASH FLOWS FROM OPERATING ACTIVITIES Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Amortization of intangible assets Stock-based compensation expense Non-cash interest expense Non-cash equipment rent expense Gain from change in fair value of derivative liability - warrants Changes in current assets and liabilities: Accounts receivable Inventory Other current and non-current assets Accounts payable and other liabilities NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES Purchases of property and equipment Purchases of intangible assets NET CASH USED IN INVESTING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES Repayments of capital lease obligations Proceeds from issuance of common stock Common stock issuance fees and expenses NET CASH PROVIDED BY FINANCING ACTIVITIES NET DECREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS AT END OF PERIOD SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid for interest SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING: Value of preferred stock issued for AAOF capital lease obligations Reclassification of derivative liability warrants to equity - ASU 2017-11 (see note 2) Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF BUSINESS AND BASIS OF PRESENTATION Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Debt Disclosure [Abstract] WARRANTS AND FINANCING AGREEMENTS Equity [Abstract] STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS Stockholders' Equity Note [Abstract] STOCKHOLDERS' EQUITY (DEFICIT) Disclosure of Compensation Related Costs, Share-based Payments [Abstract] EQUITY INCENTIVE PLAN Capital Leases of Lessee [Abstract] CAPITAL LEASES Risks and Uncertainties [Abstract] CUSTOMER, SUPPLIER, COUNTRY AND PRODUCT CONCENTRATIONS Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Subsequent Events [Abstract] SUBSEQUENT EVENTS Liquidity Use of Estimates Inventory Derivative Financial Instruments Fair Value Measurements Recent Accounting Pronouncements Schedule of inventory Schedule of financial statements Schedule of common stock warrants (including the warrants previously accounted for as derivatives) outstanding Schedule of summary of the stock option activity Schedule of capital lease obligations Raw materials Finished goods Total Operating loss Other income (expense): Incentive refund and interest income Gain from change in fair value of derivative warrants Total other income (expense) Number of shares issued in offering Price per share (in dollars per share) Gross proceeds from issued in offering Derivative liability Face amount Interest rate (in percent) Equity capital raise amount Description of raising fund Cash on hand Proceeds from capital contribution Proceeds from secured debt Amortization expense of debt Number of shares purchased (in shares) Description of conversion terms Maturity date Proceeds from issuance initial public offering Date Issued Expiration Date Exercise Price Indexed stock Number of Warrants Liquidation (in dollars per share) Description of conversion of stock Conversion price (in dollars per share) Reduction in share price (in dollars per share) Exercise price (in dollars per share) Number of shares issued Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Options outstanding at beginning of year Changes during the year: Expired New Options Granted - at market price Exercised Options outstanding at end of Period Options exercisable at end of Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [RollForward] Options outstanding at beginning of year Changes during the year: Expired New Options Granted - at market price Exercised Options outstanding at end of Period Options exercisable at end of Period Maximum number of options authorized Number of option granted Vesting percent, per year Unrecognized compensation cost Description of vesting terms Description of vesting terms of replacement options Options expiration year Exercise price (in dollars per share) Vesting period Compensation cost Description of cancellation terms Stock price Exercise Price Expected Term Dividend rate Volatility Risk free rate Aggregate grant date fair value Aggregate grant date fair value Number of shares vested (in shares) Proceeds from option granted Number of option outstanding Capital lease obligations Unamortized warrant discount Net obligations Short-term portion of obligations Long-term portion of obligations Concentration of risk Number of customers Description of product Licensing expenses Number of shares issued Royalty revenue Amount of restricted cash for letter of credit. The gross result for the period of deducting operating expenses from operating revenues. Amount of incentive refund and interest income. Represent information about the stock issued during period value for the shares preferred stock issued to pay capital lease obligations. Represent information about the stock issued during period shares preferred stock issued to pay capital lease obligations. It represents value of gain from change in fair value of derivative liability - warrants. Equity impact of the value of preferred stock issued for capita; lease obligations. It represents value of Reclassification of derivative liability warrants to equity. The entire disclosure of liquidity. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Date the warrants or rights are exercisable, in CCYY-MM-DD format. Date the warrants or rights are exercisable, in CCYY-MM-DD format. Represents as a indexed stock of warrant. Information related to number of warrants issued during period. Information by plan name pertaining to equity-based compensation arrangements. Information by plan name pertaining to equity-based compensation arrangements. Information related to four board director. Disclosure about the vesting terms of replacement options. Disclosure about cancellation terms. It represents value of aggregate grant date fair value. It represents value of aggregate grant date fair value. Information about legal entity. Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date. Information related to unamortized warrant discount. Information by category of arrangement, Information by type of related party. Information by category of arrangement, Amount of noncash equipment rent expense. Information about customer. Information about product. Information about grant and licensin revenue concentration. Information about grant revenue. Information about legal entity. Information about legal entity. Information about customer. Information about customer. Represents the number of customers. The price per share of the conversion feature embedded in the debt instrument. The amount of reduction in per share of common stock or unit outstanding during the reporting period. Information about agreement. The set of legal entities associated with a report. Description of raising fund. It represents value of equity capital raise amount. Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. Assets, Current Assets Liabilities, Current Liabilities, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Revenue, Net Cost of Goods and Services Sold OperatingGrossLoss Operating Expenses Interest Expense Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Shares, Outstanding Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Share-based Compensation GainFromChangeInFairValueOfDerivativeLiabilityWarrants Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Other Operating Assets Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities Repayments of Debt and Capital Lease Obligations Payments of Stock Issuance Costs Net Cash Provided by (Used in) Financing Activities Cash, Period Increase (Decrease) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue1 UnamortizedWarrantDiscount Capital Lease Obligations EX-101.PRE 14 cik0001435375-20180331_pre.xml XBRL PRESENTATION FILE XML 15 R1.htm IDEA: XBRL DOCUMENT v3.8.0.1

Document and Entity Information - shares
3 Months Ended

Mar. 31, 2018

May 14, 2018

Document And Entity Information

Entity Registrant Name XG SCIENCES INC

Entity Central Index Key 0001435375

Document Type 10-Q

Document Period End Date Mar. 31, 2018

Amendment Flag false

Current Fiscal Year End Date --12-31

Entity a Well-known Seasoned Issuer No

Entity a Voluntary Filer No

Entity's Reporting Status Current Yes

Entity Filer Category Smaller Reporting Company

Entity Common Stock, Shares Outstanding 2,662,525

Document Fiscal Period Focus Q1

Document Fiscal Year Focus 2018

X

- References
No definition available.
+ Details

Name: cik0001435375_DocumentAndEntityInformationAbstract

Namespace Prefix: cik0001435375_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

XML 16 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)

Mar. 31, 2018

Dec. 31, 2017

CURRENT ASSETS

Cash $ 2,285,117 $ 2,845,798

Accounts receivable, less allowance for doubtful accounts of $40,000 at March 31, 2018 and December 31, 2017 668,040 468,623

Inventories 209,711 171,864

Other current assets 91,588 15,781

Total current assets 3,254,456 3,502,066

PROPERTY, PLANT AND EQUIPMENT, NET 3,266,797 2,601,571

RESTRICTED CASH FOR LETTER OF CREDIT 195,865 195,792

LEASE DEPOSIT 20,156 20,156

INTANGIBLE ASSETS, NET 574,579 571,938

TOTAL ASSETS 7,311,853 6,891,523

CURRENT LIABILITIES

Accounts payable and other current liabilities 1,332,951 858,077

Deferred revenue 189 7,298

Current portion of capital lease obligations 91,985 118,553

Total current liabilities 1,425,125 983,928

LONG-TERM LIABILITIES

Long-term portion of capital lease obligations 14,639 15,527

Long term debt 4,869,714 4,794,596

Total long-term liabilities 4,884,353 4,810,123

TOTAL LIABILITIES 6,309,478 5,794,051

STOCKHOLDERS' EQUITY

Preferred stock, value

Common stock, no par value, 25,000,000 shares authorized, 2,555,275 and 2,353,350 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively 20,741,574 19,116,012

Additional paid-in capital 7,899,722 7,831,958

Accumulated deficit (49,641,638) (47,767,544)

Total stockholders' equity 1,002,375 1,097,472

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 7,311,853 6,891,523

Series A Convertible Preferred Stock [Member]

STOCKHOLDERS' EQUITY

Preferred stock, value $ 22,002,717 $ 21,917,046

X

- Definition
Amount of restricted cash for letter of credit.
+ References
No definition available.
+ Details

Name: cik0001435375_RestrictedCashForLetterOfCredit

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.
+ References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of capital lease obligation due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84164758&loc=d3e45023-112735
+ Details

Name: us-gaap_CapitalLeaseObligationsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84164758&loc=d3e45023-112735

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CapitalLeaseObligationsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(b).Q1(c))
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6935-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 13.A.4(a).Q1)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(b).Q2)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(b))
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3(c).Q3)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780
+ Details

Name: us-gaap_DeferredRevenueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph ((a)(1),(b))
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765
+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of obligation due after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 201.5-02(26))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(23))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 201.5-02(25))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 201.5-02(24))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of current assets classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8,17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_SecurityDeposit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 17 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($)

Mar. 31, 2018

Dec. 31, 2017

Allowance for doubtful accounts $ 40,000 $ 40,000

Common stock, no par value (in dollars per share) $ 0 $ 0

Common stock, authorized 25,000,000 25,000,000

Common stock, issued 2,555,275 2,353,350

Common stock, outstanding 2,555,275 2,353,350

Series A Convertible Preferred Stock [Member]

Preferred stock, authorized 3,000,000 3,000,000

Preferred stock, issued 1,864,956 1,857,816

Preferred stock, outstanding 1,864,956 1,857,816

Preferred stock, liquidation value $ 22,379,472 $ 22,293,792

X

- Definition
A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84173941&loc=d3e5074-111524
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face amount per share of no-par value common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockNoParValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Value of the difference between preference in liquidation and the par or stated values of the preferred shares.
+ References
No definition available.
+ Details

Name: us-gaap_PreferredStockLiquidationPreferenceValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 18 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
3 Months Ended

Mar. 31, 2018

Mar. 31, 2017

REVENUE

Product sales $ 886,337 $ 157,700

Grants 99,489

Licensing revenue 25,000

Total revenues 886,337 282,189

COST OF GOODS SOLD

Direct costs 468,191 116,770

Unallocated manufacturing expenses 746,583 371,150

Total cost of goods sold 1,214,774 487,920

GROSS LOSS (328,437) (205,731)

OPERATING EXPENSES

Research and development 277,063 263,564

Sales, general and administrative 1,186,679 996,587

Total operating expenses 1,463,742 1,260,151

OPERATING LOSS (1,792,179) (1,465,882)

OTHER INCOME (EXPENSE)

Interest expense, net (85,169) (59,088)

Gain from change in fair value of derivative liability - warrants 29,171

Government incentives, net 3,253 (24)

Total other expense (81,916) (29,941)

NET LOSS $ (1,874,095) $ (1,495,823)

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - Basic and diluted (in shares) 2,454,314 1,920,090

NET LOSS PER SHARE - Basic and diluted (in dollars per share) $ (0.76) $ (0.78)

X

- Definition
Amount of incentive refund and interest income.
+ References
No definition available.
+ Details

Name: cik0001435375_IncentiveRefundAndInterestIncome

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The gross result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: cik0001435375_OperatingGrossLoss

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_CostOfGoodsAndServicesSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CostOfGoodsAndServicesSoldAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Cost of materials used in goods produced and sold during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_CostOfGoodsSoldDirectMaterials

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5618551-113959
+ Details

Name: us-gaap_GainLossOnDerivativeInstrumentsNetPretax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28555-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_LicensesRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate costs incurred in the production of goods for sale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_ManufacturingCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756
+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_RevenueFromGrants

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(a))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_SalesRevenueGoodsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SalesRevenueNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311
+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 19 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (unaudited) - 3 months ended Mar. 31, 2018 - USD ($)

Preferred Stock (A) [Member]

Common Stock [Member]

Additional Paid-In Capital [Member]

Accumulated Deficit [Member]

Total

Balances at beginning at Dec. 31, 2017 $ 21,917,046 $ 19,116,012 $ 7,831,958 $ (47,767,544) $ 1,097,472

Balances at beginning (in shares) at Dec. 31, 2017 1,857,816 2,353,350

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock issued for cash $ 1,615,400 1,615,400

Stock issued for cash (in shares) 201,925

Stock issuance fees and expenses $ (9,838) (9,838)

Preferred stock issued to pay capital lease obligations $ 85,671 85,671

Preferred stock issued to pay capital lease obligations (in shares) 7,140

Stock-based compensation expense 20,000 67,764 87,764

Net loss (1,874,095) (1,874,095)

Balances at ending at Mar. 31, 2018 $ 22,002,717 $ 20,741,574 $ 7,899,722 $ (49,641,638) $ 1,002,375

Balances at ending (in shares) at Mar. 31, 2018 1,864,956 2,555,275

X

- Definition
Represent information about the stock issued during period shares preferred stock issued to pay capital lease obligations.
+ References
No definition available.
+ Details

Name: cik0001435375_StockIssuedDuringPeriodSharesPreferredAStockIssuedToPayCapitalLeaseObligations

Namespace Prefix: cik0001435375_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Represent information about the stock issued during period value for the shares preferred stock issued to pay capital lease obligations.
+ References
No definition available.
+ Details

Name: cik0001435375_StockIssuedDuringPeriodValuePreferredAStockIssuedToPayCapitalLeaseObligations

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in additional paid-in capital (APIC) from recognition of equity-based compensation for employee stock purchase program.
+ References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInStockholdersEquityRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares issued which are neither cancelled nor held in the treasury.
+ References
No definition available.
+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=96868048&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=96868048&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 20 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
3 Months Ended

Mar. 31, 2018

Mar. 31, 2017

CASH FLOWS FROM OPERATING ACTIVITIES

Net loss $ (1,874,095) $ (1,495,823)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization 209,131 214,770

Amortization of intangible assets 12,934 10,590

Stock-based compensation expense 87,764 88,370

Non-cash interest expense 85,973 59,480

Non-cash equipment rent expense 53,082

Gain from change in fair value of derivative liability - warrants (29,171)

Changes in current assets and liabilities:

Accounts receivable (199,417) 14,680

Inventory (37,847) 8,229

Other current and non-current assets (75,881) 103,558

Accounts payable and other liabilities 467,765 17,576

NET CASH USED IN OPERATING ACTIVITIES (1,270,591) (1,007,741)

CASH FLOWS FROM INVESTING ACTIVITIES

Purchases of property and equipment (874,357) (203,664)

Purchases of intangible assets (15,574) (37,769)

NET CASH USED IN INVESTING ACTIVITIES (889,931) (241,433)

CASH FLOWS FROM FINANCING ACTIVITIES

Repayments of capital lease obligations (5,721) (4,875)

Proceeds from issuance of common stock 1,615,400 771,800

Common stock issuance fees and expenses (9,838) (154,413)

NET CASH PROVIDED BY FINANCING ACTIVITIES 1,599,841 612,512

NET DECREASE IN CASH AND CASH EQUIVALENTS (560,681) (636,662)

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 2,845,798 1,785,343

CASH AND CASH EQUIVALENTS AT END OF PERIOD 2,285,117 1,148,681

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

Cash paid for interest 220

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING:

Value of preferred stock issued for AAOF capital lease obligations 85,671 85,672

Reclassification of derivative liability warrants to equity - ASU 2017-11 (see note 2) $ 125,481

X

- Definition
It represents value of gain from change in fair value of derivative liability - warrants.
+ References
No definition available.
+ Details

Name: cik0001435375_GainFromChangeInFairValueOfDerivativeLiabilityWarrants

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of noncash equipment rent expense.
+ References
No definition available.
+ Details

Name: cik0001435375_NoncashEquipmentRentExpense

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
It represents value of Reclassification of derivative liability warrants to equity.
+ References
No definition available.
+ Details

Name: cik0001435375_ReclassificationOfDerivativeLiabilityWarrantsToEquityAsu201711

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Equity impact of the value of preferred stock issued for capita; lease obligations.
+ References
No definition available.
+ Details

Name: cik0001435375_ValueOfPreferredStockIssuedForCapitalLeaseObligations

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906
+ Details

Name: us-gaap_CashPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in operating assets classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash paid, after deduction of cash paid for capitalized interest, for interest. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586
+ Details

Name: us-gaap_InterestPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3536-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of expense or loss included in net income that result in no cash flow, classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_OtherNoncashExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PaymentsForProceedsFromInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow for cost incurred directly with the issuance of an equity security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfStockIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow during the period from the repayment of aggregate short-term and long-term debt and payment of capital lease obligations.
+ References
No definition available.
+ Details

Name: us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 21 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1

NATURE OF BUSINESS AND BASIS OF PRESENTATION
3 Months Ended

Mar. 31, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

NATURE OF BUSINESS AND BASIS OF PRESENTATION
NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION

XG Sciences, Inc., a Michigan company located in Lansing, Michigan and its subsidiary, XG Sciences IP, LLC (collectively referred to as “we”, “us”, “our”, or the “Company”) manufactures graphene nanoplatelets made from graphite, using two proprietary manufacturing processes to split natural flakes of crystalline graphite into very small and thin particles, which we sell as xGnP^® graphene nanoplatelets. We sell our nanoparticles in the form of bulk powders or dispersions to other companies for use as additives to make composite and other materials with specially engineered characteristics. We also manufacture and sell integrated, value-added products containing these graphene nanoplatelets such as greases, composites, thin sheets, inks and coating formulations that we sell to other companies. Additionally, we license our technology to other companies in exchange for royalties and other fees.

Basis of Presentation

The accompanying interim condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and the instructions to Form 10-Q and do not include all of the information and footnotes required by GAAP for complete financial statements. All intercompany transactions have been eliminated in consolidation.

Certain information and footnote disclosures normally included in our annual audited consolidated financial statements and accompanying notes have been condensed or omitted in these interim condensed consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2017, as filed with the Securities and Exchange Commission (“SEC”) on Form 10-K on April 2, 2018.

The results of operations presented in this quarterly report are not necessarily indicative of the results of operations that may be expected for any future periods. In the opinion of management, these unaudited condensed consolidated financial statements include all adjustments and accruals, consisting only of normal recurring adjustments that are necessary for a fair statement of the results of all interim periods reported herein.

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-URI http://asc.fasb.org/topic&trid=2122149

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-URI http://asc.fasb.org/topic&trid=2197479
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 22 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended

Mar. 31, 2018

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Liquidity

We have historically incurred losses from operations and we may continue to generate negative cash flows as we implement our business plan. Our condensed consolidated financial statements are prepared using US GAAP as applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.

We filed a Registration Statement on Form S-1 (File No. 333-209131) with the SEC on April 11, 2016 which was declared effective by the SEC on April 13, 2016 (as amended, the “Registration Statement”). The Registration Statement registered up to 3,000,000 shares of common stock at a fixed price of $8.00 per share to the general public in a self-underwritten offering (the “Offering” or our “IPO”). Post-Effective Amendment No. 1 to the Registration Statement was declared effective August 26, 2016, Post-Effective Amendment No. 2 was declared effective August 31, 2016, Post-Effective Amendment No. 3 was declared effective January 17, 2017, and Post-Effective Amendments No. 4 and No. 5 were dated April 12, 2017. Post-Effective Amendment No. 5 was declared effective April 14, 2017. Although we are currently selling shares of our common stock in our IPO pursuant to our Registration Statement, we have not yet listed the company for trading on any exchanges.

In December 2016, we entered into a draw loan note and agreement (the “Dow Facility”) with The Dow Chemical Company (“Dow”) to provide up to $10 million of secured debt financing at an interest rate of 5% per year, drawable at our request under certain conditions. As of May 14, 2018, we had drawn $5.0 million under the Dow Facility. The remaining $5 million will become available to us once we have raised $10 million of equity capital after October 31, 2016. As of May 14, 2018, we have sold 1,276,007 shares of common stock pursuant to our IPO at a price of $8.00 per share for gross proceeds of $10,208,056. However, only $7,007,024 of this amount has been raised during the measurement period beginning November 1, 2016. Thus, we still need to raise $2,992,976 of additional equity capital prior to the remaining $5.0 million under the Dow Facility becoming available to us.

As of May 14, 2018, we had cash on hand of $1,660,600. We believe our cash from increasing commercial sales activity and various financing sources will fund our operations for at least the next 12 months. We intend that the primary means for raising funds will be through our IPO and the additional $5 million of proceeds from the Dow Facility that becomes available to us after we have raised another $3 million of equity capital as noted above; however, we can make no assurances that we will raise such equity capital and be able to access the additional $5 million under the Dow Facility. Taking into account our current cash position as noted above, an additional $3 million in proceeds from our IPO, which would allow us to draw up to $5 million from the Dow Facility, we believe that we can fund our operations including planned capital expenditures for at least the next 12 months. In addition, two of our shareholders have committed to provide up to $4.5 million in funding for the twelve-month period ended March 31, 2019 to the extent the Company is unable to raise such funds from other third parties.

In the event we are unable to fund our operations from existing cash on hand, operating cash flows, additional borrowings or raising equity capital, we may be forced to reduce our expenses, slow down our growth rate, or discontinue operations. Our condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

Use of Estimates

The preparation of our condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, together with amounts disclosed in the related notes to the financial statements. Actual results and outcomes may differ from our estimates, judgments and assumptions. Significant estimates, judgments and assumptions used in these condensed consolidated financial statements include, but are not limited to, those related to revenue, accounts receivable and related allowances, contingencies, useful lives and recovery of long-term assets, including intangible assets, income taxes, and the fair value of stock-based compensation. These estimates, judgments, and assumptions are reviewed periodically and the effects of material revisions in estimates are reflected in the financial statements prospectively from the date of the change in estimate.

Inventory

Inventory consists of raw materials, work-in-process and finished goods, all of which are stated at the lower of cost or market. Cost is determined on a first in, first out basis.

The following amounts were included in inventory at the end of the period:

March 31, December 31,

2018 2017

Raw materials $ 79,581 $ 39,841

Finished goods 130,130 132,023

Total $ 209,711 $ 171,864

Derivative Financial Instruments

We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. The terms of convertible preferred stock and convertible notes that we issue are reviewed to determine whether or not they contain embedded derivative instruments that are required by ASC 815: “Derivatives and Hedging” to be accounted for separately from the host contract and recorded at fair value. In addition, freestanding warrants are also reviewed to determine if they achieve equity classification. Certain stock warrants that we issued did not meet the conditions for equity classification at inception and were classified as derivative instrument liabilities measured at fair value.

In July 2017, the FASB issued Accounting Standards Update No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities From Equity (Topic 480), Derivatives and Hedging (Topic 815) (“ASU 2017-11”). This update changes the classification analysis of certain equity-linked financial instruments with down-round features. We elected to early adopt ASU 2017-11 at September 30, 2017 by applying the standard retrospectively to outstanding financial instruments with a down round feature by means of a cumulative-effect adjustment to the Company’s beginning accumulated deficit as of January 1, 2017. There were 972,720, warrants indexed to Series A Preferred Stock which were originally recorded as derivative liabilities because of their anti-dilution features. We chose to early adopt ASU 2017-11 because it permitted these warrants to be recorded as equity rather than derivative liabilities. The impact to the financial statements for the three months ended March 31, 2017 is as follows:

For three months ended March 31, 2017

As previously As

reported Adjusted

Operating loss $ (1,465,882 ) $ (1,465,882 )

Other income (expense):

Incentive refund and interest income 368 368

Interest expense, net (59,480 ) (59,480 )

Gain from change in fair value of derivative warrants 154,652 29,171

Total other income (expense) 95,540 (29,941 )

Net loss $ (1,370,342 ) $ (1,495,823 )

Fair Value Measurements

The Company utilizes a valuation hierarchy that prioritizes fair value measurements based on the types of inputs used for the various valuation techniques related to its financial assets and financial liabilities in accordance to Accounting Standards Codification (“ASC”) Topic 820 Fair Value Measurements and Disclosures.

For financial instruments such as cash, accounts payable and other current liabilities, the Company considers the recorded value of such financial instruments approximate to the current fair value because of their short-term nature.

Recent Accounting Pronouncements

ASU No. 2014-09 (ASC 606), Revenue from Contracts with Customers became effective for us beginning with the first quarter of 2018, and we adopted the new accounting standard using the modified retrospective transition approach. The modified retrospective transition approach recognized any changes from the beginning of the year of initial application through retained earnings with no restatement of comparative periods. We will record revenue under ASC 606 at a single point in time, when control is transferred to the customer, which is consistent with past practice. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure under the new standard. Based on the results of the evaluation, we have determined that the adoption of the new standard presents no material impact on our consolidated financial statements. Application of the transition requirements of the new standard did not have a material impact on opening retained earnings.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 23 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1

WARRANTS AND FINANCING AGREEMENTS
3 Months Ended

Mar. 31, 2018

Debt Disclosure [Abstract]

WARRANTS AND FINANCING AGREEMENTS

Dow Facility

In December 2016, we entered into the Dow Facility which provides us with up to $10 million of secured debt financing at an interest rate of 5% per year, drawable at our request under certain conditions. We received $2 million at closing and an additional $1 million on July 18, 2017, September 22, 2017 and December 4, 2017, respectively. An additional $5 million becomes available once we have raised $10 million of equity capital after October 31, 2016; however, we can make no assurances that we will raise such equity capital and be able to access the additional $5 million under the Dow Facility. As of May 14, 2018, we have sold 1,276,007 shares of common stock pursuant to our IPO at a price of $8.00 per share for gross proceeds of $10,208,056. However, only $7,007,024 of this amount has been raised during the measurement period beginning November 1, 2016. Thus, we still need to raise $2,992,976 of equity capital prior to the remaining $5.0 million under the Dow Facility becoming available to us.

The Dow Facility is senior to most of our other debt and is secured by all of our assets (Dow is subordinate only to the capital leases with Aspen Advanced Opportunity Fund, LP (“AAOF”). The loan matures on December 1, 2021 (subject to certain mandatory prepayments based on our equity financing activities). Interest is payable beginning January 1, 2017 although we may elect to capitalize interest through January 1, 2019. Dow received warrant coverage of one share of common stock for each $40 in loans received by us, equating to 20% warrant coverage, with an exercise price of $8.00 per share for the warrants issued at closing of the initial $2 million draw. After the initial closing, the strike price of future warrants issued is subject to adjustment if we sell shares of common stock at a lower price. As of March 31, 2018, we had issued 125,000 warrants to Dow, which are exercisable on or before the expiration date of December 1, 2023.

The aforementioned warrants meet the criteria for classification within stockholders’ equity. Proceeds were allocated between the debt and the warrants at their relative fair value. During the fiscal year ended December 31, 2017, we recognized amortization expense of $161,702, and the resulting carrying value of the Dow Facility on our balance sheet as of December 31, 2017 was $4,794,596. During the three months ended March 31, 2018, we recognized amortization expense of $75,118, and the resulting carrying value of the Dow Facility on our balance sheet as of March 31, 2018 was $4,869,714.

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564
+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 24 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1

STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS
3 Months Ended

Mar. 31, 2018

Equity [Abstract]

STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS
NOTE 4 – STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS

The following table summarizes the warrants (including the warrants previously accounted for as derivatives) outstanding at March 31, 2018, which are accounted for as equity instruments, all of which are exercisable:

Date Issued Expiration Date Indexed
Stock Exercise Price Number of
Warrants

07/01/2009 07/01/2019 Common $ 8.00 6,000

10/08/2012 10/08/2027 Common $ 12.00 5,000

01/15/2014 – 12/31/2014 01/15/2024 Series A Convertible Preferred $ 6.40 972,720

04/30/2015- 05/26/2015 04/30/2022 Common $ 16.00 218,334

06/30/2015 06/30/2022 Common $ 16.00 6,563

12/31/2015 12/31/2020 Common $ 8.00 20,625

03/31/2016 03/31/2021 Common $ 10.00 10,600

04/30/2016 04/30/2021 Common $ 10.00 895

12/14/2016 12/01/2023 Common $ 8.00 50,000

07/18/2017 12/01/2023 Common $ 8.00 25,000

09/22/2017 12/01/2023 Common $ 8.00 25,000

12/04/2017 12/01/2023 Common $ 8.00 25,000

1,365,737



The warrants indexed to Series A Convertible Preferred Stock are currently exercisable and are exchangeable into 1.875 shares of common stock.

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762
+ Details

Name: us-gaap_PreferredStockTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 25 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1

STOCKHOLDERS' EQUITY (DEFICIT)
3 Months Ended

Mar. 31, 2018

Stockholders' Equity Note [Abstract]

STOCKHOLDERS' EQUITY (DEFICIT)

NOTE 5 — STOCKHOLDERS’ EQUITY (DEFICIT)

Common Stock

The Company is authorized to issue 25,000,000 shares of common stock, no par value per share of which 2,555,275 and 2,353,350 shares were issued and outstanding as of March 31, 2018 and December 31, 2017, respectively.

During the three months ended March 31, 2018, the Company issued 201,925 shares of common stock pursuant to the Offering. As of May 14, 2018, the Company has sold 1,276,007 shares of common stock in its IPO at a price of $8.00 per share for gross proceeds of $10,208,056.

Series A Convertible Preferred Stock

The Company is authorized to issue up to 3,000,000 shares of Series A Convertible Preferred Stock (the “Series A Preferred”). Each share of the Series A Preferred, which has a liquidation preference of $12.00 per share, is convertible at any time, at the option of the holder, into one share of Common Stock at the lower of: (a) $12.00 per share, or (b) 80% of the price at which the Company sells any equity or equity-linked securities in the future. The Series A Preferred also contains typical anti-dilution provisions that provide for adjustment of the conversion price to reflect stock splits, stock dividends, or similar events. The Series A Preferred is subject to mandatory conversion into Common Stock upon the listing of the Company’s common stock on a Qualified National Exchange. However, the Series A Preferred is not subject to the mandatory conversion until all outstanding convertible securities are also converted into common stock. The Series A Preferred ranks senior to all other equity or equity equivalent securities of the Company other than those securities which are explicitly senior or pari passu in rights and liquidation preference to the Series A Preferred and pari passu with the Company’s Series B Preferred Stock.

The Company issued 1,456,126 shares of Series A Preferred in connection with the conversion of certain convertible notes on December 31, 2015.

In December 2015, the conversion price of the Series A Preferred was reduced from $12.00 to $6.40 (80% of $8.00), and thus, each share of Series A Preferred Stock is convertible into 1.875 shares of common stock.

As of March 31, 2018, and December 31, 2017, the Company had 1,864,956 and 1,857,816 shares of Series A Preferred Stock issued and outstanding, respectively.

Series B Convertible Preferred Stock

As of March 31, 2018, and December 31, 2017, 1,500,000 shares have been designated as Series B Convertible Preferred Stock (“Series B Preferred”), of which no shares were issued and outstanding. Each share of the Series B Preferred, which has a liquidation preference of $16.00 per share, is convertible at any time, at the option of the holder, into one share of common stock at $16.00 per share. The Series B Preferred also contains typical anti-dilution provisions that provide for adjustment of the conversion price to reflect stock splits, stock dividends, or similar events. Each share of Series B Preferred is subject to mandatory conversion into common stock at the then-effective Series B conversion rate upon the public listing by the Company of its common stock on a Qualified National Exchange. However, the Series B Preferred is not subject to the mandatory conversion until all outstanding convertible securities are also converted into common stock. The Series B Preferred ranks senior to all other equity or equity equivalent securities of the Company other than those securities which are explicitly senior or pari passu in rights and liquidation preference to the Series B Preferred and pari passu with the Company’s Series A Preferred.

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762
+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 26 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1

EQUITY INCENTIVE PLAN
3 Months Ended

Mar. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

EQUITY INCENTIVE PLAN
NOTE 6 – EQUITY INCENTIVE PLAN

We previously established the 2007 Stock Option Plan (the “2007 Plan”), which was scheduled to expire on October 30, 2017 and under which we granted key employees and directors options to purchase shares of our common stock at not less than fair market value as of the grant date. On May 4, 2017, the Board approved the 2017 Equity Incentive Plan (the “2017 Plan”) to replace the 2007 Plan, which became effective upon the approval of the stockholders holding a majority of the voting power in the Company on July 18, 2017. The 2017 Plan replaced the 2007 Plan and authorizes us to grant awards (stock options and restricted stock) up to a maximum of 1,200,000 shares of our common stock.

On July 24, 2017, certain stock options from the 2007 Plan were cancelled and replacement stock options were awarded. The replacement stock option awards have an exercise price of $8.00 per share and a seven-year term. Fifty percent of such awards vested on the date of grant with the remaining vesting over a 4-year period, subject to certain other terms. Each option holder received options equal to 150% of the number of cancelled stock options.

On August 10, 2017, the Company granted stock options and restricted stock to each of its Board members as part of its Board compensation package. Each of the 4 independent Board members received 2,500 stock options and 2,500 shares of restricted stock for Board services. The options were granted at a price of $8.00 per share and had an aggregate grant date fair value of $26,120. The options vest ratably over a four-year period beginning on the one-year anniversary. The restricted stock issued to the Board members has an aggregate fair value of $80,000 and vest ratably in arrears over four quarters on the last day of each fiscal quarter following the grant date. As of March 31, 2018, 7,500 shares of restricted stock had vested, resulting in total compensation expense of $60,000.

A summary of the stock option activity for the three months ended March 31, 2018 is as follows:

Weighted

Number Average

Of Exercise

Options Price

Options outstanding at December 31, 2017 677,125 $ 8.00

Changes during the period:

Expired — —

New Options Granted – at market price 10,000 8.00

Exercised — —

Options outstanding at March 31, 2018 687,125 $ 8.00

Options exercisable at March 31, 2018 337,158 $ 8.00

All options granted thus far under the 2017 Plan have an exercise price of $8.00 per share and vesting of the options ranges from immediate to 20% per year, with most options vesting on a straight-line basis over a four-year period from the date of grant. The options expire in seven years from the date of grant.

During the three months ended March 31, 2018, the Company granted 10,000 employee stock options with an aggregate grant date fair value of $28,755. The fair value of the options granted was estimated on the date of grant using the Black Scholes option-pricing model using the following assumptions: Stock price: $8.00, Exercise Price: $8.00, Expected Term: 4.75, Volatility: 37.34%, Risk free rate: 2.65%, Dividend rate: 0%. As of March 31, 2018, 687,125 stock options and 10,000 shares of restricted stock awards were outstanding under our 2017 Plan.

Stock-based compensation expense was $87,764 and $88,370 for the three months ended March 31, 2018 and 2017, respectively. As of March 31, 2018 there was approximately $895,00 in unrecognized compensation cost related to the options granted under the 2017 plan.

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-URI http://asc.fasb.org/topic&trid=2228938

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-URI http://asc.fasb.org/subtopic&trid=2208855
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 27 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1

CAPITAL LEASES
3 Months Ended

Mar. 31, 2018

Capital Leases of Lessee [Abstract]

CAPITAL LEASES
NOTE 7 – CAPITAL LEASES

As of March 31, 2018, and December 31, 2017, we have capital lease obligations as follows:

March 31, 2018 December 31, 2017

Capital lease obligations $ 114,970 $ 149,120

Unamortized warrant discount (8,346 ) (15,040 )

Net obligations 106,624 134,080

Short-term portion of obligations (91,985 ) (118,553 )

Long-term portion of obligations $ 14,639 $ 15,527

X

- References
No definition available.
+ Details

Name: us-gaap_CapitalLeasesOfLesseeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-URI http://asc.fasb.org/topic&trid=2208923

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564
+ Details

Name: us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1

CUSTOMER, SUPPLIER, COUNTRY AND PRODUCT CONCENTRATIONS
3 Months Ended

Mar. 31, 2018

Risks and Uncertainties [Abstract]

CUSTOMER, SUPPLIER, COUNTRY AND PRODUCT CONCENTRATIONS
NOTE 8 — Customer, Supplier, country, and Product Concentrations

Grants and Licensing Revenue Concentration

There was no licensing or grant revenue to report during the first quarter of 2018. Two grantors accounted for 94% and 6% respectively of total grant revenue reported during the first quarter of 2017. The company’s licensing revenue in the first quarter of 2017 came from one licensor.

Product Concentration

During the first quarter of 2018 and 2017, we had concentrations of product revenue from only one product that was greater than 10% of total product revenues. Revenue from one of the Company’s graphene nanoplatelets materials, Grade C 500 m²/g, was 83% as of March 31, 2018 and 29% as of March 31, 2017. We attempt to minimize the risk associated with product concentrations by continuing to develop new products to add to our portfolio.

Customer Concentration

During the first quarter of 2018, we had one customer whose purchases accounted for 83% of total product revenues. During the first quarter of 2017 we had two customers that represented 29% and 22 % of total product revenues. At March 31, 2018 and 2017, there were two customers who each had an accounts receivable balance greater than 10% of our total outstanding receivable balance.

Country Concentration

We sell our products on a worldwide basis. Revenue derived from customers outside of the U.S. during the first quarter of 2018 was 3% as compared with 40% during the first quarter of 2017. All of these sales are denominated in U.S. dollars.

As of March 31, 2018, there were no foreign countries with greater than 10% of product revenue. During the quarter ended March 31, 2017, two countries, the United Kingdom and South Korea accounted for approximately 24% and 16%, respectively, of total product revenue.

Suppliers

We buy raw materials used in manufacturing from several sources. These materials are available from a large number of sources. A change in suppliers has no material effect on the Company’s operations. We did not have purchases from any suppliers that were greater than 10% of total purchases during the quarters ended March 31, 2018 and 2017.

X

- Definition
The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI http://asc.fasb.org/topic&trid=2134479
+ Details

Name: us-gaap_ConcentrationRiskDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_RisksAndUncertaintiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 29 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1

RELATED PARTY TRANSACTIONS
3 Months Ended

Mar. 31, 2018

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS
NOTE 9 - RELATED PARTY TRANSACTIONS

We have a licensing agreement for exclusive use of patents and pending patents with Michigan State University (“MSU”), a shareholder of the Company via the MSU Foundation. We incurred $12,500 of licensing expense in each of the three month periods ended March 31, 2018 and 2017.

We have also entered into product licensing agreements with certain other shareholders. No royalty revenue or expenses have been recognized related to these agreements during the three months ended March 31, 2018. For the three months ended March 31, 2017, $25,000 of royalty revenue was recorded from POSCO, a shareholder.

During each of the three months ended March 31, 2018 and 2017 we issued 7,140 shares of Series A Preferred Stock to AAOF as payment for lease financing obligations under the terms of the Master Lease Agreement, dated March 18, 2013.

X

- References
No definition available.
+ Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-URI http://asc.fasb.org/topic&trid=2122745
+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 30 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1

SUBSEQUENT EVENTS
3 Months Ended

Mar. 31, 2018

Subsequent Events [Abstract]

SUBSEQUENT EVENTS
NOTE 10 – SUBSEQUENT EVENTS

During the period from April 1 through May 14, 2018, we received common stock proceeds of $858,000 for the sale of 107,250 shares of common stock in our IPO.

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended

Mar. 31, 2018

Accounting Policies [Abstract]

Liquidity
Liquidity

We have historically incurred losses from operations and we may continue to generate negative cash flows as we implement our business plan. Our condensed consolidated financial statements are prepared using US GAAP as applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.

We filed a Registration Statement on Form S-1 (File No. 333-209131) with the SEC on April 11, 2016 which was declared effective by the SEC on April 13, 2016 (as amended, the “Registration Statement”). The Registration Statement registered up to 3,000,000 shares of common stock at a fixed price of $8.00 per share to the general public in a self-underwritten offering (the “Offering” or our “IPO”). Post-Effective Amendment No. 1 to the Registration Statement was declared effective August 26, 2016, Post-Effective Amendment No. 2 was declared effective August 31, 2016, Post-Effective Amendment No. 3 was declared effective January 17, 2017, and Post-Effective Amendments No. 4 and No. 5 were dated April 12, 2017. Post-Effective Amendment No. 5 was declared effective April 14, 2017. Although we are currently selling shares of our common stock in our IPO pursuant to our Registration Statement, we have not yet listed the company for trading on any exchanges.

In December 2016, we entered into a draw loan note and agreement (the “Dow Facility”) with The Dow Chemical Company (“Dow”) to provide up to $10 million of secured debt financing at an interest rate of 5% per year, drawable at our request under certain conditions. As of May 14, 2018, we had drawn $5.0 million under the Dow Facility. The remaining $5 million will become available to us once we have raised $10 million of equity capital after October 31, 2016. As of May 14, 2018, we have sold 1,276,007 shares of common stock pursuant to our IPO at a price of $8.00 per share for gross proceeds of $10,208,056. However, only $7,007,024 of this amount has been raised during the measurement period beginning November 1, 2016. Thus, we still need to raise $2,992,976 of additional equity capital prior to the remaining $5.0 million under the Dow Facility becoming available to us.

As of May 14, 2018, we had cash on hand of $1,660,600. We believe our cash from increasing commercial sales activity and various financing sources will fund our operations for at least the next 12 months. We intend that the primary means for raising funds will be through our IPO and the additional $5 million of proceeds from the Dow Facility that becomes available to us after we have raised another $3 million of equity capital as noted above; however, we can make no assurances that we will raise such equity capital and be able to access the additional $5 million under the Dow Facility. Taking into account our current cash position as noted above, an additional $3 million in proceeds from our IPO, which would allow us to draw up to $5 million from the Dow Facility, we believe that we can fund our operations including planned capital expenditures for at least the next 12 months. In addition, two of our shareholders have committed to provide up to $4.5 million in funding for the twelve-month period ended March 31, 2019 to the extent the Company is unable to raise such funds from other third parties.

In the event we are unable to fund our operations from existing cash on hand, operating cash flows, additional borrowings or raising equity capital, we may be forced to reduce our expenses, slow down our growth rate, or discontinue operations. Our condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

Use of Estimates
Use of Estimates

The preparation of our condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, together with amounts disclosed in the related notes to the financial statements. Actual results and outcomes may differ from our estimates, judgments and assumptions. Significant estimates, judgments and assumptions used in these condensed consolidated financial statements include, but are not limited to, those related to revenue, accounts receivable and related allowances, contingencies, useful lives and recovery of long-term assets, including intangible assets, income taxes, and the fair value of stock-based compensation. These estimates, judgments, and assumptions are reviewed periodically and the effects of material revisions in estimates are reflected in the financial statements prospectively from the date of the change in estimate.

Inventory
Inventory

Inventory consists of raw materials, work-in-process and finished goods, all of which are stated at the lower of cost or market. Cost is determined on a first in, first out basis.

The following amounts were included in inventory at the end of the period:

March 31, December 31,

2018 2017

Raw materials $ 79,581 $ 39,841

Finished goods 130,130 132,023

Total $ 209,711 $ 171,864

Derivative Financial Instruments
Derivative Financial Instruments

We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. The terms of convertible preferred stock and convertible notes that we issue are reviewed to determine whether or not they contain embedded derivative instruments that are required by ASC 815: “Derivatives and Hedging” to be accounted for separately from the host contract and recorded at fair value. In addition, freestanding warrants are also reviewed to determine if they achieve equity classification. Certain stock warrants that we issued did not meet the conditions for equity classification at inception and were classified as derivative instrument liabilities measured at fair value.

In July 2017, the FASB issued Accounting Standards Update No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities From Equity (Topic 480), Derivatives and Hedging (Topic 815) (“ASU 2017-11”). This update changes the classification analysis of certain equity-linked financial instruments with down-round features. We elected to early adopt ASU 2017-11 at September 30, 2017 by applying the standard retrospectively to outstanding financial instruments with a down round feature by means of a cumulative-effect adjustment to the Company’s beginning accumulated deficit as of January 1, 2017. There were 972,720, warrants indexed to Series A Preferred Stock which were originally recorded as derivative liabilities because of their anti-dilution features. We chose to early adopt ASU 2017-11 because it permitted these warrants to be recorded as equity rather than derivative liabilities. The impact to the financial statements for the three months ended March 31, 2017 is as follows:

For three months ended March 31, 2017

As previously As

reported Adjusted

Operating loss $ (1,465,882 ) $ (1,465,882 )

Other income (expense):

Incentive refund and interest income 368 368

Interest expense, net (59,480 ) (59,480 )

Gain from change in fair value of derivative warrants 154,652 29,171

Total other income (expense) 95,540 (29,941 )

Net loss $ (1,370,342 ) $ (1,495,823 )

Fair Value Measurements
Fair Value Measurements

The Company utilizes a valuation hierarchy that prioritizes fair value measurements based on the types of inputs used for the various valuation techniques related to its financial assets and financial liabilities in accordance to Accounting Standards Codification (“ASC”) Topic 820 Fair Value Measurements and Disclosures.

For financial instruments such as cash, accounts payable and other current liabilities, the Company considers the recorded value of such financial instruments approximate to the current fair value because of their short-term nature.

Recent Accounting Pronouncements
Recent Accounting Pronouncements

ASU No. 2014-09 (ASC 606), Revenue from Contracts with Customers became effective for us beginning with the first quarter of 2018, and we adopted the new accounting standard using the modified retrospective transition approach. The modified retrospective transition approach recognized any changes from the beginning of the year of initial application through retained earnings with no restatement of comparative periods. We will record revenue under ASC 606 at a single point in time, when control is transferred to the customer, which is consistent with past practice. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure under the new standard. Based on the results of the evaluation, we have determined that the adoption of the new standard presents no material impact on our consolidated financial statements. Application of the transition requirements of the new standard did not have a material impact on opening retained earnings.

X

- Definition
The entire disclosure of liquidity.
+ References
No definition available.
+ Details

Name: cik0001435375_LiquidityPolicyTextBlock

Namespace Prefix: cik0001435375_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for its derivative instruments and hedging activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84234895&loc=d3e41620-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5579240-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5579245-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=84234895&loc=d3e41675-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84234895&loc=d3e41638-113959
+ Details

Name: us-gaap_DerivativesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueMeasurementPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66092785&loc=d3e4492-108314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=66092785&loc=d3e4556-108314

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766
+ Details

Name: us-gaap_InventoryPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6061-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6132-108592
+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended

Mar. 31, 2018

Accounting Policies [Abstract]

Schedule of inventory

The following amounts were included in inventory at the end of the period:

March 31, December 31,

2018 2017

Raw materials $ 79,581 $ 39,841

Finished goods 130,130 132,023

Total $ 209,711 $ 171,864

Schedule of financial statements
The impact to the financial statements for the three months ended March 31, 2017 is as follows:

For three months ended March 31, 2017

As previously As

reported Adjusted

Operating loss $ (1,465,882 ) $ (1,465,882 )

Other income (expense):

Incentive refund and interest income 368 368

Interest expense, net (59,480 ) (59,480 )

Gain from change in fair value of derivative warrants 154,652 29,171

Total other income (expense) 95,540 (29,941 )

Net loss $ (1,370,342 ) $ (1,495,823 )

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfCondensedFinancialStatementsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(c))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1

STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Tables)
3 Months Ended

Mar. 31, 2018

Equity [Abstract]

Schedule of common stock warrants (including the warrants previously accounted for as derivatives) outstanding
The following table summarizes the warrants (including the warrants previously accounted for as derivatives) outstanding at March 31, 2018, which are accounted for as equity instruments, all of which are exercisable:

Date Issued Expiration Date Indexed
Stock Exercise Price Number of
Warrants

07/01/2009 07/01/2019 Common $ 8.00 6,000

10/08/2012 10/08/2027 Common $ 12.00 5,000

01/15/2014 – 12/31/2014 01/15/2024 Series A Convertible Preferred $ 6.40 972,720

04/30/2015- 05/26/2015 04/30/2022 Common $ 16.00 218,334

06/30/2015 06/30/2022 Common $ 16.00 6,563

12/31/2015 12/31/2020 Common $ 8.00 20,625

03/31/2016 03/31/2021 Common $ 10.00 10,600

04/30/2016 04/30/2021 Common $ 10.00 895

12/14/2016 12/01/2023 Common $ 8.00 50,000

07/18/2017 12/01/2023 Common $ 8.00 25,000

09/22/2017 12/01/2023 Common $ 8.00 25,000

12/04/2017 12/01/2023 Common $ 8.00 25,000

1,365,737

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666
+ Details

Name: us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1

EQUITY INCENTIVE PLAN (Tables)
3 Months Ended

Mar. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of summary of the stock option activity
A summary of the stock option activity for the three months ended March 31, 2018 is as follows:

Weighted

Number Average

Of Exercise

Options Price

Options outstanding at December 31, 2017 677,125 $ 8.00

Changes during the period:

Expired — —

New Options Granted – at market price 10,000 8.00

Exercised — —

Options outstanding at March 31, 2018 687,125 $ 8.00

Options exercisable at March 31, 2018 337,158 $ 8.00

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1

CAPITAL LEASES (Tables)
3 Months Ended

Mar. 31, 2018

Capital Leases of Lessee [Abstract]

Schedule of capital lease obligations
As of March 31, 2018, and December 31, 2017, we have capital lease obligations as follows:

March 31, 2018 December 31, 2017

Capital lease obligations $ 114,970 $ 149,120

Unamortized warrant discount (8,346 ) (15,040 )

Net obligations 106,624 134,080

Short-term portion of obligations (91,985 ) (118,553 )

Long-term portion of obligations $ 14,639 $ 15,527

X

- References
No definition available.
+ Details

Name: us-gaap_CapitalLeasesOfLesseeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=77888251

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-URI http://asc.fasb.org/topic&trid=2208923
+ Details

Name: us-gaap_LeasesOfLesseeDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)

Mar. 31, 2018

Dec. 31, 2017

Accounting Policies [Abstract]

Raw materials $ 79,581 $ 39,841

Finished goods 130,130 132,023

Total $ 209,711 $ 171,864

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryFinishedGoods

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765
+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a)(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryRawMaterials

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 37 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($)
3 Months Ended

Mar. 31, 2018

Mar. 31, 2017

Operating loss $ (1,792,179) $ (1,465,882)

Other income (expense):

Incentive refund and interest income 3,253 (24)

Interest expense, net (85,169) (59,088)

Gain from change in fair value of derivative warrants 29,171

Total other income (expense) (81,916) (29,941)

Net loss $ (1,874,095) (1,495,823)

Scenario, Previously Reported [Member]

Operating loss (1,465,882)

Other income (expense):

Incentive refund and interest income 368

Interest expense, net (59,480)

Gain from change in fair value of derivative warrants 154,652

Total other income (expense) 95,540

Net loss (1,370,342)

As Adjusted [Member]

Operating loss (1,465,882)

Other income (expense):

Incentive refund and interest income 368

Interest expense, net (59,480)

Gain from change in fair value of derivative warrants 29,171

Total other income (expense) (29,941)

Net loss $ (1,495,823)

X

- Definition
Amount of incentive refund and interest income.
+ References
No definition available.
+ Details

Name: cik0001435375_IncentiveRefundAndInterestIncome

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5618551-113959
+ Details

Name: us-gaap_GainLossOnDerivativeInstrumentsNetPretax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28555-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementScenarioAxis=us-gaap_ScenarioPreviouslyReportedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementScenarioAxis=us-gaap_RestatementAdjustmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 38 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended

May 14, 2018

Apr. 13, 2016

Dec. 31, 2016

Mar. 31, 2018

Dec. 31, 2017

Mar. 31, 2017

Cash on hand $ 1,785,343 $ 2,285,117 $ 2,845,798 $ 1,148,681

Proceeds from capital contribution 4,500,000

Series A Preferred stock [Member]

Derivative liability 972,720

Subsequent Event [Member]

Cash on hand $ 1,660,600

The Dow Chemical Company [Member]

Equity capital raise amount $ 5,000,000

Description of raising fund
Additional $5 million becomes available under the Dow Facility if we have raised $10 million of equity capital after October 31, 2016.

Draw Loan Note And Agreement [Member] | Senior Secured Debt Financing [Member] | The Dow Chemical Company [Member]

Face amount $ 10,000,000 $ 4,869,714 $ 4,794,596

Interest rate (in percent) 5.00%

Equity capital raise amount $ 7,007,024 $ 2,992,976

Description of raising fund
The remaining $5 million will become available to us once we have raised $10 million of equity capital after October 31, 2016.

Draw Loan Note And Agreement [Member] | Senior Secured Debt Financing [Member] | The Dow Chemical Company [Member] | Subsequent Event [Member]

Equity capital raise amount $ 5,000,000

IPO [Member]

Number of shares issued in offering 3,000,000 201,925

Price per share (in dollars per share) $ 8.00

IPO [Member] | Subsequent Event [Member]

Number of shares issued in offering 1,276,007

Price per share (in dollars per share) $ 8.00

Gross proceeds from issued in offering $ 10,208,056

X

- Definition
Description of raising fund.
+ References
No definition available.
+ Details

Name: cik0001435375_DescriptionOfRaisingFund

Namespace Prefix: cik0001435375_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
It represents value of equity capital raise amount.
+ References
No definition available.
+ Details

Name: cik0001435375_EquityCapitalRaiseAmount

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399
+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=82849420&loc=SL20226008-175313

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13495-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13433-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41271-113958

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958
+ Details

Name: us-gaap_DerivativeLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cash inflow associated with the amount received by a corporation from a shareholder during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromContributedCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from entity's first offering of stock to the public.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceInitialPublicOffering

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=cik0001435375_TheDowChemicalCompanyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=cik0001435375_DrawLoanNoteAndAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=us-gaap_SecuredDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 39 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1

WARRANTS AND FINANCING AGREEMENTS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended

May 14, 2018

Dec. 04, 2017

Sep. 22, 2017

Jul. 18, 2017

Apr. 13, 2016

Dec. 31, 2016

Mar. 31, 2018

Dec. 31, 2017

IPO [Member]

Number of shares issued in offering 3,000,000 201,925

Price per share (in dollars per share) $ 8.00

Subsequent Event [Member] | IPO [Member]

Number of shares issued in offering 1,276,007

Price per share (in dollars per share) $ 8.00

Proceeds from issuance initial public offering $ 10,208,056

The Dow Chemical Company [Member]

Description of raising fund
Additional $5 million becomes available under the Dow Facility if we have raised $10 million of equity capital after October 31, 2016.

Equity capital raise amount $ 5,000,000

Draw Loan Note And Agreement [Member] | Senior Secured Debt Financing [Member] | The Dow Chemical Company [Member]

Face amount $ 10,000,000 4,869,714 $ 4,794,596

Proceeds from secured debt $ 1,000,000 $ 1,000,000 $ 1,000,000 $ 2,000,000

Amortization expense of debt $ 75,118 $ 161,702

Description of raising fund
The remaining $5 million will become available to us once we have raised $10 million of equity capital after October 31, 2016.

Number of shares purchased (in shares) 125,000

Description of conversion terms
Interest is payable beginning January 1, 2017 although we may elect to capitalize interest through January 1, 2019. Dow received warrant coverage of one share of common stock for each $40 in loans received by us, equating to 20% warrant coverage, with an exercise price of $8.00 per share for the warrants issued at closing of the initial $2 million draw.

Interest rate (in percent) 5.00%

Maturity date Dec. 01, 2021

Equity capital raise amount $ 7,007,024 $ 2,992,976

Draw Loan Note And Agreement [Member] | Senior Secured Debt Financing [Member] | The Dow Chemical Company [Member] | Subsequent Event [Member]

Equity capital raise amount $ 5,000,000

X

- Definition
Description of raising fund.
+ References
No definition available.
+ Details

Name: cik0001435375_DescriptionOfRaisingFund

Namespace Prefix: cik0001435375_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
It represents value of equity capital raise amount.
+ References
No definition available.
+ Details

Name: cik0001435375_EquityCapitalRaiseAmount

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of amortization expense attributable to debt issuance costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28555-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(8))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(8))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_AmortizationOfFinancingCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Description of the conversion terms of a debt instrument which may include the conversion ratio (including all potential conversion ratios if contingently adjustable), type of debt or equity security into which the debt is convertible, the dollars of debt or the number of shares into which the instrument is convertible (or potentially convertible into), the conversion period, any contingencies associated with the conversion terms, and the existence and amount of a beneficial conversion feature.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21521-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(5))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21506-112644

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21475-112644
+ Details

Name: us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399
+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentMaturityDate

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from entity's first offering of stock to the public.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceInitialPublicOffering

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfSecuredDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=cik0001435375_TheDowChemicalCompanyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=cik0001435375_DrawLoanNoteAndAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=us-gaap_SecuredDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 40 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1

STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Details)
3 Months Ended

Mar. 31, 2018

$ / shares

shares

Number of Warrants 1,365,737

Warrant [Member]

Date Issued Jul. 01, 2009

Expiration Date Jul. 01, 2019

Exercise Price | $ / shares $ 8.00

Indexed stock
Common

Number of Warrants 6,000

Warrant 1 [Member]

Date Issued Oct. 08, 2012

Expiration Date Oct. 08, 2027

Exercise Price | $ / shares $ 12.00

Indexed stock
Common

Number of Warrants 5,000

Warrant 2 [Member]

Expiration Date Jan. 15, 2024

Exercise Price | $ / shares $ 6.40

Indexed stock
Series A Convertible Preferred

Number of Warrants 972,720

Warrant 2 [Member] | Minimum [Member]

Date Issued Jan. 15, 2014

Warrant 2 [Member] | Maximum [Member]

Date Issued Dec. 31, 2014

Warrant 3 [Member]

Expiration Date Apr. 30, 2022

Exercise Price | $ / shares $ 16.00

Indexed stock
Common

Number of Warrants 218,334

Warrant 3 [Member] | Minimum [Member]

Date Issued Apr. 30, 2015

Warrant 3 [Member] | Maximum [Member]

Date Issued May 26, 2015

Warrant 4 [Member]

Date Issued Jun. 30, 2015

Expiration Date Jun. 30, 2022

Exercise Price | $ / shares $ 16.00

Indexed stock
Common

Number of Warrants 6,563

Warrant 5 [Member]

Date Issued Dec. 31, 2015

Expiration Date Dec. 31, 2020

Exercise Price | $ / shares $ 8.00

Indexed stock
Common

Number of Warrants 20,625

Warrant 6 [Member]

Date Issued Mar. 31, 2016

Expiration Date Mar. 31, 2021

Exercise Price | $ / shares $ 10

Indexed stock
Common

Number of Warrants 10,600

Warrant 7 [Member]

Date Issued Apr. 30, 2016

Expiration Date Apr. 30, 2021

Exercise Price | $ / shares $ 10.00

Indexed stock
Common

Number of Warrants 895

Warrant 8 [Member]

Date Issued Dec. 14, 2016

Expiration Date Dec. 01, 2023

Exercise Price | $ / shares $ 8.00

Indexed stock
Common

Number of Warrants 50,000

Warrant 9 [Member]

Date Issued Jul. 18, 2017

Expiration Date Dec. 01, 2023

Exercise Price | $ / shares $ 8.00

Indexed stock
Common

Number of Warrants 25,000

Warrant 10 [Member]

Date Issued Sep. 22, 2017

Expiration Date Dec. 01, 2023

Exercise Price | $ / shares $ 8

Indexed stock
Common

Number of Warrants 25,000

Warrant 11 [Member]

Date Issued Dec. 04, 2017

Expiration Date Dec. 01, 2023

Exercise Price | $ / shares $ 8.00

Indexed stock
Common

Number of Warrants 25,000

X

- Definition
Date the warrants or rights are exercisable, in CCYY-MM-DD format.
+ References
No definition available.
+ Details

Name: cik0001435375_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExpiration

Namespace Prefix: cik0001435375_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Date the warrants or rights are exercisable, in CCYY-MM-DD format.
+ References
No definition available.
+ Details

Name: cik0001435375_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsIssued

Namespace Prefix: cik0001435375_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents as a indexed stock of warrant.
+ References
No definition available.
+ Details

Name: cik0001435375_IndexedStockOfWarrant

Namespace Prefix: cik0001435375_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Information related to number of warrants issued during period.
+ References
No definition available.
+ Details

Name: cik0001435375_NumberOfWarrantsIssuedDuringPeriod

Namespace Prefix: cik0001435375_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Exercise price per share or per unit of warrants or rights outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=cik0001435375_Warrant1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=cik0001435375_Warrant2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=cik0001435375_Warrant3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=cik0001435375_Warrant4Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=cik0001435375_Warrant5Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=cik0001435375_Warrant6Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=cik0001435375_Warrant7Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=cik0001435375_Warrant8Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=cik0001435375_Warrant9Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=cik0001435375_Warrant10Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=cik0001435375_Warrant11Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 41 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1

STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended

May 14, 2018

Apr. 13, 2016

Mar. 31, 2018

Dec. 31, 2015

Dec. 31, 2017

Common stock, authorized 25,000,000 25,000,000

Common stock, issued 2,555,275 2,353,350

Common stock, outstanding 2,555,275 2,353,350

IPO [Member]

Number of shares issued in offering 3,000,000 201,925

Price per share (in dollars per share) $ 8.00

IPO [Member] | Subsequent Event [Member]

Number of shares issued in offering 1,276,007

Price per share (in dollars per share) $ 8.00

Proceeds from issuance initial public offering $ 10,208,056

Series A Convertible Preferred Stock [Member]

Preferred stock, authorized 3,000,000 3,000,000

Liquidation (in dollars per share) $ 12.00

Description of conversion of stock
one share of Common Stock at the lower of: (a) $12.00 per share, or (b) 80% of the price at which the Company sells any equity or equity-linked securities in the future.

Series A Preferred was reduced from $12.00 to $6.40 (80% of $8.00), and thus, each share of Series A Preferred Stock is convertible into 1.875 shares of common stock.

Conversion price (in dollars per share) $ 12.00

Reduction in share price (in dollars per share) $ 6.40

Exercise price (in dollars per share) $ 8.00

Preferred stock, issued 1,864,956 1,857,816

Preferred stock, outstanding 1,864,956 1,857,816

Number of shares issued 1,456,126

Series A Convertible Preferred Stock [Member] | Aspen Advance Opportunity Fund, LP [Member] | Master Leasing Agreement [Member]

Number of shares issued 7,140

Preferred stock (B) [Member]

Preferred stock, authorized 1,500,000 1,500,000

Liquidation (in dollars per share) $ 16.00

Conversion price (in dollars per share) $ 16.00

Preferred stock, issued 0 0

Preferred stock, outstanding 0 0

X

- Definition
The price per share of the conversion feature embedded in the debt instrument.
+ References
No definition available.
+ Details

Name: cik0001435375_ConversionOfStockConversionPrice

Namespace Prefix: cik0001435375_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The amount of reduction in per share of common stock or unit outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: cik0001435375_ReductionInSharePriceInDollarsPerShare

Namespace Prefix: cik0001435375_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Exercise price per share or per unit of warrants or rights outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586
+ Details

Name: us-gaap_ConversionOfStockDescription

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_PreferredStockLiquidationPreference

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The cash inflow associated with the amount received from entity's first offering of stock to the public.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceInitialPublicOffering

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued during the period as a result of the conversion of convertible securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21475-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=cik0001435375_AspenAdvanceOpportunityFundLPMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=cik0001435375_MasterLeasingAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 42 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1

EQUITY INCENTIVE PLAN (Details)
3 Months Ended

Mar. 31, 2018

$ / shares

shares

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]

Options outstanding at beginning of year | shares 677,125

Changes during the year:

Expired | shares

New Options Granted - at market price | shares 10,000

Exercised | shares

Options outstanding at end of Period | shares 687,125

Options exercisable at end of Period | shares 337,158

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [RollForward]

Options outstanding at beginning of year | $ / shares $ 8

Changes during the year:

Expired | $ / shares

New Options Granted - at market price | $ / shares 8

Exercised | $ / shares

Options outstanding at end of Period | $ / shares 8

Options exercisable at end of Period | $ / shares $ 8

X

- References
No definition available.
+ Details

Name: cik0001435375_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAbstract

Namespace Prefix: cik0001435375_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: cik0001435375_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAbstract

Namespace Prefix: cik0001435375_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(4)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 43 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1

EQUITY INCENTIVE PLAN (Details Narrative) - USD ($)
3 Months Ended

Aug. 10, 2017

Jul. 24, 2017

Mar. 31, 2018

Mar. 31, 2017

Dec. 31, 2017

Number of option granted 10,000

Exercise price (in dollars per share) $ 8

Stock-based compensation expense $ 87,764 $ 88,370

Proceeds from option granted $ 28,755

Number of option outstanding 687,125 677,125

Incentive Stock Option Plan [Member]

Vesting percent, per year 20.00%

Description of vesting terms
Vesting of the options ranges from immediate to 20% per year, with most options vesting on a straight-line basis over a four-year period from the date of grant.

Description of vesting terms of replacement options
Vesting of the options ranges from immediate to 20% per year, with most options vesting on a straight-line basis over a four-year period from the date of grant.

Options expiration year 7 years

2007 Stock Option Plan [Member]

Unrecognized compensation cost $ 89,500

Description of vesting terms
Fifty percent of such awards vested on the date of grant with the remaining vesting over a 4-year period

Exercise price (in dollars per share) $ 8.00

Vesting period 7 years

Description of cancellation terms
Each option holder received options equal to 150% of the number of cancelled stock options.

Stock price $ 8.00

Exercise Price $ 8.00

Expected Term 4 years 9 months

Dividend rate 0.00%

Volatility 37.34%

Risk free rate 2.65%

2007 Stock Option Plan [Member] | Restricted Stock [Member]

Number of option outstanding 10,000

2007 Stock Option Plan [Member] | Restricted Stock [Member] | Four Diretors [Member]

Number of option granted 2,500

Compensation cost $ 60,000

Aggregate grant date fair value $ 80,000

Number of shares vested (in shares) 7,500

2007 Stock Option Plan [Member] | Stock Option [Member]

Number of option outstanding 687,125

2007 Stock Option Plan [Member] | Stock Option [Member] | Four Diretors [Member]

Number of option granted 2,500

Description of vesting terms
The options vest ratably over a four-year period beginning on the one-year anniversary.

Exercise price (in dollars per share) $ 8.00

Aggregate grant date fair value $ 26,120

2007 Stock Option Plan [Member] | Maximum [Member]

Maximum number of options authorized 1,200,000

X

- Definition
Disclosure about the vesting terms of replacement options.
+ References
No definition available.
+ Details

Name: cik0001435375_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights1

Namespace Prefix: cik0001435375_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
It represents value of aggregate grant date fair value.
+ References
No definition available.
+ Details

Name: cik0001435375_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue1

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
It represents value of aggregate grant date fair value.
+ References
No definition available.
+ Details

Name: cik0001435375_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue1

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Disclosure about cancellation terms.
+ References
No definition available.
+ Details

Name: cik0001435375_SharebasedCompensationArrangementBySharebasedPaymentAwardCancellationTerms

Namespace Prefix: cik0001435375_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Unrecognized cost of unvested share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3098-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3095-108585
+ Details

Name: us-gaap_PaymentsForProceedsFromInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Description of award terms as to how many shares or portion of an award are no longer contingent on satisfaction of either a service condition, market condition or a performance condition, thereby giving the employee the legal right to convert the award to shares, to sell the shares, and be entitled to the cash proceeds of such sale. For example, vesting may be expressed as being 25 percent of the shares under option on each anniversary of the grant date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Price of a single share of a number of saleable stocks of a company.
+ References
No definition available.
+ Details

Name: us-gaap_SharePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Percentage of vesting of share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of options vested.
+ References
No definition available.
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_PlanNameAxis=cik0001435375_IncentiveStockOptionPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=cik0001435375_StockOptionPlan2007Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cik0001435375_FourBoardDirectorMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 44 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1

CAPITAL LEASES (Details) - USD ($)

Mar. 31, 2018

Dec. 31, 2017

Capital Leases of Lessee [Abstract]

Capital lease obligations $ 114,970 $ 149,120

Unamortized warrant discount (8,346) (15,040)

Net obligations 106,624 134,080

Short-term portion of obligations (91,985) (118,553)

Long-term portion of obligations $ 14,639 $ 15,527

X

- Definition
Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.
+ References
No definition available.
+ Details

Name: cik0001435375_CapitalLeaseObligationsGross

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Information related to unamortized warrant discount.
+ References
No definition available.
+ Details

Name: cik0001435375_UnamortizedWarrantDiscount

Namespace Prefix: cik0001435375_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_CapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of capital lease obligation due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84164758&loc=d3e45023-112735
+ Details

Name: us-gaap_CapitalLeaseObligationsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84164758&loc=d3e45023-112735

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CapitalLeaseObligationsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_CapitalLeasesOfLesseeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 45 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1

CUSTOMER, SUPPLIER, COUNTRY AND PRODUCT CONCENTRATIONS (Details Narrative) - Customer
3 Months Ended

Mar. 31, 2018

Mar. 31, 2017

Customer Concentration Risk [Member] | Accounts Receivable Greater Than 10% [Member] | Customer [Member]

Number of customers 2

Customer Concentration Risk [Member] | Total Product Revenues [Member] | Customer One [Member]

Concentration of risk 83.00% 29.00%

Customer Concentration Risk [Member] | Total Product Revenues [Member] | Customer Two [Member]

Concentration of risk 22.00%

Product Concentration Risk [Member] | Total Product Revenues [Member] | Product One [Member]

Concentration of risk 83.00% 29.00%

Description of product
Graphene nanoplatelets materials, Grade C 500 m2/g

Grants and Licensing Revenue Concentration [Member] | Total Grant Revenue [Member] | Grantor One [Member]

Concentration of risk 94.00%

Grants and Licensing Revenue Concentration [Member] | Total Grant Revenue [Member] | Grantor Two [Member]

Concentration of risk 6.00%

Country Concentration Risk [Member] | Total Product Revenues [Member] | United Kingdom

Concentration of risk 24.00%

Country Concentration Risk [Member] | Total Product Revenues [Member] | Korea (South), Won

Concentration of risk 16.00%

Country Concentration Risk [Member] | Total Product Revenues [Member] | Foreign [Member]

Concentration of risk 3.00% 40.00%

X

- Definition
Represents the number of customers.
+ References
No definition available.
+ Details

Name: cik0001435375_NumberOfCustomers

Namespace Prefix: cik0001435375_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6351-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13531-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6404-108592

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13537-108611
+ Details

Name: us-gaap_ConcentrationRiskPercentage1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Description of risks that arise due to the volume of revenue generated by a particular product or other reliance placed on the success of that product, and the characteristics of that product that may give rise to the risk (for example, a patent or trademark expiration date). At a minimum, the description informs financial statement users of the general nature of the risk.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6351-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6327-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6404-108592
+ Details

Name: us-gaap_ConcentrationRiskProduct

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorCustomersAxis=cik0001435375_CustomerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorCustomersAxis=cik0001435375_CustomerOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorCustomersAxis=cik0001435375_CustomerTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ProductOrServiceAxis=cik0001435375_ProductOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=cik0001435375_GrantsAndLicensingRevenueConcentrationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=cik0001435375_GrantRevenueMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=cik0001435375_GrantorOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=cik0001435375_GrantorTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_GB

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=currency_KRW

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 46 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
3 Months Ended

Mar. 31, 2018

Mar. 31, 2017

POSCO [Member]

Royalty revenue $ 25,000

Licensing Agreement [Member] | Michigan State University (Patents and Pending Patents) [Member]

Licensing expenses $ 12,500 $ 12,500

Master Leasing Agreement [Member] | Aspen Advance Opportunity Fund, LP (AAOF) [Member] | Series A Preferred stock [Member]

Number of shares issued 7,140 7,140

X

- Definition
Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864
+ Details

Name: us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Revenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_RoyaltyRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cik0001435375_POSCOMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=cik0001435375_LicensingAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cik0001435375_MichiganStateUniversityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=cik0001435375_MasterLeasingAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=cik0001435375_AspenAdvanceOpportunityFundLPMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 47 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1

SUBSEQUENT EVENTS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended

May 14, 2018

Mar. 31, 2018

Mar. 31, 2017

Proceeds from issuance of common stock $ 1,615,400 $ 771,800

Subsequent Event [Member]

Number of shares issued 107,250

Proceeds from issuance of common stock $ 858,000

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

EXCEL 48 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 49 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 50 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 103 179 1 false 54 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://xgsciences.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) Sheet http://xgsciences.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) Sheet http://xgsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) Sheet http://xgsciences.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) Statements 4 false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (unaudited) Sheet http://xgsciences.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquityDeficit CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (unaudited) Statements 5 false false R6.htm 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) Sheet http://xgsciences.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION Sheet http://xgsciences.com/role/NatureOfBusinessAndBasisOfPresentation NATURE OF BUSINESS AND BASIS OF PRESENTATION Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://xgsciences.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - WARRANTS AND FINANCING AGREEMENTS Sheet http://xgsciences.com/role/WarrantsAndFinancingAgreements WARRANTS AND FINANCING AGREEMENTS Notes 9 false false R10.htm 00000010 - Disclosure - STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS Sheet http://xgsciences.com/role/StockWarrantsAccountedForAsEquityInstruments STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS Notes 10 false false R11.htm 00000011 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://xgsciences.com/role/StockholdersEquityDeficit STOCKHOLDERS' EQUITY (DEFICIT) Notes 11 false false R12.htm 00000012 - Disclosure - EQUITY INCENTIVE PLAN Sheet http://xgsciences.com/role/EquityIncentivePlan EQUITY INCENTIVE PLAN Notes 12 false false R13.htm 00000013 - Disclosure - CAPITAL LEASES Sheet http://xgsciences.com/role/CapitalLeases CAPITAL LEASES Notes 13 false false R14.htm 00000014 - Disclosure - CUSTOMER, SUPPLIER, COUNTRY AND PRODUCT CONCENTRATIONS Sheet http://xgsciences.com/role/CustomerSupplierCountryAndProductConcentrations CUSTOMER, SUPPLIER, COUNTRY AND PRODUCT CONCENTRATIONS Notes 14 false false R15.htm 00000015 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://xgsciences.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 15 false false R16.htm 00000016 - Disclosure - SUBSEQUENT EVENTS Sheet http://xgsciences.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 16 false false R17.htm 00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://xgsciences.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 17 false false R18.htm 00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://xgsciences.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://xgsciences.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 00000019 - Disclosure - STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Tables) Sheet http://xgsciences.com/role/StockWarrantsAccountedForAsEquityInstrumentsTables STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Tables) Tables http://xgsciences.com/role/StockWarrantsAccountedForAsEquityInstruments 19 false false R20.htm 00000020 - Disclosure - EQUITY INCENTIVE PLAN (Tables) Sheet http://xgsciences.com/role/EquityIncentivePlanTables EQUITY INCENTIVE PLAN (Tables) Tables http://xgsciences.com/role/EquityIncentivePlan 20 false false R21.htm 00000021 - Disclosure - CAPITAL LEASES (Tables) Sheet http://xgsciences.com/role/CapitalLeasesTables CAPITAL LEASES (Tables) Tables http://xgsciences.com/role/CapitalLeases 21 false false R22.htm 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://xgsciences.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://xgsciences.com/role/SummaryOfSignificantAccountingPoliciesTables 22 false false R23.htm 00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Sheet http://xgsciences.com/role/SummaryOfSignificantAccountingPoliciesDetails1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Details http://xgsciences.com/role/SummaryOfSignificantAccountingPoliciesTables 23 false false R24.htm 00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://xgsciences.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://xgsciences.com/role/SummaryOfSignificantAccountingPoliciesTables 24 false false R25.htm 00000025 - Disclosure - WARRANTS AND FINANCING AGREEMENTS (Details Narrative) Sheet http://xgsciences.com/role/WarrantsAndFinancingAgreementsDetailsNarrative WARRANTS AND FINANCING AGREEMENTS (Details Narrative) Details http://xgsciences.com/role/WarrantsAndFinancingAgreements 25 false false R26.htm 00000026 - Disclosure - STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Details) Sheet http://xgsciences.com/role/StockWarrantsAccountedForAsEquityInstrumentsDetails STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Details) Details http://xgsciences.com/role/StockWarrantsAccountedForAsEquityInstrumentsTables 26 false false R27.htm 00000027 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative) Sheet http://xgsciences.com/role/StockholdersEquityDeficitDetailsNarrative STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative) Details http://xgsciences.com/role/StockholdersEquityDeficit 27 false false R28.htm 00000028 - Disclosure - EQUITY INCENTIVE PLAN (Details) Sheet http://xgsciences.com/role/EquityIncentivePlanDetails EQUITY INCENTIVE PLAN (Details) Details http://xgsciences.com/role/EquityIncentivePlanTables 28 false false R29.htm 00000029 - Disclosure - EQUITY INCENTIVE PLAN (Details Narrative) Sheet http://xgsciences.com/role/EquityIncentivePlanDetailsNarrative EQUITY INCENTIVE PLAN (Details Narrative) Details http://xgsciences.com/role/EquityIncentivePlanTables 29 false false R30.htm 00000030 - Disclosure - CAPITAL LEASES (Details) Sheet http://xgsciences.com/role/CapitalLeasesDetails CAPITAL LEASES (Details) Details http://xgsciences.com/role/CapitalLeasesTables 30 false false R31.htm 00000031 - Disclosure - CUSTOMER, SUPPLIER, COUNTRY AND PRODUCT CONCENTRATIONS (Details Narrative) Sheet http://xgsciences.com/role/CustomerSupplierCountryAndProductConcentrationsDetailsNarrative CUSTOMER, SUPPLIER, COUNTRY AND PRODUCT CONCENTRATIONS (Details Narrative) Details http://xgsciences.com/role/CustomerSupplierCountryAndProductConcentrations 31 false false R32.htm 00000032 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://xgsciences.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://xgsciences.com/role/RelatedPartyTransactions 32 false false R33.htm 00000033 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://xgsciences.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://xgsciences.com/role/SubsequentEvents 33 false false All Reports Book All Reports cik0001435375-20180331.xml cik0001435375-20180331.xsd cik0001435375-20180331_cal.xml cik0001435375-20180331_def.xml cik0001435375-20180331_lab.xml cik0001435375-20180331_pre.xml http://xbrl.sec.gov/currency/2017-01-31 http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/dei/2014-01-31 http://xbrl.sec.gov/country/2017-01-31 true true ZIP 54 0001615774-18-003697-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001615774-18-003697-xbrl.zip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

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2018	May 14, 2018
Document And Entity Information
Entity Registrant Name	XG SCIENCES INC
Entity Central Index Key	0001435375
Document Type	10-Q
Document Period End Date	Mar. 31, 2018
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity a Well-known Seasoned Issuer	No
Entity a Voluntary Filer	No
Entity's Reporting Status Current	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		2,662,525
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2018

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
CURRENT ASSETS
Cash	$ 2,285,117	$ 2,845,798
Accounts receivable, less allowance for doubtful accounts of $40,000 at March 31, 2018 and December 31, 2017	668,040	468,623
Inventories	209,711	171,864
Other current assets	91,588	15,781
Total current assets	3,254,456	3,502,066
PROPERTY, PLANT AND EQUIPMENT, NET	3,266,797	2,601,571
RESTRICTED CASH FOR LETTER OF CREDIT	195,865	195,792
LEASE DEPOSIT	20,156	20,156
INTANGIBLE ASSETS, NET	574,579	571,938
TOTAL ASSETS	7,311,853	6,891,523
CURRENT LIABILITIES
Accounts payable and other current liabilities	1,332,951	858,077
Deferred revenue	189	7,298
Current portion of capital lease obligations	91,985	118,553
Total current liabilities	1,425,125	983,928
LONG-TERM LIABILITIES
Long-term portion of capital lease obligations	14,639	15,527
Long term debt	4,869,714	4,794,596
Total long-term liabilities	4,884,353	4,810,123
TOTAL LIABILITIES	6,309,478	5,794,051
STOCKHOLDERS' EQUITY
Preferred stock, value
Common stock, no par value, 25,000,000 shares authorized, 2,555,275 and 2,353,350 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively	20,741,574	19,116,012
Additional paid-in capital	7,899,722	7,831,958
Accumulated deficit	(49,641,638)	(47,767,544)
Total stockholders' equity	1,002,375	1,097,472
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	7,311,853	6,891,523
Series A Convertible Preferred Stock [Member]
STOCKHOLDERS' EQUITY
Preferred stock, value	$ 22,002,717	$ 21,917,046

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Allowance for doubtful accounts	$ 40,000	$ 40,000
Common stock, no par value (in dollars per share)	$ 0	$ 0
Common stock, authorized	25,000,000	25,000,000
Common stock, issued	2,555,275	2,353,350
Common stock, outstanding	2,555,275	2,353,350
Series A Convertible Preferred Stock [Member]
Preferred stock, authorized	3,000,000	3,000,000
Preferred stock, issued	1,864,956	1,857,816
Preferred stock, outstanding	1,864,956	1,857,816
Preferred stock, liquidation value	$ 22,379,472	$ 22,293,792

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
REVENUE
Product sales	$ 886,337	$ 157,700
Grants		99,489
Licensing revenue		25,000
Total revenues	886,337	282,189
COST OF GOODS SOLD
Direct costs	468,191	116,770
Unallocated manufacturing expenses	746,583	371,150
Total cost of goods sold	1,214,774	487,920
GROSS LOSS	(328,437)	(205,731)
OPERATING EXPENSES
Research and development	277,063	263,564
Sales, general and administrative	1,186,679	996,587
Total operating expenses	1,463,742	1,260,151
OPERATING LOSS	(1,792,179)	(1,465,882)
OTHER INCOME (EXPENSE)
Interest expense, net	(85,169)	(59,088)
Gain from change in fair value of derivative liability - warrants		29,171
Government incentives, net	3,253	(24)
Total other expense	(81,916)	(29,941)
NET LOSS	$ (1,874,095)	$ (1,495,823)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - Basic and diluted (in shares)	2,454,314	1,920,090
NET LOSS PER SHARE - Basic and diluted (in dollars per share)	$ (0.76)	$ (0.78)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (unaudited) - 3 months ended Mar. 31, 2018 - USD ($)	Preferred Stock (A) [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Balances at beginning at Dec. 31, 2017	$ 21,917,046	$ 19,116,012	$ 7,831,958	$ (47,767,544)	$ 1,097,472
Balances at beginning (in shares) at Dec. 31, 2017	1,857,816	2,353,350
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued for cash		$ 1,615,400			1,615,400
Stock issued for cash (in shares)		201,925
Stock issuance fees and expenses		$ (9,838)			(9,838)
Preferred stock issued to pay capital lease obligations	$ 85,671				85,671
Preferred stock issued to pay capital lease obligations (in shares)	7,140
Stock-based compensation expense		20,000	67,764		87,764
Net loss				(1,874,095)	(1,874,095)
Balances at ending at Mar. 31, 2018	$ 22,002,717	$ 20,741,574	$ 7,899,722	$ (49,641,638)	$ 1,002,375
Balances at ending (in shares) at Mar. 31, 2018	1,864,956	2,555,275

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,874,095)	$ (1,495,823)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	209,131	214,770
Amortization of intangible assets	12,934	10,590
Stock-based compensation expense	87,764	88,370
Non-cash interest expense	85,973	59,480
Non-cash equipment rent expense	53,082
Gain from change in fair value of derivative liability - warrants		(29,171)
Changes in current assets and liabilities:
Accounts receivable	(199,417)	14,680
Inventory	(37,847)	8,229
Other current and non-current assets	(75,881)	103,558
Accounts payable and other liabilities	467,765	17,576
NET CASH USED IN OPERATING ACTIVITIES	(1,270,591)	(1,007,741)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment	(874,357)	(203,664)
Purchases of intangible assets	(15,574)	(37,769)
NET CASH USED IN INVESTING ACTIVITIES	(889,931)	(241,433)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayments of capital lease obligations	(5,721)	(4,875)
Proceeds from issuance of common stock	1,615,400	771,800
Common stock issuance fees and expenses	(9,838)	(154,413)
NET CASH PROVIDED BY FINANCING ACTIVITIES	1,599,841	612,512
NET DECREASE IN CASH AND CASH EQUIVALENTS	(560,681)	(636,662)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	2,845,798	1,785,343
CASH AND CASH EQUIVALENTS AT END OF PERIOD	2,285,117	1,148,681
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	220
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING:
Value of preferred stock issued for AAOF capital lease obligations	85,671	85,672
Reclassification of derivative liability warrants to equity - ASU 2017-11 (see note 2)		$ 125,481

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Accounting Policies [Abstract]
Raw materials	$ 79,581	$ 39,841
Finished goods	130,130	132,023
Total	$ 209,711	$ 171,864

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)			1 Months Ended	3 Months Ended
	May 14, 2018	Apr. 13, 2016	Dec. 31, 2016	Mar. 31, 2018	Dec. 31, 2017	Mar. 31, 2017
Cash on hand			$ 1,785,343	$ 2,285,117	$ 2,845,798	$ 1,148,681
Proceeds from capital contribution				4,500,000
Series A Preferred stock [Member]
Derivative liability				972,720
Subsequent Event [Member]
Cash on hand	$ 1,660,600
The Dow Chemical Company [Member]
Equity capital raise amount				$ 5,000,000
Description of raising fund				Additional $5 million becomes available under the Dow Facility if we have raised $10 million of equity capital after October 31, 2016.
Draw Loan Note And Agreement [Member] \| Senior Secured Debt Financing [Member] \| The Dow Chemical Company [Member]
Face amount			$ 10,000,000	$ 4,869,714	$ 4,794,596
Interest rate (in percent)			5.00%
Equity capital raise amount			$ 7,007,024	$ 2,992,976
Description of raising fund			The remaining $5 million will become available to us once we have raised $10 million of equity capital after October 31, 2016.
Draw Loan Note And Agreement [Member] \| Senior Secured Debt Financing [Member] \| The Dow Chemical Company [Member] \| Subsequent Event [Member]
Equity capital raise amount	$ 5,000,000
IPO [Member]
Number of shares issued in offering		3,000,000		201,925
Price per share (in dollars per share)		$ 8.00
IPO [Member] \| Subsequent Event [Member]
Number of shares issued in offering	1,276,007
Price per share (in dollars per share)	$ 8.00
Gross proceeds from issued in offering	$ 10,208,056

WARRANTS AND FINANCING AGREEMENTS (Details Narrative) - USD ($)						1 Months Ended	3 Months Ended	12 Months Ended
	May 14, 2018	Dec. 04, 2017	Sep. 22, 2017	Jul. 18, 2017	Apr. 13, 2016	Dec. 31, 2016	Mar. 31, 2018	Dec. 31, 2017
IPO [Member]
Number of shares issued in offering					3,000,000		201,925
Price per share (in dollars per share)					$ 8.00
Subsequent Event [Member] \| IPO [Member]
Number of shares issued in offering	1,276,007
Price per share (in dollars per share)	$ 8.00
Proceeds from issuance initial public offering	$ 10,208,056
The Dow Chemical Company [Member]
Description of raising fund							Additional $5 million becomes available under the Dow Facility if we have raised $10 million of equity capital after October 31, 2016.
Equity capital raise amount							$ 5,000,000
Draw Loan Note And Agreement [Member] \| Senior Secured Debt Financing [Member] \| The Dow Chemical Company [Member]
Face amount						$ 10,000,000	4,869,714	$ 4,794,596
Proceeds from secured debt		$ 1,000,000	$ 1,000,000	$ 1,000,000		$ 2,000,000
Amortization expense of debt							$ 75,118	$ 161,702
Description of raising fund						The remaining $5 million will become available to us once we have raised $10 million of equity capital after October 31, 2016.
Number of shares purchased (in shares)							125,000
Description of conversion terms							Interest is payable beginning January 1, 2017 although we may elect to capitalize interest through January 1, 2019. Dow received warrant coverage of one share of common stock for each $40 in loans received by us, equating to 20% warrant coverage, with an exercise price of $8.00 per share for the warrants issued at closing of the initial $2 million draw.
Interest rate (in percent)						5.00%
Maturity date							Dec. 01, 2021
Equity capital raise amount						$ 7,007,024	$ 2,992,976
Draw Loan Note And Agreement [Member] \| Senior Secured Debt Financing [Member] \| The Dow Chemical Company [Member] \| Subsequent Event [Member]
Equity capital raise amount	$ 5,000,000

STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Details)	3 Months Ended
	Mar. 31, 2018 $ / shares shares
Number of Warrants	1,365,737
Warrant [Member]
Date Issued	Jul. 01, 2009
Expiration Date	Jul. 01, 2019
Exercise Price \| $ / shares	$ 8.00
Indexed stock	Common
Number of Warrants	6,000
Warrant 1 [Member]
Date Issued	Oct. 08, 2012
Expiration Date	Oct. 08, 2027
Exercise Price \| $ / shares	$ 12.00
Indexed stock	Common
Number of Warrants	5,000
Warrant 2 [Member]
Expiration Date	Jan. 15, 2024
Exercise Price \| $ / shares	$ 6.40
Indexed stock	Series A Convertible Preferred
Number of Warrants	972,720
Warrant 2 [Member] \| Minimum [Member]
Date Issued	Jan. 15, 2014
Warrant 2 [Member] \| Maximum [Member]
Date Issued	Dec. 31, 2014
Warrant 3 [Member]
Expiration Date	Apr. 30, 2022
Exercise Price \| $ / shares	$ 16.00
Indexed stock	Common
Number of Warrants	218,334
Warrant 3 [Member] \| Minimum [Member]
Date Issued	Apr. 30, 2015
Warrant 3 [Member] \| Maximum [Member]
Date Issued	May 26, 2015
Warrant 4 [Member]
Date Issued	Jun. 30, 2015
Expiration Date	Jun. 30, 2022
Exercise Price \| $ / shares	$ 16.00
Indexed stock	Common
Number of Warrants	6,563
Warrant 5 [Member]
Date Issued	Dec. 31, 2015
Expiration Date	Dec. 31, 2020
Exercise Price \| $ / shares	$ 8.00
Indexed stock	Common
Number of Warrants	20,625
Warrant 6 [Member]
Date Issued	Mar. 31, 2016
Expiration Date	Mar. 31, 2021
Exercise Price \| $ / shares	$ 10
Indexed stock	Common
Number of Warrants	10,600
Warrant 7 [Member]
Date Issued	Apr. 30, 2016
Expiration Date	Apr. 30, 2021
Exercise Price \| $ / shares	$ 10.00
Indexed stock	Common
Number of Warrants	895
Warrant 8 [Member]
Date Issued	Dec. 14, 2016
Expiration Date	Dec. 01, 2023
Exercise Price \| $ / shares	$ 8.00
Indexed stock	Common
Number of Warrants	50,000
Warrant 9 [Member]
Date Issued	Jul. 18, 2017
Expiration Date	Dec. 01, 2023
Exercise Price \| $ / shares	$ 8.00
Indexed stock	Common
Number of Warrants	25,000
Warrant 10 [Member]
Date Issued	Sep. 22, 2017
Expiration Date	Dec. 01, 2023
Exercise Price \| $ / shares	$ 8
Indexed stock	Common
Number of Warrants	25,000
Warrant 11 [Member]
Date Issued	Dec. 04, 2017
Expiration Date	Dec. 01, 2023
Exercise Price \| $ / shares	$ 8.00
Indexed stock	Common
Number of Warrants	25,000

EQUITY INCENTIVE PLAN (Details)	3 Months Ended
EQUITY INCENTIVE PLAN (Details)	Mar. 31, 2018 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options outstanding at beginning of year \| shares	677,125
Changes during the year:
Expired \| shares
New Options Granted - at market price \| shares	10,000
Exercised \| shares
Options outstanding at end of Period \| shares	687,125
Options exercisable at end of Period \| shares	337,158
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [RollForward]
Options outstanding at beginning of year \| $ / shares	$ 8
Changes during the year:
Expired \| $ / shares
New Options Granted - at market price \| $ / shares	8
Exercised \| $ / shares
Options outstanding at end of Period \| $ / shares	8
Options exercisable at end of Period \| $ / shares	$ 8

EQUITY INCENTIVE PLAN (Details Narrative) - USD ($)			3 Months Ended
EQUITY INCENTIVE PLAN (Details Narrative) - USD ($)	Aug. 10, 2017	Jul. 24, 2017	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Number of option granted			10,000
Exercise price (in dollars per share)			$ 8
Stock-based compensation expense			$ 87,764	$ 88,370
Proceeds from option granted			$ 28,755
Number of option outstanding			687,125		677,125
Incentive Stock Option Plan [Member]
Vesting percent, per year			20.00%
Description of vesting terms			Vesting of the options ranges from immediate to 20% per year, with most options vesting on a straight-line basis over a four-year period from the date of grant.
Description of vesting terms of replacement options			Vesting of the options ranges from immediate to 20% per year, with most options vesting on a straight-line basis over a four-year period from the date of grant.
Options expiration year			7 years
2007 Stock Option Plan [Member]
Unrecognized compensation cost			$ 89,500
Description of vesting terms		Fifty percent of such awards vested on the date of grant with the remaining vesting over a 4-year period
Exercise price (in dollars per share)		$ 8.00
Vesting period		7 years
Description of cancellation terms		Each option holder received options equal to 150% of the number of cancelled stock options.
Stock price			$ 8.00
Exercise Price			$ 8.00
Expected Term			4 years 9 months
Dividend rate			0.00%
Volatility			37.34%
Risk free rate			2.65%
2007 Stock Option Plan [Member] \| Restricted Stock [Member]
Number of option outstanding			10,000
2007 Stock Option Plan [Member] \| Restricted Stock [Member] \| Four Diretors [Member]
Number of option granted	2,500
Compensation cost			$ 60,000
Aggregate grant date fair value	$ 80,000
Number of shares vested (in shares)			7,500
2007 Stock Option Plan [Member] \| Stock Option [Member]
Number of option outstanding			687,125
2007 Stock Option Plan [Member] \| Stock Option [Member] \| Four Diretors [Member]
Number of option granted	2,500
Description of vesting terms	The options vest ratably over a four-year period beginning on the one-year anniversary.
Exercise price (in dollars per share)	$ 8.00
Aggregate grant date fair value	$ 26,120
2007 Stock Option Plan [Member] \| Maximum [Member]
Maximum number of options authorized			1,200,000

CAPITAL LEASES (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Capital Leases of Lessee [Abstract]
Capital lease obligations	$ 114,970	$ 149,120
Unamortized warrant discount	(8,346)	(15,040)
Net obligations	106,624	134,080
Short-term portion of obligations	(91,985)	(118,553)
Long-term portion of obligations	$ 14,639	$ 15,527

CUSTOMER, SUPPLIER, COUNTRY AND PRODUCT CONCENTRATIONS (Details Narrative) - Customer	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Customer Concentration Risk [Member] \| Accounts Receivable Greater Than 10% [Member] \| Customer [Member]
Number of customers	2
Customer Concentration Risk [Member] \| Total Product Revenues [Member] \| Customer One [Member]
Concentration of risk	83.00%	29.00%
Customer Concentration Risk [Member] \| Total Product Revenues [Member] \| Customer Two [Member]
Concentration of risk		22.00%
Product Concentration Risk [Member] \| Total Product Revenues [Member] \| Product One [Member]
Concentration of risk	83.00%	29.00%
Description of product	Graphene nanoplatelets materials, Grade C 500 m2/g
Grants and Licensing Revenue Concentration [Member] \| Total Grant Revenue [Member] \| Grantor One [Member]
Concentration of risk		94.00%
Grants and Licensing Revenue Concentration [Member] \| Total Grant Revenue [Member] \| Grantor Two [Member]
Concentration of risk		6.00%
Country Concentration Risk [Member] \| Total Product Revenues [Member] \| United Kingdom
Concentration of risk		24.00%
Country Concentration Risk [Member] \| Total Product Revenues [Member] \| Korea (South), Won
Concentration of risk		16.00%
Country Concentration Risk [Member] \| Total Product Revenues [Member] \| Foreign [Member]
Concentration of risk	3.00%	40.00%

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
POSCO [Member]
Royalty revenue		$ 25,000
Licensing Agreement [Member] \| Michigan State University (Patents and Pending Patents) [Member]
Licensing expenses	$ 12,500	$ 12,500
Master Leasing Agreement [Member] \| Aspen Advance Opportunity Fund, LP (AAOF) [Member] \| Series A Preferred stock [Member]
Number of shares issued	7,140	7,140

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
SUBSEQUENT EVENTS (Details Narrative) - USD ($)	May 14, 2018	Mar. 31, 2018	Mar. 31, 2017
Proceeds from issuance of common stock		$ 1,615,400	$ 771,800
Subsequent Event [Member]
Number of shares issued	107,250
Proceeds from issuance of common stock	$ 858,000